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Eukaryotic gene expression begins with transcription of DNA into RNA by 
RNA polymerases and for protein coding genes is followed by translation into 
protein in the cytoplasm. Production of functioning mature RNA relies on proper 
processing events including 5’ capping, splicing and 3’ end processing. 
Endonucleases that cleave RNA are vital for these processing events and are 
involved in degradation pathways that may also be relevant for the turnover of 
aberrant transcripts. Studies investigating transcription, processing events and 
degradation pathways of RNA have generally focused on RNA polymerase II 
transcripts, which includes protein-coding genes. Many of these pathways were 
elucidated by studies in yeast due to the high conservation of the transcription 
process between yeast and metazoans.  
The discovery and development of CRISPR/Cas9 mediated genome 
editing techniques have led to a more complete and direct approach to study 
specific protein functions, within human cells, than previous methods such as 
RNAi. In this study, a combination of CRISPR/Cas9 with protein tags including 
the auxin inducible degron and small molecule assisted shut-off, allowed rapid 
and conditional protein depletion in human cell lines for three endonucleases, 
DIS3, INTS11 and CPSF73. These endonucleases cooperate with accessory 
proteins and actively transcribing polymerase complexes to target a broad range 
of RNA transcripts, to ensure proper RNA processing and integrity of the 
transcriptome. Generation of these cell lines, coupled with high-throughput RNA 
sequencing analysis of nuclear transcriptomes, helped to elucidate specific 
substrates for each endonuclease. The following work shows the effects of 
aberrant processing in a variety of transcripts, their subsequent potential 
degradation and what happens when a major degradation pathway is disrupted. 
A major finding in this study was disruption of 3’ end processing in protein coding 
mRNA resulted in extensive readthrough and termination defects, whereas 3’ end 
misprocessing in smaller RNA species including snRNAs and replication 
dependent histones results in a much smaller extension and termination that 
occurs relatively close to the gene transcription end site.  Additionally,  this works 
shows the importance of the exosome subunit, DIS3, in maintaining appropriate 
gene expression and RNA environment, whilst suggesting aberrant RNA 
processing may commonly occur in human cells.  
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1.1 RNA Polymerase II and transcription 
RNA polymerase II (Pol II) is a 12 subunit complex that transcribes protein-
coding RNA (messenger RNA / mRNA) and a variety of functional non-coding 
RNA (ncRNA) including small nuclear RNA (snRNA), small nucleolar RNA 
(snoRNA), histones and a plethora of as yet uncharacterised transcripts. The 
catalytic and largest component of Pol II is Rpb1, whose C terminal domain 
(hereafter referred to as CTD), contains numerous tandem heptad repeats. 
These repeats consist of the amino acid consensus sequence Tyr1 - Ser2 - Pro3 
- Thr4 - Ser5 - Pro6 - Ser7, with humans having 52 repeats compared to yeast 
with 26 (Corden, 1990).  
 Post-transcriptional modifications occur frequently on the CTD, principally 
phosphorylation at Ser 2 and Ser 5 residues of the heptad repeats by cyclin-
dependent kinases (CDKs), although phosphorylation at other residues has been 
observed (Heidemann et al, 2013). The phosphorylation state of the CTD 
influences transcription by acting as a platform for multiple transcription factors 
and other protein complexes. This in turn regulates the three different stages of 




Transcription initiation requires recruitment of Pol II to the DNA promoter 
alongside transcription factors (TFs) and an open chromatin structure. Five TFs 
recognise the TATA-box domain located approximately 25 – 30 nucleotides (nt) 
upstream of many gene promoters and form the pre-initiation complex (PIC) by 
binding to the TATA-box. Pol II, with an unphosphorylated CTD, binds to the PIC 
and initiates recruitment of TFs including helicases that unwind the DNA and 
CDKs for phosphorylation (Krishnamurthy and Hampsey, 2009).  
Pol II release from the initiation complex, allowing it to move into an early 
elongation phase, is believed to be initiated by CDK7 phosphorylation of the CTD 
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at Ser5 as Pol II moves along the promoter (Glover-Cutter et al, 2009). At 20 – 
60 nts downstream of the transcription start site (TSS), Pol II is paused at a 
promoter-proximal pause site (Guenther et al, 2007; Kwak et al, 2013). Negative 
Elongation Factor (NELF) and DRB-sensitivity-inducing factor (DSIF) facilitate 
Pol II proximal-pausing in a large number of genes (Ping and Rana, 2001). During 
this pause, a 5’ cap is added to nascent RNA and positive elongation factor b (P-
TEFb) is recruited to reverse the elongation inhibition effects of NELF (Peterlin 
and Price, 2006). P-TEFb contains a kinase subunit CDK9 and is an important 
factor for Pol II release from the pause site and move to elongation. CDK9 
phosphorylates NELF, DSIF and the CTD at Ser 2. These interactions in part 
regulate the release of paused Pol II by recruiting necessary processing factors, 
releasing NELF from Pol II, converting DSIF to a positive elongation factor and 
reorganising TFs. A CTD phosphorylated at both Ser 5 and Ser 2 is a hallmark of 
Pol II transition to elongation (Liu et al, 2015; Kwak and Lis, 2013).  
 
1.1.2 Elongation 
During elongation toward the 3’ end, phosphorylation of Ser 5 is gradually 
removed whereas phosphorylation of Ser 2 accumulates, peaking towards the 3’ 
end of genes (Davidson et al, 2014; Mayer et al, 2010; Tietjen et al, 2010; Kim et 
al, 2010a). Elongation factors are recruited to Pol II and enable it to elongate at 
a high rate (approximately 4 Kb / minute) (Singh and Padgett, 2009).  However, 
throughout the gene there are variations in the transcription elongation rate and 
this may be due to a few factors. Firstly, the rate of transcription can be restricted 
by histone marks causing tightening of DNA binding around nucleosomes and 
vice versa. Secondly, transcription can be hindered by GC rich DNA areas, which 
may cause R-loops, or facilitated by elongation factors, histone chaperones and 
nucleosome remodellers maintaining elongation conducive chromatin (Jonkers 
and Lis, 2015).  
Although Pol II rapidly elongates in a 5’ to 3’ direction, Pol II also performs 
retrograde motion during elongation, known as backtracking that is triggered by 
a weak DNA-RNA hybrid. During backtracking, the active site of Pol II becomes 
dissociated from the 3’ end of RNA, leading to transcriptional arrest (Nudler et al, 
1997). These backtracking-mediated pauses in transcription are important for 
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transcriptional regulation and processing of many genes (Nudler, 2012). In 
eukaryotic cells, backtracked Pol II elongation complexes can be corrected by 
transcript cleavage factors (TFIIS / SII) (Reinberg and Roeder, 1987). These 
factors promote cleavage of the extruded 3’ transcript end to produce a new 3’ 
end that realigns with the Pol II active site, allowing transcription to continue 
(Izban and Luse, 1992). Mutations in TFIIs inhibited intrinsic Pol II transcript 
cleavage and prevented both transcription through pause sites and elongation 
(Sigurdsson et al, 2010). 
 
1.1.3 Termination 
Termination pathways of Pol II transcription vary between mRNA and 
ncRNA genes. The termination pathway is thought to be defined by specific 
termination signals on the nascent RNA and distinctive phosphorylation patterns 
of the CTD. Currently there are three main pathways of Pol II termination 
described in metazoans that generate either mRNAs, snRNAs or replication-
dependent histone encoding transcripts. However, the most studied termination 
pathway is that of mRNAs. 
It is commonly believed that the poly(A) site (PAS) is required for 
termination of mRNAs, with Pol II pausing after transcription of the PAS 
increasing transcription termination efficiency and facilitating selection of 
alternative PAS sites (Fusby et al, 2016; Eaton et al, 2018). This is supported by 
studies that observed Pol II accumulation around the PAS (Gromak et al, 2006; 
Glover-Cutter et al, 2008). As previously mentioned, toward the 3’ end of genes 
the CTD becomes highly phosphorylated on Ser 2. Inhibition of Ser 2 
phosphorylation in metazoan cells leads to impaired recruitment of processing 
factors at 3’ ends of genes and defects in mRNA polyadenylation (Ni et al, 2004). 
Therefore CTD Ser 2 phosphorylation enhances recruitment of processing 
factors.  
Recruitment of processing factors include cleavage and polyadenylation 
specificity factor (CPSF) and cleavage stimulation factor (CstF) complexes, which 
recognise the AAUAAA hexamer and G / U rich sequences, respectively, of the 
PAS (Proudfoot et al, 2011). Co-transcriptional cleavage of transcripts occurs 18 
– 30 nts downstream of the PAS by the endonuclease CPSF component, 
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CPSF73, which forms a heterodimer with CPSF100. This cleavage releases the 
nascent RNA, allowing polyadenylation factors to bind to the 3’ end.  
Observations that cleavage was required for termination lead to the 
development of the “torpedo” model of transcription termination. In this model, 
Pol II continues to transcribe a downstream transcript after cleavage. For 
termination to occur, this downstream transcript is degraded by a 5’ – 3’ 
exoribonuclease, namely Rat 1 in yeast (Kim et al, 2004) and the  homolog XRN2 
in humans (West et al, 2004). Upon the exoribonuclease reaching transcribing 
Pol II, it acts as a trigger to release Pol II from the DNA and therefore cause 
termination. XRN2 termination is enhanced by pausing of Pol II which may be 
caused by R-loops. R-loops are a nucleic acid structure consisting of two 
antiparallel DNA strands and a RNA strand, creating a DNA:RNA hybrid that 
particularly form over G-rich terminator elements (Skourti-Stathaki et al, 2011). 
Interestingly, the homolog of yeast Sen1, Senataxin (SETX), may also play a role 
in termination of some mRNAs (Suraweera et al, 2009; Wagschal et al, 2012). 
SETX is a RNA:DNA helicase and may facilitate XRN2 degradation of 
downstream transcripts by resolving R-loops and exposing DNA.  
 An alternative method for transcription termination is the “allosteric” model. 
It is proposed that transcription of the PAS causes a conformational change in 
the Pol II elongation complex. This change leads to termination by recruitment of 
termination factors and / or dissociation of elongation factors (Logan et al, 1987;). 
Support for this model has come from studies showing cleavage is not required 
for termination and thus disputing the “torpedo” model (Osheim et al, 1999; 
Osheim et al, 2002). Additionally, Zhang et al (2015a) observed PAS-dependent 
termination could occur without the requirement of cleavage. However, a more 
recent study argues against a cleavage independent method for transcription 
termination (Eaton et al, 2018). They showed CPSF73 loss caused extensive 
read-through transcription and that catalytically inactive CPSF73 could not 






1.1.4 Structure and biology of eukaryotic mRNA 
In eukaryotes, after transcription of a gene, a pre-mRNA is produced that 
then undergoes multiple processing events to become a mature mRNA, some of 
which occur co-transcriptionally (Proudfoot et al, 2002). A mature mRNA contains 
a 5’ cap, which consists of a guanine nucleotide connected to the mRNA via a 5’ 
– 5’ triphosphate linkage; the mRNA is polyadenylated at the 3’ end, where 
approximately 200 adenosine residues are added to form the poly(A) tail; and 
mature mRNA are spliced, meaning the introns are removed from the pre-mRNA 
and exons ligated together to form mature mRNA (Proudfoot et al, 2002). 
Between the cap and coding sequence of the mRNA, there is a 5’ untranslated 
region (UTR) that regulates translation of a transcript and is commonly not 
translated itself (Moore, 2005). Similarly, there is a 3’ UTR found between the 
coding sequence and poly(A) tail of mRNA. These UTRs have roles in mRNA 
export, localisation, stability and translation efficiency (Matoulkova et al, 2012).  
Mature mRNA is recognised by its processed modifications and exported 
from the nucleus into the cytoplasm, by cap binding proteins and the TREX 
complex, where it can be translated into a protein (Katahira, 2012). At the 
ribosome, the coding region of mature mRNA is translated into a protein. Upon 
the small ribosomal subunit, attached to the mRNA, reaching the start codon 
(commonly AUG) the large ribosomal subunit and the initiation tRNA join. The 
ribosome reads the coding sequence in a set of 3 nts, called a codon. A tRNA 
corresponding to the codon sequence transfers an amino acid to the growing 
polypeptide chain, continuing until the ribosomal subunits reach the stop codon 
and the polypeptide is released. The polypeptide then undergoes folding to 









1.2 Diverse transcripts of Pol II  
Pol II not only transcribes mRNAs, but it also produces RNA transcripts 
that lack polyadenylation including: snRNAs and replication-dependent histones 
(RDH). snRNAs play a critical role in mRNA processing, formation of the 
spliceosome, regulation of transcription factors, expression and processing of 
histone mRNA and ribosomal RNA (rRNA) biosynthesis. The majority of RDH 
proteins, which act to package newly replicated DNA into chromatin, are encoded 
by RDH genes which are physically linked in large genome clusters (Marzluff et 
al, 2002). RDH and snRNA transcripts have alternative processing and 
transcription pathways than described above. However, some mechanisms do 
overlap, for example the CTD appears to play a role in 3’ end processing of both 
snRNAs and RDHs and CPSF73 is involved in cleavage of protein-coding 
mRNAs and RDH pre-mRNA (Jacobs et al, 2004; Hsin et al, 2011).  
 
1.2.1 RDH processing 
RDH genes are rapidly transcribed in the S-phase of the cell cycle, to 
coordinate with DNA replication and generally lack both introns and 
polyadenylation, instead having a conserved stem-loop at their 3’ untranslated 
region (UTR). Downstream of the stem-loop, RDHs contain a purine-rich histone 
downstream element (HDE) and cleavage of RDH pre-mRNA occurs in-between 
the stem loop and HDE regions. For processing to occur, a stem-loop binding 
protein (SLBP) binds to the stem-loop region and a small nuclear 
ribonucleoprotein, U7 snRNP, binds to the HDE (Dominski and Marzluff, 2007). 
U7 snRNP contains a heptameric Sm ring and U7 snRNA with a complementary 
sequence to the HDE at its 5’ end to allow base-pairing binding to the HDE. SLBP 
is thought to stabilise U7 snRNP binding to RDH pre-mRNA, possibly by 
interaction with the U7 snRNP subunit ZFP100 (Dominski et al, 2002).  
Lsm10 and Lsm11 are U7 snRNP specific subunits, replacing 
spliceosomal SmD1 and SmD2 in the Sm ring (Pillai et al, 2001; Pillai et al; 2003). 
Lsm11 contains an extended N-terminal domain that interacts with Flice-
associated huge protein (FLASH) and ZFP100 (Yang et al, 2009a; Wagner and 
Marzluff, 2006). Together, Lsm11 and FLASH form a docking platform that 
recruits the histone cleavage complex (HCC), consisting of multiple 
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polyadenylation subunits including CPSF100 (homolog to Integrator subunit 9), 
Symplekin and CPSF73 endonuclease. CPSF73 is part of the b-CASP (metallo-
b-lactamase-associated CPSF Artemis SNM1/PSO2) family, whose protein 
members contain features amicable for endonuclease function. CPSF100 is also 
a b-CASP protein, however critical residues in the active site are altered 
suggesting it is catalytically inactive (Mandel et al, 2006; Callebaut et al, 2002). 
Similar to cleavage of protein-coding mRNAs, CPSF73 is responsible for the 
cleavage of RDH pre-mRNA (Dominski et al, 2005) (Figure 1.1).  
As observed in both humans and Drosophila melanogaster, misprocessing 
of RDH pre-mRNA leads to their polyadenylation due to read-through and the 
usage of a secondary downstream polyadenylation signal (Kari et al, 2013; 
Romeo et al, 2014; Sullivan et al, 2009). In contrast to properly processed RDH 
mRNA, these polyadenylated histones are stable throughout the cell cycle 
(Levine et al, 1987).  
The description above for RDH pre-mRNA processing may not be the full 
story however. Recently, Pettinati et al (2018) found another protein that appears 
to have a critical role in RDH 3’ processing and showed that it has 
endoribonucleolytic activity in vitro. MBL domain containing protein 1 (MBLAC1) 
contains a MBL domain with similar di-zinc ion binding to CPSF73, although they 
have differing active site flanking loops and only CPSF73 contains a b-CASP 
domain. Depletion of MBLAC1 in HeLa cells caused a cell cycle defect, with 
accumulation of cells in G1 / early S phase. Additionally, read-through of 
approximately 200 bp downstream of the RDH transcription end site (TES) was 
observed when CPSF73 and MBLAC1 were depleted, with both genes 
expressing a similar transcription termination defect pattern for RDHs.  It was 
suggested that MBLAC1 and CPSF73 may selectively affect different RDH pre-











Figure 1.1: Replication-dependent histone (RDH) processing 
The stem loop binding protein (SLBP) binds to the stem-loop of RDH pre-mRNA 
and aids in stabilization of U7 snRNP binding to the RDH pre-mRNA at the 
histone downstream element (HDE). Within the heptameric Sm ring structure of 
U7 snRNP are two spliceosomal subunits, Lsm10 and Lsm11. Lsm11 interacts 
with FLASH and together they recruit the histone cleavage complex (HCC). The 
HCC includes CPSF100, Symplekin and CPSF73, the latter of which is 
responsible for cleavage of the pre-mRNA between the stem loop and HDE. 
Overall this produces unpolyadenylated mature RDH mRNAs. For simplicity, 






snRNAs are uridine-rich, approximately 60 – 200 nts long and play a 
critical role in spliceosome formation. They are transcribed by Pol II, with the 
exception of U6 snRNA which is transcribed by RNA polymerase III. snRNAs are 
not polyadenylated, they do not contain a TATA-box sequence and lack introns. 
Similar to histone genes, snRNAs are also found within clusters of the genome 
and have multiple copies (Chen and Wagner, 2010). The promoter of snRNAs 
contain two elements: an enhancer-like distal sequence element (DSE) that 
recruits transcription factors Oct1 and Sp1 and a proximal sequence element 
(PSE). The PSE, as well as specific phosphorylation of the CTD and a consensus 
sequence (3’ box) located 9 – 19 nts downstream of the snRNA coding region, 
are required for 3’ end snRNA processing (Chen and Wagner, 2010).  
Transcription initiation and the phosphorylation pattern of the CTD differs 
at snRNA genes, compared to protein-coding genes as previously described. In 
brief, initiation is mediated by the snRNA activator protein complex binding to the 
PSE, which recruits Pol II to the promoter. After Pol II recruitment, Ser 5 is 
phosphorylated by the CDK7 subunit of TFIIH. In addition, CTD Ser 7 is also 
phosphorylated by CDK7, has been shown to be essential for processing and 
facilitates interactions with a snRNA processing complex (Egloff et al, 2007; 
Egloff et al, 2010). Ser 7 phosphorylation may allow interaction with RNA 
Polymerase II Associated Protein II (RPAPII), which dephosphorylates Ser 5 as 
Pol II transcribes the snRNA and recruits snRNA 3’ end processing factors (Egloff 
et al 2011).  
Conversely, Hsin et al (2014) mutated Ser 7 to an alanine in a chicken 
DT40 cell line and found no defects on snRNA levels or processing.  This 
discrepancy may be a result of the use of chicken vs human cell lines, although 
this seems unlikely as there is a high degree of conservation in snRNA genes 
and their processing factors. Alternatively, findings from Egloff et al may be linked 
to their use of a-amanitin. Treatment with a-amanitin can increase degradation 
of some proteins, including DSIF, which plays a role in snRNA expression (Tsao 
et al, 2012; Yamamoto et al, 2014; Laitem et al, 2015). Thus the observed 
phenotype may be due to a reduction in DSIF accumulation and not due to the 
Ser 7 phosphorylation state. As snRNAs are relatively short transcripts, Ser 2 
CTD phosphorylation for efficient elongation as seen in mRNAs is not required. 
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However, Ser 2 phosphorylation by P-TEFb instead plays an important role in 
snRNA 3’ end formation (Medlin et al, 2005). It is thought PTEFb phosphorylates 
Ser 2 near the 3’ end of snRNA genes and with Ser7 allows recruitment of 
necessary snRNA 3’ end processing factors, specifically INTS9 and INTS11 
subunits belonging to the Integrator complex (Zaborowska et al, 2016; Egloff et 
al 2010) (Figure 1.2).  
 
1.2.3 snRNA 3’ end processing and termination 
Integral to snRNA processing is a complex called the Integrator (Baillat et 
al, 2005; Ezzeddine et al, 2011). The Integrator is formed of 12 - 14 subunits, 
including a homolog of CPSF73 (INTS11) and a homolog of CPSF100 (INTS9). 
In humans, these proteins are numbered in order of predicted molecular mass, 
with INTS1 having the largest mass (Chen and Wagner, 2010). The Integrator is 
recruited to the snRNA promoter, possibly through RPAPII, and associates with 
the CTD, travelling with Pol II as it transcribes the snRNA. Upon transcription and 
recognition of the 3’ box, the nascent 3’ snRNA is cleaved by the catalytic 
endonuclease subunit of the Integrator, INTS11 (Baillat et al, 2005). INTS9 and 
INTS11 form a heterodimeric complex that is thought to be functionally required 
for snRNA 3’ end processing and are recruited later than other Integrator subunits 
(Dominski et al, 2005; Albrecht and Wagner, 2012; Egloff et al, 2011) (Figure 
1.2). They are also members of the b-CASP family, however INTS9 contains the 
same amino acid changes that are suggested to inactivate catalytic activity in 
CPSF100 (Chen and Wagner, 2010). Depletion of INTS9 and INTS11 has been 
shown to cause accumulation of misprocessed snRNA (Ezzeddine et al, 2011; 
Baillat et al, 2005). Recently, depletion of the integrator subunit 4 (INTS4) was 
shown to have a similar defect in snRNA processing to that observed upon INTS9 
or INTS11 depletion. It was also reported that INTS4 specifically interacts with 
the INTS9 / INTS11 heterodimer to potentially form a heterotrimeric integrator 
cleavage module (Albrecht et al, 2018).   
Cleavage of precursor snRNA into mature snRNA is linked with efficient 
transcription termination, as demonstrated by disruption of snRNA termination 
causing inefficient snRNA processing and vice versa (Ramamurthy et al, 1996; 






Figure 1.2 Pol II phosphorylation and recruitment of the Integrator at snRNA 
genes  
After recruitment of Pol II to the TSS of a snRNA gene, TFIIH phosphorylates the  
Pol II CTD at Ser 5 and Ser 7 through its CDK7 subunit. Phosphorylated Ser7 
interacts with RPAPII, which recruits the Integrator complex. It is thought that 
catalytic subunits INTS9 and INTS11 are not recruited at this time. As Pol II 
transcribes the snRNA, Ser5 is dephosphorylated by RPAPII and the CDK9 
subunit of PTEFb phosphorylates Ser2 near the 3’ end of the snRNA. This 
phosphorylation state of Pol II may then allow recruitment of the INTS9/INTS11 
heterodimer and therefore snRNA 3’ end processing. Figure adapted from Guiro 
and Murphy (2017).  
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Currently, the mechanisms of snRNA transcription termination are not fully 
understood although it has been suggested chromatin structure, polyadenylation 
factors and both DSIF and NELF play a role (Egloff et al, 2009; O’Reilly et al, 
2014; Yamamoto et al 2014). Interestingly, NELF knockdown causes Pol II to 
transcribe past the 3’ box, creating read-through transcripts and suggesting NELF 
is essential for proper transcription termination (Yamamoto et al, 2014). NELF 
was commonly believed to act only at promoter-proximal regions (Sun et al, 
2011). Consistent with this, ChIP analysis confirmed NELF signal accumulated 
around the TSS of beta-actin mRNA compared to 300 bp downstream. 
Conversely, these findings weren’t replicated in snRNA. NELF signal was higher 
at 180 and 370 bp downstream compared to the TSS of U1 snRNA, showing a 
difference in NELF localisation at these genes. In addition, NELF was found to 
interact with the Integrator and knockdown caused accumulation of uncleaved 
snRNAs (Yamamoto et al, 2014).  
 
1.2.4 Additional functions of the Integrator 
Findings from more recent studies have implicated a role for the Integrator 
in other aspects of transcriptional regulation. Firstly, Skaar et al (2015) found that 
the Integrator not only has a role in snRNA termination, but also termination of 
RDHs and genes with polyadenylated mRNAs. HIT-Seq and ChIP-Seq methods 
were utilised and the authors found extensive binding of the Integrator to the 3’ 
end of RDHs. Depletion of Integrator subunit, INTS3, caused a significant 
increase in unprocessed RDH transcripts with poly(A) tails.  Furthermore, INTS3 
knockdown resulted in an increased localisation of Pol II downstream of RDH 
genes, suggesting a defect in Pol II termination. The Integrator was also found 
localised at the TSS of various gene types, reflecting binding of DSIF and NELF 
at these same locations.  Binding of the Integrator at promoter-proximal sites was 
found to negatively regulate expression of genes with polyadenylated mRNAs 
(Skaar et al, 2015).  
 The Integrator also functions in initiation and Pol II pause-release at 
protein-coding genes. As discussed previously, P-TEFb is responsible for 
phosphorylation of multiple units at the proximal-pause site of protein-coding 
mRNAs which leads to Pol II pause-release. P-TEFb also exists as an active 
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factor of the larger multi-subunit super elongation complex (SEC) (Lin et al, 2010; 
Luo et al, 2012). Gardini et al (2014) used epidermal growth factor (EGF) in HeLa 
cells to promote transcription of immediate early genes (IEGs) by Pol II, which 
are known for their regulation through Pol II pause-release. They found the 
Integrator was necessary for recruitment of SEC-containing P-TEFb to paused 
Pol II, leading to Pol II pause-release and elongation. EGF stimulation caused a 
robust increase in Integrator occupancy at IEG TSS and 3’ ends, as well as the 
TSS and body of EGF-responsive genes, suggesting the Integrator remains 
associated with elongating Pol II at these genes. Depletion of Integrator subunits 
INTS1 or INTS11 caused a loss of EGF-response. Diminished transcriptional 
activation, decrease in Pol II occupancy of nascent RNA and abolishment of two 
SEC components to IEGs was observed upon INTS11 depletion. Overall these 
findings suggest the Integrator has additional roles at protein coding genes, by 
association with the SEC complex and facilitating initiation and pause-release.  
 In support of an Integrator role in Pol II pause-release, Stadelmayer et al 
(2014) found the Integrator regulates NELF-mediated Pol II pause-release at 
coding genes. Genes bound by NELF and INTS3 showed a decreased pausing 
index and lower Pol II occupancy at the TSS. Depletion of INTS3 reduced Pol II 
occupancy over NELF-regulated genes, whereas INTS11 depletion increased 
Pol II occupancy at promoters bound by NELF and INTS3 but not at the 3’ end. 
This resulted in defective RNA processing and is in accord with the Integrator 
recruiting SEC to promote elongation. However, Stadelmayer et al (2014) 
contrasts the findings of Gardini et al (2015) that showed INTS11 knockdown 
decreased Pol II occupancy. This may highlight the two functions of NELF in 
reducing transcription in non-induced conditions, whilst at the promoter helping 
to maintain open chromatin structure. Alternatively, this contrast may reflect the 
differences in cellular context and gene type, with Gardini investigating IEGs and 
Stadelmayer focusing on genes with increased transcription upon NELF and 
Integrator depletion. Regardless, both studies promote a role for the Integrator in 
transcriptional regulation of protein coding genes.  
 The additional functions of the Integrator discussed here are only some of 
the roles that have been postulated. Studies have reported a role of the Integrator 
in eRNA biogenesis, DNA damage response and viral miRNA biogenesis (Lai et 
al, 2015;  Skaar et al, 2009; Cazalla et al, 2011; Xie et al, 2015). This list is not 
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extensive, but it does suggest the Integrator is important for a number of 
biological processes, with mutations or altered expression changes in Integrator 
genes being linked to several diseases (Rienzo and Casamassimi, 2016).  
 
1.2.5 Cryptic transcripts 
In addition to mRNA, Pol II also transcribes other types of polyadenylated 
transcripts. A cryptic transcript is a broad term for transcribed RNA that is highly 
unstable, meaning it is normally rapidly degraded and not detected in the cell. 
Upon depletion or defects in nuclear RNA surveillance pathways, these cryptic 
transcripts are revealed. In yeast these short, capped and polyadenylated 
transcripts are known as cryptic unstable transcripts (CUTs), which were found 
to be widely stabilised upon loss of a catalytic subunit of the exosome, Rrp6, that 
is responsible for degradation of RNA. CUTs are normally targets for degradation 
by the Nrd1-exosome-TRAMP complexes, immediately after synthesis (Wyers et 
al, 2005). 
CUTs are derived from transcription of unannotated intergenic regions and 
transcription at bidirectional promoters. Studies in S. cerevisiae showed initiation 
sites for CUTs are often located in nucleosome-free regions (NFRs), which is 
common for sites around an active gene promoter. Additionally, it was shown 
many CUTs derived from transcription in the antisense direction to a protein-
coding gene, with CUT initiation beginning near the TSS of active protein-coding 
genes (Neil et al, 2009). Another initiation site was found downstream of stop 
codons, which contains NFRs (Xu et al, 2009). Therefore, NFRs at 5’ and 3’ ends 
of protein-coding genes appear to be suitable locations for CUT transcription and 
bidirectional promoters may promote this pervasive transcription by maintaining 
NFRs.   
Bidirectional promoter transcription can also be observed in humans and 
related to CUTs in yeast is the divergent transcription of Promoter Upstream 
Transcripts (PROMPTs). PROMPTs are generated between 500 and 2500 nts 
upstream of TSS of promoters for Pol II, RNA polymerase I and RNA polymerase 
III transcribed genes (Preker et al, 2011). Both CUTs and PROMPTs can be 
transcribed in a sense or antisense direction, depending on the downstream 
32 
 
gene; they are relatively small; they are polyadenylated and are only detectable 
upon depletion of components of the exosome (Preker et al, 2008).  
PROMPTs are structurally similar to protein-coding mRNA transcripts, in 
that they contain a 5’ cap and 3’ adenosine tail, suggesting they are also 
processed by similar transcription machinery. In support of this, Pol II CTD 
phosphorylation was similar between PROMPTs and mRNAs at equal distances 
(Preker et al, 2011). However, PROMPT 3’ adenylation has been shown to utilise 
PAPD5 (elsewhere referred to as Trf4-2), a homolog of yeast Trf4p that is part of 
the Trf4 / 5-Air1 / 2-Mtr4 Complex (TRAMP) (Preker et al, 2011). In yeast, the 
Nrd1-Nab3 pathway is used to terminate CUTs (Thiebaut et al, 2006). TRAMP 
polyadenylates terminated CUTs, rRNAs and snoRNAs and this facilitates their 
subsequent degradation or 3’ end processing catalysed by the nuclear exosome 
(LaCava et al, 2005; Kadaba et al, 2006; Egecioglu et al, 2006). In contrast to 
CUTs, where both the exosome and TRAMP complex are required for 
degradation, 3’ adenylation of PROMPTs is not required for their degradation by 
the exosome (Reis et al, 2007; Preker et al, 2011).  
Whilst mRNA transcription from a bidirectional promoter is predominately 
elongation competent, the opposing-direction PROMPT transcription terminates 
early. This early termination and subsequent PROMPT degradation is affected 
by the location of proximal PASs that are more abundant upstream than 
downstream of the mRNA TSS (Ntini et al, 2013). PROMPTs were found to 
harbour PAS hexamers 10 – 30 nts upstream of their 3’ end as well as CstF64 
binding sites downstream of the 3’ end (Ntini et al, 2013). In addition, 5’ splice 
site sequences which are able to suppress PAS utilisation, are accumulated in 
proximal mRNAs compared to PROMPTs and therefore protect mRNAs from 
premature termination (Kaida et al, 2010).  
Chen et al (2016) conducted genome-wide RNA profiling methods in HeLa 
cells and found a correlation of PROMPT stability and length with distance 
between mRNA promoters. Gene TSS can be closely positioned to each other, 
which can cause transcriptional overlap especially when bidirectional 
transcription occurs. The authors showed that neighbouring promoters with larger 
distances between them produce PROMPTs that are readily degraded by the 
exosome and whose 3’ ends are believed to be defined by TSS proximal PASs. 
However, neighbouring promoters in close proximity cause PROMPT 
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transcription to overlap with mRNA sequences and instead these PROMPTs 
utilise the distal PAS site of the mRNA for 3’ processing. These PROMPTs have 
been described as alternative mRNA isoforms.  
 
1.3 Co-transcriptional RNA modifications 
RNA modifications include 5’ capping, splicing, cleavage and polyadenylation 
all of which are co-transcriptional events. These events act as methods of gene 
regulation to allow precise control of gene expression. Coordinating RNA 
processing events with Pol II transcription is facilitated by the CTD. 
Phosphorylation of the CTD modulates the interactions and actions of RNA 
processing factors, with the CTD also acting as a platform for these proteins 
(Figure 1.3).  
 
1.3.1 5’ Capping 
Addition of a 5’ cap to pre-mRNA is important for multiple reasons: to 
prevent 5’ – 3’ degradation of nascent mRNA, to aid recruitment of protein factors 
for splicing, polyadenylation and nuclear export and for recognition by initiation 
factors to facilitate and maintain efficient translation (Ramanathan et al, 2016). 5’ 
capping occurs early in transcription, on Pol II transcripts specifically. 
Phosphorylation of the CTD aids this specificity by recruiting capping enzymes. 
Nascent pre-mRNAs are capped on their 5’ end as the first 25 – 30 nts extrude 
from the active site of transcribing Pol II (Zhou et al, 2012). Two enzymes are 
responsible for 5’ capping, a RNA guanylyltransferase, RNGTT, containing both 
triphosphatase and guanylyltransferase activity and a RNA guanine-7-
methyltransferase, RNMT-RAM (Ramanathan et al, 2016). Firstly the 5’ 
triphosphate end of mRNA is hydrolysed by triphosphatase activity to a 
diphosphate. The diphosphate is then capped with GMP by guanylyltransferase 
activity and finally this cap is converted to a 7-methylguanosine cap by RNMT-
RAM (Shuman, 2001; Varshney et al, 2018). This process is reversible and 
decapping can generate an entry site for XRN2 degradation as well as causing 





Splicing involves the removal / excision of introns from pre-mRNA and 
ligation of exons, mediated by the spliceosome. For intron removal, cleavage 
occurs at conserved sequences known as splice sites, found at the 5’ and 3’ ends 
of introns (GU and AG respectively). Approximately 18 – 40 nts upstream of the 
3’ splice site is a branch point sequence (BPS) which is required for splicing, 
along with a polypyrimidine tract located between the BPS and 3’ splice site in 
humans. Major components of the spliceosome are U1, U2, U4, U5 and U6 
snRNPs and spliceosome assembly occurs anew for each splicing reaction 
(Ward and Cooper, 2010). The first step in splicing involves U1 snRNP binding 
to a complementary sequence found within the intron. This catalyses cleavage of 
the intron at the 5’ end. The cut 5’ end then forms a lariat through a 
transesterification process, pairing guanine and adenine nts of the 5’ end and 
BPS. The other spliceosome snRNPs are recruited to form a functioning 
spliceosome, which contributes to positioning of the lariat, release of the lariat by 
cleavage at the 3’ end and ligation of the adjoining exons (Herzel et al, 2017). 
Splicing occurs co-transcriptionally, with spliceosome formation relying 
upon transcription of the 5’ and 3’ splice sites (Wang and Burge, 2008). 
Therefore, Pol II elongation is a rate-limiting step of splicing and can be regulated 
to allow or prevent alternative splicing (Bentley, 2014). In fact, a slow mutant Pol 
II has been shown to increase the inclusion of alternative exons (de la Mata et al, 
2003) and it has been postulated that a specific Pol II elongation rate is required 
for alternative exon inclusion, potentially caused by nucleosome density slowing 
elongation (Saldi et al, 2016).  
Alternative splicing has been attributed for the existence of multiple mRNA 
transcripts from single genes and can explain the numerous proteins produced 
from relatively few genes. It is suggested that at least 90 % of human genes 
undergo alternative splicing, with introns being retained or exons being extended 
or skipped (Wang et al, 2008). Consequently, alternatively spliced mRNAs will 
produce proteins with different amino acids sequences and often different 
function to their constitutively spliced counterparts. Splice-site selection is 
regulated by various proteins such as SR proteins, which contain long repeats of 
serine and arginine residues, and hnRNPs (Martinez-Contreras et al, 2007; Long 
and Caceres, 2009).  
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SR proteins recognise short RNA motifs in the pre-mRNA that when bound 
to exons commonly act as splicing enhancers and conversely repress splicing 
when bound to introns (Änkö et al, 2014). In constitutive splicing, SR proteins 
promote U1 snRNP and U2 snRNP binding to the 5’ and 3’ splice sites, 
respectively. SR proteins promote alternative splicing by promoting spliceosome 
formation at weaker 5’ splice sites of alternative exons (Jeong, 2017). hnRNPs 
also recognise specific sequences of RNA but mainly act as splicing silencers, 
although some can also act as splicing activators i.e. hnRNPL (Martinez-
Contreras et al, 2007). Typically, SR proteins bind to cis-acting elements i.e. 
exonic splicing enhancers or intronic splicing enhancers to promote splicing, 
whereas hnRNPs bind to exonic or intronic splicing silencers. It is the interplay of 
hnRNPs and SR proteins binding to enhancer or silencer sites, located within the 
vicinity of exon/intron junctions, that either promote or inhibit splicing at weak 
splice sites and therefore govern alternative splicing (Wang et al, 2015).  
 
1.3.3 Cleavage and polyadenylation 
Most protein-coding genes that have undergone cleavage by CPSF / CstF 
factors are then polyadenylated.  Firstly, the pre-mRNA contains a 3’ – OH which 
is polyadenylated by the poly(A) polymerase (PAP). To increase the affinity of 
PAP, poly(A) binding protein nuclear 1 (PABPN1) binds to the newly formed short 
poly(A) tail and suppresses proximal PASs (Jenal et al, 2012). PAP continues to 
increase the poly(A) tail length by addition of adenosine monophosphate units. 
PABPN1 interacts with CPSF and PAP to control poly(A) tail length and upon 
reaching a length of approximately 250 nts, PABPN1 stops or disrupts these 
interactions (Kuhn et al, 2009). Thus, the polyadenylation factors dissociate and 
polyadenylation terminates. The poly(A) tail length is important in initiation of 
translation and in protection of mRNAs from degradation (Eckmann et al, 2011). 
Cleavage and polyadenylation has been previously discussed in this work with 
regards to termination and processing of transcripts. However, there are some 
contradictory and interesting findings that will be mentioned in this section in 
















Figure 1.3 Co-transcriptional RNA modifications  
Pol II transcription consists of initiation, elongation and termination phases with 
co-transcriptional RNA modifications. At the 5’ end capping enzymes add a 
methylguanosine cap (mG); during elongation the spliceosome complex splices 
introns from the pre-mRNA and ligates exons; at the 3’ end cleavage and 
polyadenylation factors (CPA) cleave the pre-mRNA and add a poly(A) tail. 
Throughout transcription the phosphorylation state of the CTD changes to aid 







As previously mentioned and in support of the allosteric termination model, 
an in vitro study by Zhang et al (2015a) observed cleavage was not necessary 
for Pol II termination. However, another study refutes this by observing highly 
delayed termination of protein-coding mRNA upon CPSF73 depletion, suggesting 
PAS cleavage is indeed required for termination (Eaton et al, 2018). The authors 
used ChIP experiments in CPSF73 depleted HCT116 cells and found both 
decreased Pol II signal in the gene body, suggesting a strong reduction in 
transcription, and accumulation of Pol II after the TES showing a large termination 
defect. When comparing XRN2 and CPSF73, CPSF73 loss caused a greater 
termination defect than XRN2 depletion, suggesting cleavage of protein coding 
mRNA is important for promoting Pol II termination. These contrasting results 
may be due to the experimental systems used, with Zhang et al (2015a) using an 
in vitro system compared to a human cell line in Eaton et al (2018).  
Eaton et al (2018) also found no role for XRN2 in snRNA or RDH gene 
termination, even though both undergo 3’ processing. This is supported by 
another study who showed degradation of the downstream cleavage product 
(DCP), formed from cleavage of RDH pre-mRNA, does not require XRN2 (Yang 
et al, 2009b). Instead the study suggested CPSF73 was involved in degradation. 
Degradation patterns of the DCP demonstrate the DCP is degraded in a 5’ – 3’ 
direction, therefore utilising exonuclease activity. This exonuclease activity was 
blocked by inhibiting U7 snRNP binding to the HDE and inhibiting CPSF73 
recruitment. UV cross-linking demonstrated that CPSF73 specifically interacts 
with the DCP, in a U7-dependent manner. Yang et al (2009b), concluded that 
CPSF73 exonuclease activity degraded DCP and that HDE distance 
requirements upstream and downstream of the cleavage site determine CPSF73 
endonuclease or exonuclease activity for cleavage of RDH pre-mRNA. 
Interestingly, b-lactamase fold protein, Artemis, which contains the same b-CASP 
domain as CPSF73, shows both exonuclease and endonuclease activity (Ma et 
al, 2002). These are not the only enzymes suggested to have both exonuclease 
and endonuclease activities, indeed RNase J is another example and is involved 
in RNA processing and degradation (Mäder et al, 2008; Even et al, 2005; Mathy 
et al, 2007; Daou-Chabo and Condon, 2009). However, currently CPSF73 has 
not been directly shown to have exonuclease activity.   
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It has already been mentioned that NELF localises downstream of the TSS 
of snRNAs and knockdown causes snRNA processing defects. A similar role for 
NELF in RDH pre-mRNA processing, alongside another protein complex, has 
also been reported (Narita et al, 2007). Using immunoprecipitation in HeLa cells, 
it was shown NELF interacts with two cap binding complex (CBC) subunits, 
CBP80 and CBP20. The well-characterised function of the CBC is to bind the 5’ 
cap of pre-mRNA to facilitate export for translation. Defects in cleavage of RDH 
pre-mRNA results in polyadenylated transcripts by utilising downstream PASs. 
Interestingly, knockdown of either NELF or CBC resulted in accumulation of 
polyadenylated RDHs, suggesting these proteins may play a role in 3’ processing 
of RDH pre-mRNA (Narita et al, 2007). The CBC was shown to directly interact 
with SLBP and pull-down assay confirmed that the CBC is sandwiched between 
NELF and SLBP. SLBP knockdown also resulted in abnormal RDH mRNA 
processing and therefore it was hypothesised that NELF may recruit SLBP to the 
RDH stem-loop through an interaction with the CBC (Sullivan et al, 2001; Narita 
et al, 2007).  
Similar to defects in 3’ processing of RDH pre-mRNA, misprocessed 
snRNAs often become polyadenylated. However, snRNA genes don’t commonly 
contain a PAS closely downstream of their 3’ box, where transcription termination 
predominately occurs. Yamamoto et al (2014) questioned if aberrant 
polyadenylation could occur in a similar method to mRNA 3’ end processing. 
Interestingly, CPSF73 knockdown caused a significant decrease in 
polyadenylated U1 snRNA. CPSF73 or CtsF-64 knockdown was also able to 
rescue accumulation of polyadenylated U1 snRNA caused by NELF knockdown. 
Overall this suggests that NELF, present at 3’ end of snRNAs, may play a role in 









1.3.4 Other RNA modifications 
Modification of RNA can also occur internally, for example N1-
methyladenosine, 5-methylcytosine and isomerisation of Uridine (Roundtree et 
al, 2017; Desrosiers et al, 1974; Carlile et al, 2014). The most prevalent internal 
modification of both mRNA and long non-coding RNA is N6-Methyladenosine 
(m6A), where the N6 position of adenosine in mRNA is methylated (Perry and 
Kelley, 1974; Desrosiers et al, 1975; Wei et al, 1975). Lavi et al (1977) estimated 
poly(A) mRNA contained m6A modification every 1 per 700-800 nts. This 
essential modification has been found to accelerate mRNA processing and 
transport in mammalian cells (Camper et al, 1984; Finkel and Groner, 1983). The 
m6A modification is produced by a METTL3 and METTL14 heterodimer, with 
METTL3 providing catalytic activity, that is regulated by its association with a 
WTAP protein subunit (Liu et al, 2014; Ping et al, 2014; Wang et al, 2016). 
Previous research has suggested that methylation occurs preferentially in 3’ 
UTRs, around the stop codon and also within intronic sequences. This could 
show that m6A modification occurs co-transcriptionally (Liu et al, 2014; Ping et 
al, 2014).  
Biological functions of m6A are produced by interactions with m6A readers 
that specifically recognise the RNA modification. These include the YTH family of 
proteins that then allow m6A regulation of cellular processes (Dominissini et al, 
2012) For example, YTHDC1 binding to m6A modifications of mRNA increases 
the inclusion of alternative exons through interactions with SR proteins (Xiao et 
al, 2016). Additionally, hnRNP proteins also interact with m6A modified RNAs to 
regulate alternative splicing.  HNRNPC and HNRNPG recognise and bind m6A 
dependent structural switches to regulate splicing (Liu et al, 2017). These few 
examples demonstrate the importance of RNA modifications on post-








1.4 Regulation of gene expression by degradation pathways 
Degradation of RNA is an important stage in gene expression control and 
different classes of degradation can be characterised. Firstly, Pol II transcription 
generates a multitude of transcripts which undergo extensive processing. These 
processing events produce excised introns and spacer fragments that must 
undergo degradation. Secondly, regulated turnover of mRNA is important for 
gene expression control. Similarly, RDH degradation is important in cell cycle 
function; is tightly coupled to DNA replication to ensure proper chromatin 
formation and enhances recombination rates in response to DNA damage 
(Mullen and Marzluff, 2008; Hauer et al, 2017). Finally, degradation acts as a 
quality control mechanism. Due to the complexity of RNA processing 
mechanisms, errors can often occur that generate aberrant or defective 
transcripts. Additionally, mRNAs with premature translation termination codons 
are generated by alternative splicing. The levels of these defective RNAs must 
be controlled to prevent potential problems such as the saturation of RNA 
processing machinery and therefore they are rapidly degraded (Houseley and 
Tollervery, 2009).  
 There are different classes of RNA-degrading enzymes. Endonucleases 
cleave the phosphodiester bond between nucleotides, cleaving RNA internally. 
Exonucleases cleave RNA from the end, with one type hydrolysing RNA from the 
5’ end and another type hydrolysing from the 3’ end (Houseley and Tollervey, 
2009). In addition, some nucleases also exhibit kinase activity, such as NDK1 
(Yoon et al, 2005). Pol II transcripts commonly obtain a 5’ cap which protects 
RNA from degradation by 5’ exonucleases such as XRN2 (Ramanathan et al, 
2016). Therefore, RNA decapping is an important process in degradation. Dcp2 
is predominately found in the cytoplasm but is able to shuttle into the nucleus and 
interact with XRN2 and transcription termination factors. This interaction allows 
Dcp2 to catalyse hydrolysis of the 5’ cap, resulting in its removal (Piccirillo et al, 
2003). XRN2 is not only involved near transcription termination of genes, but is 
associated with transcription machinery during initiation (Davidson et al, 2012; 
Jimeno-Gonzalez et al, 2010). Pol II aborted transcripts generated by promoter-
proximal pausing, defectively spliced or capped transcripts are often retained at 
the TSS and can be degraded by XRN2. XRN2 accounts for the removal of some 
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transcripts, however other RNA transcripts are degraded by the exosome 
complex, which is one of the main focusses of this thesis.  
 
1.4.1 Exosome complex 
The human nuclear exosome has vital functions in processing, nuclear 
surveillance and degradation of nearly every class of RNA. The exosome is a 
multi-subunit complex composed of a 9 subunit barrel-like core lacking catalytic 
activity (EXO-9). These subunits are arranged as a hexamer (PH-like ring) 
capped with a trimeric S1/KH ring and they interact with 3’ – 5’ exonucleases 
DIS3 (homolog of yeast RRP44) and EXOSC10 (homolog of yeast RRP6) 
(Allmang et al, 1999; Mitchell, 2014). A central channel runs through the EXO-9 
core, with EXOSC10 localised on top of the S1/KH cap and DIS3 at the opposite 
end (Figure 1.4). The channel is essential to exosome function as it mediates 
RNA binding to allow access of RNA substrates to DIS3 and EXOSC10 (Makino 
et al, 2015). During association with the exosome, the exonuclease domain of 
EXOSC10 is exposed whereas the exonuclease domain of DIS3 faces towards 
the channel at the exit pore. It is thought that RNA passes through the central 
channel to facilitate their interaction with DIS3 (Lorentzen et al, 2008).  
EXOSC10, located at the entry pore of EXO-9, may regulate this RNA 
threading by widening the channel and thus allosterically mediating DIS3 activity 
(Wasmuth et al, 2014). Mutant catalytically-dead EXOSC10 is still able to 
enhance DIS3 activity in vitro. Additionally, mutations in the exosome complex 
that obstruct the channel inhibit DIS3 and EXOSC10 activities in yeast (Wasmuth 
and Lima, 2012), although RNA substrates can also be directed to the nuclease 
domains independently (Bonneau et al, 2009; Schneider et al, 2012). RNA 
threaded through the entire channel is degraded by DIS3, whereas RNA that 
enters the S1/KH ring before being deflected outwards is degraded by EXOSC10 






Figure 1.4 Exosome structure 
The 2D structure of the exosome shows the core subunits, EXOSC1-9, that make 
up the barrel-like structure of the exosome, with EXOSC10 and DIS3 attached on 
either end. The exosome structure can exist in different formations with either 
EXOSC10, DIS3, both or neither subunits. The 3D structure shows EXOSC10 at 
the entry pore and DIS3 at the exit pore of the core, with the central channel 
running through the middle of the core. As shown, it is possible for RNA to thread 
















These structural exosome findings were conducted in yeast, however 
recent studies suggest the human nuclear exosome may show some slight 
differences. Through cyro-EM, Gerlach et al (2018) found the position of human 
DIS3 (hDIS3) on EXO-9 more closely resembles an open conformation of RNA 
binding directly to RRP44 in yeast than a closed conformation of RNA accessing 
the active site of RRP44 through the exosome channel. A long RNA channel path 
was still observed with RNA travelling through the EXO-9 channel to then bind 
DIS3, however the RNA path was longer in humans than yeast (Gerlach et al, 
2018; Weick et al, 2018).  
DIS3 encompasses two domains with different catalytic activities. Firstly, 
DIS3 includes a N-terminal PIN domain which is responsible for 
endoribonuclease activity and interacts with EXO-9 subunits RRP41 and RRP45. 
(Lebreton et al, 2008; Schneider et al, 2009; Schaeffer et al, 2009; Bonneau et 
al, 2009). Secondly, there is a ribonuclease domain (RNB) containing the active 
site for exoribonuclease activity (Lorentzen et al, 2008). Although knockdown of 
DIS3 is essential to cell growth (Mitchell et al, 1997), it was shown that inhibiting 
DIS3 exoribonuclease activity by mutating the RNB domain (D551N) is not lethal 
although a slower growth phenotype is observed (Dziembowski et al, 2007). 
Similarly mutating the PIN domain (D171N), thus preventing endoribonuclease 
activity, produced no obvious phenotype. However, expression of both these 
mutations together caused growth inhibition (Schaeffer et al, 2009). This 
suggests that catalytically inactive DIS3 results in a non-functional exosome 
however, at least one type of DIS3 nuclease activity is sufficient for cell viability. 
It is important to note that Schaeffer et al (2009) used RNAi methods to 
knockdown endogenous DIS3 levels whilst expressing mutant DIS3 constructs. 
Therefore, DIS3 may not have been fully depleted by RNAi and low levels of 
functioning DIS3 may be present. This could have a slight rescue effect on the 
mutant phenotypes and it is possible that mutations through genetic modification 
would instead be lethal.  
DIS3 mutations not only affect cell viability in different ways but also 
exosome function. The D171N mutant produced no degradation intermediates 
whereas D551N mutation caused accumulation of degradation and processing 
intermediates. A combination of both mutations produced a similar phenotype to 
that of D551N alone. Therefore a viable RNB domain, but not PIN domain, is 
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essential for exosome function. These differences could be explained by 
exoribonuclease and endoribonuclease domains of DIS3 acting on separate 
specific substrates. Alternatively, both catalytic domains may increase the 
efficiency of each other and act synergistically on substrates (Schaeffer et al, 
2009).  
Although mutation of the PIN domain did not prevent degradation of 
exosome substrates, it may affect the speed and efficiency of degradation. The 
RNB domain aids in hydrolysis of single-stranded RNA in a 3’ – 5’ direction. 
Nucleotides are singularly released to produce an end product of only a few 
nucleotides. Normally DIS3 can unwind secondary structures of RNA provided 
there are unstructured regions of adequate length at the 3’ end (Robinson et al, 
2015). The PIN domain could act in releasing exosome substrates where 
degradation has stalled due to their secondary structure. PIN domain function 
may enhance exoribonuclease activity of DIS3 or EXOSC10 by providing them 
with alternative 3’ end substrates and aiding exosome degradation functions 
when progression is blocked (Lebreton et al, 2008).  
In yeast, RRP6 is located solely in the nucleus but both RRP44 and RRP6 
can be found in the nucleoplasm and nucleolus. In comparison, EXOSC10 and 
DIS3 are located mainly in the nucleus of human cells, with exclusion of DIS3 
from the nucleolus and enrichment of EXOSC10 in the nucleolar compartment 
(Tomecki et al, 2010). There are 2 other isoforms of DIS3 which are found 
exclusively in the cytoplasm, DIS3L and DIS3L2. DIS3L can associate with the 
exosome but it does not exhibit endoribonuclease activity as the two catalytic 
residues within the PIN domain are absent. Conversely, DIS3L2 lacks a PIN 
domain due to splicing of exon 2 and is not known to be part of any stable 
macromolecular assembly (Tomecki et al, 2010; Kumakura et al, 2013; Staals et 
al, 2010). Overall three potential exosome complexes may exist within the human 
nucleus; EXO-9 with EXOSC10, nucleoplasmic EXO-9 with DIS3 and 
nucleoplasmic EXO-9 with EXOSC10 and DIS3 (Lykke-Anderson et al, 2011). 
The differing subcellular distributions of these exosome complexes may allow 
each to perform specialised functions within the cellular compartments (Kilchert 
et al, 2016).  
EXOSC10 and DIS3 may have specific substrates. It has been suggested 
that EXOSC10 is more involved in processing of RNAs than DIS3, specifically in 
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the processing of small RNAs. Additionally, EXOSC10 is more efficient in 
degrading substrates with more complex secondary substructures including small 
nucleolar RNAs and pre-rRNA (Januszyk et al, 2011). On the other hand, 
previous studies have suggested that DIS3 is the main catalytic subunit of the 
exosome for degrading nearly all classes of RNAs, including pervasive transcripts 
(Dziembowski et al, 2007). Szczepinska et al (2015) proposed that DIS3 also 
degrades enhancer RNAs (eRNAs) and snoRNAs.  
In addition to the degradation of aberrant transcripts, the nuclear exosome 
has an important function in degradation of cryptic transcripts known as CUTs in 
yeast and PROMPTs in humans. As described earlier, cryptic transcripts are 
derived from transcription in the opposite direction to a protein-coding gene, at 
bidirectional promoters. Due to their quick turnover, they are only detectable in 
the cell upon exosome dysfunction (Preker et al, 2008). DIS3 is suggested as the 
predominant, if not only, degradation pathway for PROMPTs in humans.   
Szczepinska et al (2015) used PAR-CLIP techniques in HEK293 cells expressing 
a catalytically-dead DIS3 mutant and found that upon DIS3 dysfunction there was 
robust accumulation of PROMPTs. PROMPT accumulation was also observed 
when other exosome components were downregulated, including EXOSC10 and 
EXOSC3 (hRRP40) (Preker et al, 2008; Flynn et al, 2011). 
 
1.4.2 Exosome co-factors  
Nuclear exosome function is modulated by various cofactors and 
interacting partners. Of high significance is the yeast TRAMP complex which aids 
the exosome in substrate specificity (Schmidt and Butler, 2013). The TRAMP 
complex contributes to exosome RNA processing through Trf4p subunit addition 
of a short poly (A) tail (3 – 50 nts) to transcripts (Wyers et al, 2005). In addition to 
Trf4p, the TRAMP complex also contains the essential helicase MTR4 (LaCava 
et al, 2005). A TRAMP-like complex has been identified in humans which contains 
a MTR4 homolog and close orthologues such as Trf4p and PAPD5. However, 
unlike yeast, the activity of the TRAMP complex in humans is predominately 
restricted to the nucleolus due to TRAMP subunit nucleolar localisation (Lubas et 
al, 2011). Consistent with this localisation is the finding that PAPD5 
polyadenylates snoRNA and pre-rRNA transcripts (Ogami et al, 2018).  
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MTR4 helicase activity is enhanced by Mpp6 binding to the EXO-9 subunit, 
RRP40. A secondary structure forms at the 3’ end of RNA substrates, which is 
unwound by MTR4. This produces single-stranded RNA that is more capable of 
threading through the channel in a 3’ – 5’ direction (Falk et al, 2017). TRAMP 
polyadenylation activity may help prepare RNA as a substrate for degradation, 
by generating poly(A) tails long enough for binding by MTR4 (Zinder and Lima, 
2017). In humans it was found that MTR4 binds to the exosome through contact 
with Mpp6 and exosome subunit EXOSC2 (Weick et al, 2018).  
Human MTR4 is also part of the nuclear exosome targeting (NEXT) and 
poly(A) tail exosome targeting complexes (PAXT) (Lubas et al, 2011; Meola et al, 
2016). The NEXT complex has been shown to promote degradation of PROMPTs 
and 3’ extended RNAs (Lubas et al, 2011; Tseng et al, 2015; Hrossova et al, 
2015), whereas PAXT promotes degradation of transcripts with larger poly(A) 
tails (Meola et al, 2016). Lubas et al (2011) found that depletion of NEXT 
components, Rbm7 and ZCCHC8, leads to accumulation of PROMPTs showing 
the importance of NEXT in exosome degradation of certain transcripts.  
The exosome has also been observed to be tethered to nascent capped 
transcripts, through NEXT and PAXT interaction with the cap-binding complex 
containing ARS2 (CBCA) (Andersen et al, 2013; Meola et al, 2016). ARS2 binds 
to the CBC and acts as a scaffold protein, recruiting various protein complexes 
involved in 3’ end processing, maturation, degradation and export to the 5’ CBC 
(Gruber et al, 2009; Hallais et al, 2013; Andersen et al, 2013).  Premature 
transcription termination produces RNA 3’ ends within the first introns of protein-
coding genes. These pervasive transcripts are exosome substrates and their 
turnover is supported by ARS2 function (Iasillo et al, 2017). In addition, Iasillo et 
al, (2017) found through ARS2 depletion in HeLa cells and RNA-Seq that ARS2 
plays a role in transcription termination downstream of short snRNA, RDH, 







1.4.3 Cytoplasmic mRNA degradation  
Messenger RNAs in the cytoplasm are normally protected from 
endonucleases by their 5’ cap and 3’ poly(A) tail. The majority of cytoplasmic 
mRNAs are degraded in a deadenylation-depenent manner. Deadenylation is 
often the rate-limiting step of cytoplasmic mRNA decay and is conducted by 2 
main deadenylases, CCR4-NOT and PAN2-PAN3 (Siwaszek et al, 2014). PAN2-
PAN3 complex firstly shortens the poly(A) tail to approximately 110 nt and then 
the CCR4-NOT complex deadenylates the mRNA to a poly(A) tail length of 
approximately 10 nts (Yamashita et al, 2005; Chen et al, 2011). After 
deadenylation the mRNA may undergo decapping by DCP2, which can also 
decap mRNA in the nucleus as previously mentioned (Piccirillo et al, 2003). 
Decapped mRNA is then a substrate for 5’ – 3’ exonuclease degradation by 
XRN1 (Braun et al, 2012).  
Alternatively, cytoplasmic mRNA can be degraded in a 3’ – 5’ direction by 
the cytoplasmic exosome. The cytoplasmic exosome is similar in structure to the 
nuclear exosome, except DIS3 is not present. Instead a paralogue DIS3L, which 
does not contain endonuclease activity due to mutations in the PIN domain, is 
responsible for the catalytic activity of the cytoplasmic exosome. (Tomecki et al, 
2010). After degradation by the exosome a scavenging decapping enzyme, DcpS 
that has a specific for shorter RNA species, hydrolyses the residual 5’ cap (Chen 
et al, 2005). Interestingly, DIS3L2 is another paralogue of DIS3 and is found 
specifically in the cytoplasm, doesn’t interact with the exosome and lacks a PIN 
domain. It is found to preferentially degrade 3’ uridylated RNAs in an exosome-
independent manner (Malecki et al, 2013; Lubas et al, 2013). Depletion of DIS3L2 
causes an accumulation of a multitude of mRNAs in the cytoplasm, suggesting 
DIS3L2 may be responsible for a third cytoplasmic degradation pathway (Malecki 








1.4.4 Nonsense-mediated decay 
As discussed, formation of aberrant mRNAs can occur at multiple stages 
and can be hazardous to cells through the generation of potentially toxic proteins 
or by sequestering processing machinery. There are different posttranscriptional 
quality-control mechanisms to prevent this occurrence and the best characterised 
is the Nonsense-mediated decay (NMD) pathway. NMD removes aberrant 
mRNAs which contain a premature stop codon possibly due to mutations, 
transcriptional errors or splicing errors (Popp and Maquat, 2013). Translational 
termination, which involves eukaryotic release factor 1 and 3 (eRF1 and eRF3),  
is the first signal to trigger NMD.  
As a consequence of pre-mRNA splicing, an exon-junction complex (EJC) 
is found on the mRNA approximately 20 – 24 nts upstream of the exon-exon 
junction. (Le Hir et al, 2000). During the first round of translation, EJC’s are 
removed from the mRNA. After this, NMD occurs if any EJCs remain bound to 
the mRNA, which would occur if the ribosome was released before reaching the 
EJC i.e. if eRF1 and eRF3 assemble at a premature stop codon located ≥ 50 – 
55 nts upstream of a EJC then NMD is triggered (Popp and Maquat, 2013). NMD 
is mediated by up-frameshift proteins UPF1, UPF2, UPF3A and UPF3B and 
aided by suppressors with morphological effects on genitalia, SMG1, SMG5-9. 
UPF1 is an ATP-dependent RNA helicase that with SMG1 kinase binds to eRF1 
and eRF3 to form the SURF complex near a premature stop codon (Kashima et 
al, 2006; Chakrabarti et al, 2011).  
UPF2 and UPF3 are found on the EJC and their subsequent contact with 
UPF1 results in phosphorylation of UPF1 by SMG1 and release of eRF1 and 
eRF3 (Kashima et al, 2006). Phosphorylated UPF1 becomes an active helicase 
that resolves mRNA secondary structure and removes bound proteins, as well as 
recruiting SMG5-7 and other general mRNA degradation factors including XRN1 
(Fiorini et al, 2015; Okada-Katsuhata et al, 2012). SMG6 is capable of 
endonucleotytically cleaving the aberrant mRNA to generate RNA fragments that 
can be degraded by XRN1 or the cytoplasmic exosome (Huntzinger et al, 2008; 





1.5 Gene engineering using CRISPR/Cas9 
Precise, targeted changes to the genome are important for many 
applications across science, including systemic interrogation of genetic elements 
and development of disease models. Previous methods have used zinc-finger 
nucleases or transcription-activator like effector nucleases, but a faster, cheaper, 
highly specific and more efficient gene editing method was developed, Clustered 
Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 (Gaj et al, 
2013; Gupta and Musunuru, 2014; Cong et al, 2013).  
CRISPR/Cas9 was developed from a naturally occurring gene editing 
system in bacteria, with the most commonly used CRISPR/Cas9 technology in 
human cells being adapted from Streptococcus pyogenes. CRISPR/Cas9 
provides bacteria with adaptive immunity by acting as an immune memory of viral 
infections and preventing re-infection (Barrangou et al, 2007). The CRISPR loci 
consists of repetitive elements, 30 – 40 bp, which flank short sequences of DNA 
with viral and plasmid origins known as protospacers. In bacterial adaptation, new 
protospacers are introduced during infection and their DNA is homologous to 
bacteriophages or plasmids, to provide specific immunity (Mali et al, 2013a; Mali 
et al, 2013b).   
Genome engineering by CRISPR/Cas9 requires a conserved 3’ 
protospacer adjacent motif (PAM), that is associated downstream of every 
protospacer. Different CRISPR systems have various PAM sequences, for 
example the PAM sequence for Cas9 from Streptococcus pyogenes is 5’-NGG 
whereas the Cas9 ortholog in Neisseria meningiditis is 5’-NNNNGATT (Jinek et 
al, 2012; Zhang et al, 2013). For specific gene editing in mammalian cells, a 
human codon-optimised Cas9 must be expressed alongside a guideRNA 
(gRNA), consisting of DNA complementary to the genome target that associates 
with Cas9 and the genome. The Cas9 nuclease can therefore be targeted toward 
any part of the genome by altering the gRNA, as long as there is a PAM sequence 
located 3’ of the target DNA.  
	 The gRNA directs CRISPR/Cas9 to the DNA target, where Cas9 can 
cleave the DNA. Upon cleavage, a double stranded break (DSB) is formed and 
using the cell’s own DNA repair machinery, is either repaired by non-homologous 
end joining (NHEJ) or high-fidelity homology-directed repair (HDR). With NHEJ, 
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the broken DNA strands are re-ligated creating insertion/deletion (indel) 
mutations, making NHEJ repair an effective way to study genetic variation by 
introducing random deleterious mutations (Bibikova et al, 2002). On the other 
hand, HDR occurs less frequently in vivo but creates more accurate repairs by 
using a repair template to ligate the DNA. Through the design of custom repair 
templates introduced to the cell, HDR can introduce large and precise DNA 
modifications (Chen et al, 2011).  
 
1.5.1 Altering gene expression post-transcriptionally 
Regulating gene expression in eukaryotes can be achieved by altering 
transcription levels and mRNA abundance, except these methods can be limited 
by their rate of downregulation, especially for proteins with a long half-life. 
Therefore, methods have been developed that instead modify protein levels more 
directly. A commonly used technique for post-transcriptional modifications is RNA 
interference (RNAi), that utilises complementary small RNA molecules to 
specifically target and degrade mRNA transcripts via the RNA inducing silencing 
complex (RISC) and thus prevent their translation (Elbashir et al, 2001). However, 
RNAi methods have been criticised for producing off-target effects, requiring long 
periods of time for gene downregulation and causing incomplete downregulation. 
Therefore, it has been important to find other methods that may combat these 
limitations and alter gene expression levels post-translationally. For this, various 
methods have been proposed that utilise the CRISPR/Cas9 system (Zhang et al, 










1.5.2 The auxin system in plants 
Plants contain a hormone, indole-3-acetic acid (IAA or auxin), which is 
detrimental to regulation of plant cell division, expansion and differentiation 
(Teale et al, 2006). Auxin enacts its role by regulating gene expression and to do 
this a ubiquitin-dependent proteolytic system is involved. Specifically, the F-box 
protein transport inhibitor response 1 (TIR1), which contains an auxin binding 
site, forms a functional E3 ubiquitin ligase complex with Skp1 and Cullin 1 
(SCFTIR1). The SCFTIR1 recruits an E2 ubiquitin conjugating enzyme that catalyses 
ubiquitination of proteins containing an auxin inducible degron (AID) (Gray et al, 
1999). Auxin inducible genes are bound by auxin response factors (ARF), whose 
interaction with auxin transcriptional repressors (ATR) prevents gene expression 
(Tan et al, 2007). Auxin brings together the ATRs with SCFTIR1, causing 
polyubiquitination of the ATRs and leading to their degradation. This in turn 
releases the inhibition of ARFs, causing activation of gene expression at auxin 
inducible genes (Gray et al, 2001) (Figure 1.5).  
 
1.5.3 Implementation of the Auxin inducible degron system (AID) in 
eukaryotes 
The plant auxin-regulated protein degradation system has since been 
exploited in various studies to allow ubiquitination of specific substrates and their 
subsequent degradation. Although non-plant eukaryotes express the ubiquitin 
ligase SCF, in which the F-box protein determines substrate specificity, they lack 
orthologs of TIR1 and auxin inducible degrons (Holland et al, 2012). However, 
due to the highly conserved Skp1, Nishimura et al (2009) was able to express the 
Arabidopsis thaliana TIR1 gene in budding yeast and find evidence for formation 
of SCFTIR1. They also fused the AID, IAA17, to the N and C terminus of GFP and 
expressed these fusion proteins in cells expressing SCFTIR1. Both AID-GFP-NLS 
and GFP-AID-NLS were depleted in a TIR1 and auxin-dependent manner. The 
AID system has also been implemented in mammalian cells and reversible 
protein degradation within minutes of auxin removal was observed (Holland et al, 










Figure 1.5: Auxin system in plants 
1) Auxin inducible genes are bound by auxin response factors (ARF), which 
interact with auxin transcriptional repressors (ATR). 2) Auxin brings together the 
ATR and a E3 ubiquitin ligase complex, SCFTIR1. SCFTIR1 recruits a E2 ubiquitin 
enzyme that causes ubiquitination of the ATR. 3) Polyubiquitination of ATR leads 
to its subsequent degradation. 4) ARFs are no longer inhibited and transcription 
















Figure 1.6: Auxin system in human cell lines 
A protein of interest (POI) is tagged to an auxin inducible degron (AID) by 
CRISPR/Cas9 technology, in cells expressing plant TIR1. Upon addition of auxin, 
the SCFTIR1 complex binds to the POI and recruits a E2 ubiquitin enzyme. The 




1.5.4 AID system and CRISPR/Cas9 
The AID system causes rapid depletion of a protein; however, its’ 
implementation can be time consuming and difficult due to the necessity of 
tagging the endogenous target protein and co-expressing TIR1 within the desired 
eukaryote system. This caveat has been improved by the use of CRISPR/Cas9 
technology. Zhang et al (2015b) used CRISPR/Cas9 genome editing to introduce 
the AID tag to a protein of interest (POI) in C.elegans and found a rapid 
degradation (20 minutes) of the POI in the presence of auxin. The authors also 
compared the AID system to RNAi depletion from a previous study (Kostrouchova 
et al, 2001) and found the AID system produced a highly pronounced phenotype 
(2 % progeny arrested in development compared to 100 %, respectively). This 
suggests that the AID system is able to produce a more robust phenotype than 
RNAi.  
Natsume et al (2016) used a similar method in mammalian cells. They 
tagged endogenous genes with the AID-tag using donor vectors containing 
synthetic short homology arms as a repair cassette for HDR. This was done in 
human colorectal cancer (HCT116) cells due to their well-established diploid 
karyotype. Other studies have also used CRISPR/Cas9 to achieve biallelic 
insertion of the AID tag into human cells, a method which can be adapted to allow 
insertion of other tags (Lambrus et al, 2018).  
 
1.5.5 Small Molecule Assisted Shutoff (SMASh) 
Small Molecule Assisted Shutoff (SMASh) is another technique that can 
be used to modulate protein activity at a post-transcriptional level using chemical 
regulation (Chung et al, 2015). In contrast to the AID system, SMASh involves 
only a single component and is selective for new proteins. SMASh suppression 
of a protein works firstly by using CRISPR/CAS9 technology to fuse a SMASh tag 
to the target of interest via a hepatitis C virus (HCV) nonstructural protein 3 (NS3) 
protease recognition site. The SMASh tag consists of a NS3 protease and 
destabilising degron. After protein folding, the internal protease activity causes 
cleavage at the HCV NS3 recognition site, resulting in an unmodified protein 
product. The cleaved SMASh tag is then degraded due its’ internal degron 
activity. Upon addition of a protease inhibitor, asunaprevir, the POI remains 
55 
 
tagged and is now targeted for proteasomal and / or autophagosomal degradation 
alongside the SMASh tag (Figure 1.7). Therefore asunaprevir causes the rapid 
degradation of newly synthesised POI.  
Regulation by asunaprevir allows for stringent control and quick recovery 
of protein production. Chung et al (2015) showed the SMASh tag can be attached 
to the POI at either the N or C terminus and that due to the absence of protein 
structural modifications after cleavage, it is expected the POI will have normal 
functionality. However, as it is the protein’s processing into a functional protein 
that is inhibited by asunaprevir, the SMASh system will work best when an 
accumulation of protein is required upon removal of asunaprevir or in cases 
where the POI is short-lived. This will prevent protein produced prior to 
asunaprevir addition from having an effect (Bondeson and Crews, 2017). This 
system has been previously used to regulate the replication of Influenza A Virus 
(IAV) in vitro and in vivo, without directly targeting viral proteins (Fay et al, 2019). 
In addition, Yan et al (2015) used the SMASh tag to alter expression of a reporter 
in a dual-reporter screen, thus increasing its statistical power and demonstrating 
endogenous yeast gene modification by the SMASh system.  
Overall both the AID system and SMASh-tag are bioorthogonal and 
produce inducible and reversible protein degradation, making them efficacious 












Figure 1.7: Small Molecule Assisted Shut-Off (SMASh)  
The SMASh tag consists of a protease and degron linked to the protein of interest 
(POI) by a HCV NS3 protease recognition site. The SMASh tag internal protease 
activity cleaves the tag at the recognition site, when cells are untreated. The POI 
becomes untagged and is able to conduct its normal function whereas the 
SMASh tag is degraded due to internal degron activity. Upon addition of a 




1.6 Project Aims 
This introduction has discussed the role of endonucleases in cleavage and 
polyadenylation events, 3’ end processing and degradation of RNAs, with some 
endonucleases acting in more than one pathway. Although previous studies have 
attempted to elucidate the differing functions of the endonucleases CPSF73, 
INTS11 and DIS3, a lot is still unknown. Being able to determine their specific 
substrates would be beneficial in revealing functional roles.  
Aforementioned work in these areas have mainly been conducted in yeast, 
due to their smaller genomes and therefore are more easily genetically modified. 
Studies conducted in human tissues have often used RNAi techniques to regulate 
expression of proteins of interest. RNAi methods utilise small interfering RNAs 
(siRNAs) to specifically target a mRNA. siRNAs associate with the RNA-inducing 
silencing complex (RISC) which unwinds the siRNA to produce a single-strand. 
The single-stranded RNA binds to the complementary mRNA target, allowing the 
RISC complex to cleave mRNA and in effect, silence gene expression. Although 
RNAi methods made manipulation of gene activity more accessible, with 
increased specificity and relative ease-of-use to previous methods, there are 
caveats. 
 RNAi mediated-knockdown of a gene is often time-consuming, with an 
adequate level of protein reduction taking multiple days depending on the half-
life of the protein of interest. Over these long periods, RNAi has increased 
potential for off-target effects and complicates the interpretation of phenotypic 
effects. Indeed, siRNAs have been shown to have reduced specificity causing 
silencing of non-target genes (Jackson et al, 2003). In addition, RNAi does not 
always produce complete protein depletion. It was recently shown that because 
of these limitations, trace levels of protein remaining after RNAi may cause false 
negative results or a reduced phenotype (Eaton et al, 2018). Therefore gene 
editing techniques, such as CRISPR/Cas9 and the AID system, may be beneficial 
to produce an increased repertoire of protein functions. Furthermore it allows 
conditional depletion in a quicker manner than RNAi, which will be important 





The aims of this study were to further reveal the roles of three 
endonuclease proteins, DIS3, INTS11 and CPSF73, in human cells (Figure 1.8). 
Additionally, to provide insight into the substrates and mechanisms of the three 
endonucleases by investigating changes in transcription upon protein depletion. 
It was hypothesised that: 1) Using CRISPR/Cas9 technology to genetically 
modify gene targets with tags would allow conditional protein depletion; 2) 
Depletion of the exosome subunit DIS3 would cause an accumulation of RNA 
transcripts, due to loss of their degradation; 3) Depletion of CPSF73 would cause 
misprocessing and possible extension at protein-coding genes and RDHs, as 
CPSF73 is believed to play a major role in the 3’ end processing of these genes; 
4) Depletion of INTS11 would result in dysfunction of the Integrator complex, 
causing misprocessing at snRNA genes. The research questions that we asked 
throughout this study included: Are our protein-depletion cell lines capable of 
quick, specific and near complete depletion of our protein target? Can these cell 
lines, with the use of RNA-Seq, elucidate specific substrates of these 
endonucleases? If depletion of endonucleases responsible for 3’ end processing 
of specific genes results in extension, where does this extension terminate? And 
do the findings support or refute the model of transcription termination? My 
objectives to address these aims and research questions were to use 
CRISPR/Cas9 technology to produce conditional-depletion cell lines of three 
endonucleases: CPSF73, INTS11 and DIS3. Upon generation of these cell lines, 
to utilise transcriptome-wide high-throughput RNA-Seq analysis of nascent RNA 
to determine specific substrates and effects of protein depletion. Finally, to 





















Figure 1.8 Domain organisation of DIS3, CPSF73 and INTS11 
Domain organisations of human DIS3, CPSF73 and INTS11. The PIN domain of 
DIS3 contains endoribonuclease activity and the RNB domain contains the active 
site for exoribonuclease activity. As INTS11 and CPSF73 are homologs, their 
domain organisation is similar. CPSF73 also contains a CTD, but its sequence is 
highly divergent from INTS11 and the exact boundary is unknown (Robinson et 







2. Materials and Methods 
 
2.1  Buffer compositions 
Before use, buffers were sterilised either by autoclave or filter-syringe, Millex-
GP 0.22 µm filter (Sigma). 
 
2.1.1 DNA/RNA Buffers 
• DNA Loading Buffer: Gel loading dye purple (6 x) (B7024S, NEB) 
• 1 x TBE buffer: 10 mM Tris-HCl (pH 8) (ThermoFisher Scientific), 
1 mM  EDTA (pH 8) (ThermoFisher Scientific) 
• Total RNA Extraction: TRI Reagent Solution (Sigma) 
 
2.1.2 SDS-Polyacrylamide gel electrophoresis (PAGE) and Western 
blot buffers 
• RIPA Buffer: 50 mM Tris-HCl (pH 7.4) (ThermoFisher Scientific), 
150 mM NaCl (ThermoFisher Scientific), 0.5 % Sodium 
Deoxycholate (Sigma), 1 % NP40 (ThermoFisher Scientific), 0.1 % 
Sodium Dodecyl Sulphate (SDS) (ThermoFisher Scientific) 
• 4 x SDS-PAGE sample buffer: 40 % Glycerol (ThermoFisher 
Scientific), 8 % SDS (ThermoFisher Scientific), 0.006 % 
Bromophenol Blue (Sigma), 0.25 M Tris-HCl (pH 6.8) 
(ThermoFisher Scientific). Before use, 0.5 ml was separated and 
warmed to 50 °C, then 50 µl b-mercaptoethanol added.  
• 4 x SDS-PAGE Stacking gel buffer: 0.5 M Tris-HCl pH 6.8 
(ThermoFisher Scientific), 0.4% SDS (ThermoFisher Scientific) 
• 4 x SDS-PAGE Resolving gel buffer: 1.5 M Tris-HCl pH 8.8 
(ThermoFisher Scientific), 0.4% SDS (ThermoFisher Scientific) 
• SDS-PAGE running buffer: 192 mM Glycine (ThermoFisher 
Scientific), 25 mM Tris, 0.1 % SDS (ThermoFisher Scientific) 




• 5% Blocking Solution: 2.5 g milk in 50 ml PBST  
• Enhanced Chemi-Luminescence (ECL) Solution 1: 100 mM Tris-
HCl (pH 8.5), 2.5 mM Luminol (Sigma), 400 µM p-Coumaric Acid 
(Sigma) 
• ECL Solution 2: 100 mM Tris-HCl (pH 8.5) 5.3 mM Hydrogen 
Peroxide (Sigma) 
 
2.1.3 Miscellaneous buffers 
• 1 x PBS: 137 mM NaCl (ThermoFisher Scientific), 10 mM Na2HPO4 
(Sigma), 2.7 mM KCl (ThermoFisher Scientific), 1.8 mM KH2PO4 
(pH 7.4 with HCl) (Sigma) 
• 1 x PBST: Same as 1 x PBS, except with addition of 0.05% Tween 
20 (Sigma) 
• Trypsin PBS-EDTA: 500 ml 1 x PBS, 1 mM EDTA (ThermoFisher 
Scientific), 0.25% Trypsin (Sigma) 
• 2 x Oligo annealing buffer: 100 mM NaCl (ThermoFisher 
Scientific), 20 mM Tris-HCl (pH 7.5) (ThermoFisher Scientific), 
1mM EDTA (pH 8) (ThermoFisher Scientific) 
• qPCR Master Mix: Agilent Brilliant III Ultra-Fast SYBR Green 
qPCR Master Mix (Agilent) 
 
2.1.4 RNA-Seq buffers and kits 
• HLBN: 10 mM Tris-HCl (pH 7.5) (ThermoFisher Scientific), 10 mM 
NaCl (ThermoFisher Scientific), 2.5 mM MgCl2 (Sigma), 0.5 % 
NP40 (ThermoFisher Scientific) 
• HLBNS: Same as HLBN with addition of 10 % sucrose.  
• Ribosomal RNA Depletion: Illumina Ribo-Zero Gold rRNA 
Removal Kit  
• RNA-Seq Library Generation: Illumina TruSeq Stranded Total 
RNA Library Prep Kit 
• RNA Purification: Beckman Coulter Agencourt RNAClean XP 
Beads 
• DNA Purification: Beckman Coulter Agencourt AMPure XP Beads 
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• QC Analysis of RNA and DNA: Agilent ScreenTape RNA; High 
Sensitivity RNA; D1000 Assay for TapeStation 
 
2.1.5 ChIP buffers 
• RIPA ChIP: 1 % NP40 (ThermoFisher Scientific), 150 mM NaCl 
(ThermoFisher Scientific), 0.5 % Sodium Deoxycholate (DOC) 
(Sigma), 0.1 % Sodium Dodecyl Sulfate (SDS) (Sigma), 50 mM Tris 
(pH 8) (ThermoFisher Scientific), 5 mM EDTA (ph 8) (ThermoFisher 
Scientific) 
• ChIP wash: 500 mM NaCl (ThermoFisher Scientific), 1 % NP40 
(ThermoFisher Scientific), 1 % DOC (Sigma), 100 mM Tris (pH 8.5) 
(ThermoFisher Scientific) 
• Elution buffer: 1 % SDS (Sigma), 0.1 M NaHCO3 (Sigma) 
 
2.1.6 Molecular biology kits 




















Western Blot Analysis detected levels of proteins using the following 
antibodies: 
 
Table 2.1 Antibodies used for Western Blot 
Protein Detected Antibody name Code Manufacturer 
DIS3 Rabbit Anti-DIS3 A303-764A Bethyl 










RNA Pol II Mouse anti-RNA 
Polymerase II CTD 
MABI0601 MBL 
























2.3  Vectors 
All vectors were supplied by Addgene and can be seen in Table 2.2.  
 
Table 2.2 Vectors 
Plasmid name Description 
pUC19 Cloning vector with empty backbone 
pX330-U6-Chimeric_BB-CBh-
hSpCas9 
Cloning vector for gRNA with U6 
driven expression, containing human 
codon optimised Cas9 
pBABE osTIR1 Human codon optimised TIR1 
pMK243 (Tet-osTIR1-Puro) Plasmid expressing OsTIR1 under 
control of the Tet promoter 
pCMV(CAT) T7SB100 SB-transposase 
pSBbi-Blast Empty SB-transposon with Blasticidin 
resistance gene 
 
2.4  Bacterial strains 
Molecular cloning / genetic recombination was conducted using high 
efficiency NEB 5 - alpha competent Escherichia coli, with the following conditions. 
 
2.4.1 Bacterial growth media 
Bacterial growth media was autoclave sterilised and stored at room 
temperature.  
• Luria Bertani (LB) Broth: 5 % Yeast Extract (Sigma), 10 % 
tryptone (Sigma) and 10 % NaCl (ThermoFisher Scientific) 






2.4.2 Antibiotic selection in bacteria 
Bacteria were grown in the presence of antibiotics, to select for positively 
transformed bacterial clones. The final concentrations of selective antibiotics 
used are as follows: 
• Ampicillin: 100 µg / ml 
• Kanamycin: 50 µg / ml 
 
2.5 Molecular Cloning 
 
2.5.1 Polymerase chain reaction (PCR) 
PCR was used to amplify specific sequences of DNA, using Q5 High-
Fidelity DNA Polymerase (NEB). Typically, a 50 µl reaction consisted of 20 ng 
template DNA, 5 µl of 5 x Q5 reaction buffer, 0.5 µl of 10 mM dNTPs (NEB), 1.25 
µl of 10 µM each primer, 0.25 µl Q5 High-Fidelity DNA Polymerase, 5 µl of Q5 
High GC Enhancer (optional), made up to 25 µl total volume with nuclease-free 
water. The PCR reaction was then set up as follows: 
 
 
Table 2.3 PCR Protocol 
Step Temperature Time Number of cycles 









30 seconds / Kb 
 
25 - 30 
Final extension 72 °C 2 minutes 1 
Hold 4 °C -  -  




 If original template DNA was from bacteria, the PCR product underwent a 
1 hour incubation at 37 °C with 0.5 µl DPN1 (NEB), to remove bacterial template 
DNA. DNA was then purified by a DNA phenol-chloroform extraction and ethanol 
precipitation (see section 2.5.4).  
 For colony screening transformed competent cells, a PCR reaction was 
set up using Taq polymerase (NEB). In a 25 µl volume this contained: variable 
template DNA (< 500ng), 200 µM dNTPS, 0.2 µM each of forward and reverse 
primer, 1 x Standard Taq Reaction Buffer and 1.25 Units Taq DNA Polymerase. 
The same PCR protocol was used as above, except with 30 – 32 cycles, an 
annealing temperature between 50 – 65 °C and an extension temperature of 68 
°C for 1 minute / Kb.  
 
2.5.2 Agarose gel Electrophoresis 
To perform agarose gel electrophoresis, agarose gels were prepared 
using 1 x TBE buffer containing 1 - 2 % (w/v) agarose that was heated until 
dissolved. 5 % of Midori Green Advanced DNA Stain (Geneflow) was added and 
the solution was left to cool and set in a OwlTM EasyCastTM Gasketed UVT gel 
tray (ThermoFisher Scientific). Gels were placed into an electrophoresis tank 
filled with 0.5 x TBE buffer and DNA samples containing 10 % DNA loading buffer 
were loaded into the wells alongside an appropriate DNA ladder. To separate 
DNA or RNA bands, gels were run under 120 V or 180 V respectively. Afterwards, 
visualisation by UV light was conducted using a Gel Doc XR + System (Bio-Rad). 
If gel separated DNA was to be used in downstream applications, a scalpel 
was carefully used to extract the required DNA from the gel. UV light was used 
to visualise the bands of DNA and extraction conducted swiftly to minimise UV 
exposure. DNA was then filtered for 20 seconds at 10,000 rpm into a 0.5 ml 







2.5.3 Restriction Digest 
Commercial enzymes were used to digest DNA according to 
manufacturer’s protocol, unless otherwise stated.  
 
2.5.4 Phenol-Chloroform extraction and Ethanol precipitation 
A 1:1 ratio of either DNA (pH 8) or RNA (pH 4.3) phenol-chloroform 
solution (Sigma) was added to DNA or RNA respectively, with a minimum total 
volume of 200 µl. Samples were vortexed and centrifuged for 5 minutes at 13,000 
rpm. The upper-phase solution was transferred to an Eppendorf containing 2.5 
times the volume of 100% Ethanol and a 10% volume of 3 M Sodium Acetate (pH 
5.4). Samples were vortexed again and centrifuged for 15 minutes at 13,000 rpm. 
The supernatant was completely removed and samples allowed to air-dry for 5 
minutes at room temperature. Cell pellets were resuspended in dH2O.  
 
2.5.5 Ligation with T4 DNA Ligase 
Ligation of linearised or restriction digested DNA occurred using T4 DNA 
Ligase (NEB). DNA concentrations were determined by a NanoDrop 2000 
Spectrophotometer (ThermoFisher) and 100 ng of DNA used in a 20 µl reaction 
containing T4 DNA Ligase Buffer and T4 DNA Ligase as stated in the 
manufacturer’s protocol. After incubation at 16 °C for 2 hours to overnight, 4 µl of 
reaction was transformed into competent bacterial cells.  
 
2.5.6 Gibson Assembly 
Gibson Assembly (NEB) was used to anneal DNA where vectors had been 
amplified as multiple fragments. To create blunt ended vectors, plasmid cassettes 
were amplified using divergent PCR. Cut vectors were treated with 1U Calf 
Intestinal Alkaline Phosphatase (CIP) (NEB) and 2 µl CutSmart Buffer for 30 
minutes at 37 °C to prevent re-ligation. DNA was purified by phenol-chloroform 
extraction and ethanol precipitation.  
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Insert fragments for Gibson Assembly were generated either by PCR or 
synthesised DNA oligos. In the case of small inserts, including gRNAs, DNA 
oligos were produced with homologous 5’ and 3’ arms to the blunt ends of the 
vector backbone. The complementary oligos were annealed together using 1 x 
Oligo annealing buffer and incubated for 5 minutes at 90 °C. Hybridisation 
occurred by gradual cooling to room temperature, forming a dsDNA insert. Other 
insert fragments, generated by PCR, were designed with 5’ and 3’ sequence 
complementarity with the cut vector. All insert fragments were purified by DNA 
phenol-chloroform extraction and ethanol precipitation.  
Typically for ligation, a 1:3 volume ratio (depending on relative size) of 
vector to insert was used with 1 x Gibson Reaction Master Mix (NEB). Ligations 
were incubated for 1 hour at 50 °C before subsequent transformation into 
competent bacterial cells.  
 
2.5.7 Transformation of plasmids into bacteria 
For transformation into bacterial cells, 10 - 20 ng of purified plasmid DNA 
or 4 µl of a ligation reaction was used. DNA was equilibrated to 4  °C by placing 
on ice for 5 minutes; concurrently 60 µl of bacterial cells were thawed on ice. After 
this incubation, 60 µl of thawed cells were added to the DNA and mixed once by 
pipetting. This was kept on ice for 5 minutes, before undergoing a heat-shock at 
42 °C for 90 seconds and immediately being transferred to ice for 2 minutes. 500 
µl of Super Optimal broth with Catabolite repression (SOC) medium (NEB) was 
added and mixed gently by inversion. Cells underwent a recovery step for 1 hour 
at 37 °C to allow expression of the antibiotic resistance gene, present in the 
transformed plasmid. After this time, approximately 250 µl of cells were pipetted 
onto a LB agar plate supplemented with the appropriate antibiotic and stored 
overnight at 37 °C.   
 
2.5.8 Plasmid purification from bacteria 
 Plasmids were isolated from single bacterial colonies that had grown on 
LB agar plates supplemented with the appropriate selection drug. Single colonies 
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were used to inoculate 6 ml of LB media supplemented with the relevant 
antibiotic, then stored at 37 °C overnight in a shaking incubator (180 rpm) to allow 
for bacterial growth. Following this, a cell pellet was obtained by centrifugation for 
5 minutes at 13,000 rpm. Plasmids were purified from cell pellets using the 
QIAprep Spin Miniprep Kit following manufacturer’s instructions.  
 
2.5.9 Plasmid construction for CRISPR/Cas9 
Repair templates generated for CRISPR/Cas9, were assembled using the 
empty pUC19 backbone. Homology arms for the gene of interest were 
synthesised flanking the poly(A) site using Integrated DNA Technologies (IDT) 
and ligated into pUC19. Using Gibson Assembly (NEB), a pre-synthesised (IDT) 
AID-P2A was inserted into the vector with either a hygromycin or neomycin 
resistance gene. For this incorporation, the vector was linearised between the 
penultimate and stop codon. 
IDT synthesised gRNA oligos to our gene of interest were inserted into a Cas9 
expression plasmid (pX330-U6-Chimeric_BB-CBh-hSpCas9) using Gibson 
Assembly (NEB). Sequences to create gRNA oligos were obtained using the 
online Benchling software (https://benchling.com).  
 HCT116:TIR1 cells had been previously made in the West lab by isolating 
human codon optimised TIR1 from pBABE osTIR1 and using SFI1 restriction 
sites in the pSBbi-Blast empty vector. CPSF73-AID doxycycline inducible and 
Ints11-SMASh cell lines were generated by Professor Steven West using the 
same approach as above except the Ints11-SMASh repair template contained a 
SMASh-tag instead of AID-P2A. Additionally, for the CPSF73-AID doxycycline 
inducible cell line osTIR1 was expressed under a tetracycline promoter using the 








2.6 Tissue culture 
 
2.6.1 Cell lines 
Multiple cells lines were created using HCT116 cells, by simple 
transfection protocols or CRISPR/Cas9 genome engineering. HCT116 cells were 
used due to their obligate diploid karyotype, to increase efficiency of 
CRISPR/Cas9 methods. A description of the cell lines generated are shown in 
Table 2.4. HCT116:TIR1, INTS11-SMASh, XRN2-AID and CPSF73-AID cell lines 
were made by Steven West.  
 
Table 2.4 Cell lines 
Cell line name Description 
HCT116 Unmodified human colon carcinoma cells; parental 
cells 
HCT116:TIR1 SB - integrated TIR1 in HCT116 cells 
DIS3-AID SB - integrated TIR1; homozygous 3’ AID tagged DIS3 




Homozygous 3’ AID tagged CPSF73; osTIR1 
expressed under a Tet promoter 
XRN2-AID SB-integrated TIR1; homozygous 3’ AID tagged XRN2 
 
 
For depletion of the protein of interest, 500 µM of auxin was added to DIS3-
AID for 60 minutes or XRN2-AID for 120 minutes. In CPSF73-AID doxycycline 
inducible cells, TIR1 expression was induced by addition of 2 µg / ml doxycycline 
for 16 hours, followed by 500 µM auxin addition for 2 hours to deplete CPSF73. 
In INTS11-SMASh cells, 2 µM of asunaprevir was added for 48 hours. Untreated 





2.6.2 Cell growth and maintenance 
All cells were incubated at 37 °C with 5 % CO2 and maintained in T75 
flasks containing Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10 % foetal calf serum (FCS) and 1 % Penicillin Streptomycin. Additionally, 
cells expressing TIR1 were maintained with blasticidin (5 µg / ml), to prevent loss 
of the TIR1 Sleeping Beauty (SB) plasmid.  
Once cells had grown to approximately 80 % confluency, they were 
passaged. For passaging, cells were washed with 1 x PBS, then washed with 
Trypsin PBS-EDTA and incubated for 3 minutes. 10 ml of DMEM media was 
added to cells to neutralise trypsinisation and pipetted up and down to remove 
cells from the flask wall. Approximately 1 ml of cells were seeded into a T75 flask 
containing 12 ml of DMEM media, then allowed to grow at 37 °C with 5 % CO2.  
 
2.6.3 Long-term storage of cultured cell lines 
Confluent T75 flasks (Greiner) of cultured cell lines were passaged as 
above, with cells resuspended in 10 ml of DMEM and centrifuged at 500 x g for 
5 minutes. For long-term storage at - 80 °C, cell pellets were resuspended in 1 
ml of FCS supplemented with 10 % DMSO and transferred to a cryovial. To 
recover cells from storage, cells were slowly thawed to room temperature and 
homogenised in 5 ml of DMEM. After centrifugation for 5 minutes at 500 x g, all 
media was removed and cells resuspended in 12 ml of DMEM (Sigma) and 
placed into a T75 for growth.   
 
2.6.4 Generation of the HCT116:TIR1 cell-line.  
Using the SB transposon system, HCT116 cells expressing TIR1 (HCT116:TIR1) 
were generated (Hackett et al 2010, Skipper et al 2013, Hou et al 2015). 400 ng 
of SB transposon and 50 ng of transposase plasmids were transfected using 
JetPrime Reagent according to manufacturer’s protocol. After 48 hours, cells 
were passaged into 10 cm dishes containing DMEM supplemented with 20 µg / 




2.6.5 Generation of stable cell-lines 
For generating CRISPR/Cas9 stable cell-lines with integration of either 3’ 
AID tag or SMASh tag, cells were split into 3 cm plates at approximately 30 % 
confluency. 2 µg of repair plasmid containing hygromycin or neomycin resistance 
and 2 µg of gRNA were transfected into cells using JetPrime Reagent (Polyplus). 
After 24 hours, media was changed and at 48 hours cells were passaged into 10 
cm plates. 
Stable cell-lines that had been successfully transfected with either a 3’ AID 
tag or SMASh tag on the target gene and, where stated, TIR1 integration at SB 
loci or doxycycline inducible TIR1 transfection, were selected using antibiotic 
resistance. Single colonies that grew in the presence of antibiotics were picked, 
transferred to 24 well plates and screened for homozygous integration. Final 
concentrations of antibiotics used are as follows: 
• Hygromycin: 150 µg / ml 
• Neomycin: 800 µg / ml 
• Blasticidin: 20 µg / ml 
• Puromycin: 1 µg / ml 
 
2.6.6 Genomic DNA isolation from stable cell-lines 
Positive cultured cells were screened for homozygous CRISPR/Cas9 
repair cassette incorporation by extracting genomic DNA using QuickExtract DNA 
Extraction Solution (Cambio). Cells were grown in 3 cm dishes to 80 % 
confluency, before being washed with 4 °C 1 x PBS. Cells were scraped and spun 
down in 1 ml of 1 x PBS, for 5 minutes at 500 x g. Supernatant was discarded 
and cell pellets resuspended in QuickExtract depending on pellet size. This was 
incubated for 6 minutes at 65 °C, then samples vortexed before incubation for 2 
minutes at 98 °C to denature the QuickExtract. Subsequently, 1 µl was used for 






2.6.7 RNAi transfections 
To deplete proteins using RNAi methods, cells were firstly split into 6-well 
dishes at approximately 30 % confluency and grown in DMEM media without 
antibiotics. Appropriate siRNA was transfected into cells using Lipofectamine 
RNAiMax (Life Technologies) following the manufacturer’s guidelines. 
Transfection was repeated after 48 hours and RNA was isolated 24 hours later.  
 
2.6.8 Transfection by electroporation 
Antisense morpholino oligonucleotides (AMO) were transfected into cells 
by electroporation. To do this, 1 x T75 flask of cells were grown in DMEM media 
without FCS or antibiotics. Cells were trypsinised, resuspended in 10 ml of media 
and centrifuged for 5 minutes at 300 x g. The cell pellet was resuspended in 800 
µl media. 10 µM of control morpholino was added to half of the cell volume and 
10 µM of U7 snRNA AMO was added to the remaining cells, ensuring full 
resuspension. Afterwards cells were placed into a 4mm cuvette and 
electroporated at 280 V, with a capacitance of 950 µF and infinity resistance, 
using a BioRad Gene Pulser Xcell. Electroporated cells were resuspended in 6 
ml of media before allowing to grow in a 3 cm plate for 5 hours. After this time 
RNA was extracted from cells following the protocol in Section 2.7.4.  
 
 
2.7  Molecular Biology 
 
2.7.1 Protein extraction for Western blot 
A confluent 3 cm plate of cells was used for protein extraction. Cells were 
washed with PBS, then scraped off the plate in 1 ml of 1 x PBS and added to a 
1.5 ml Eppendorf. Cells were spun for 5 minutes at 500 x g to create a cell pellet. 
The cell pellet was resuspended in RIPA buffer using 10 x volume of the cell 
pellet; the samples were vortexed then placed on ice for 20 minutes. Finally, 
samples were spun for 10 minutes at 13,000 rpm. The supernatant containing 
protein was removed and stored at - 20 °C.  
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2.7.2 SDS-PAGE  
Protein samples were separated by molecular weight using Sodium 
Dodecyl Sulphate PolyAcrylamide Gel Electrophoresis (SDS-PAGE). Gels were 
made using a 5 % stacking gel and a resolving gel, with the resolving gel varying 
in percentage of acrylamide depending on the size of the POI. Most commonly a 
10 % resolving gel was made as shown in Table 2.5. After addition of TEMED 
and 10 % Ammonium Persulphate (APS), the resolving gel was poured into the 
assembled Mini-PROTEAN Tetra Cell Casting Module (Bio-Rad). 500 µl of dH2O 
was pipetted on top of the resolving gel to minimise bubbles and then left until 
set, approximately 15 minutes. The stacking gel was poured on top and a 1.5 mm 
comb inserted, then the gel left to set. After setting, the comb was removed and 
wells were washed with 1 x SDS running buffer.  
Cast gels were placed into a Mini-PROTEAN system (Bio-Rad) inside a 
Buffer tank (Bio-Rad). The Buffer tank was then half filled with 1 x SDS-PAGE 
Running Buffer. Protein samples were prepared by addition of 4 x SDS-PAGE 
sample buffer containing b-mercaptoethanol and heated at 95 °C for 3 minutes 
to denature proteins. An appropriate protein marker was loaded and up to 20 µl 
of each sample. The gel was then run at 25 mA until the dye front passed through 
the stacking gel, upon which the gel was run at 50 mA until passed through the 
resolving gel.  
 
2.7.3 Western Blot 
Following from SDS-PAGE, proteins were transferred from the gel to a 
nitrocellulose membrane (GE Healthcare) using the Trans-Blot Turbo Transfer 
System (Bio-Rad) and Transfer Buffer. For 1 hour the membrane was blocked in 
5% blocking solution, whilst shaking. After blocking, the membrane was 
incubated on a shaker with 2% blocking solution and primary antibody for 1 hour. 
The membrane was then washed 3 times for 5 minutes each in PBST. 
Membranes were incubated for 1 hour with 2 % blocking solution containing a 
1:10,000 concentration of secondary antibody. Afterwards the membrane was 
washed 3 times in PBST for 5 minutes each. To visualise proteins, an equal 
volume of ECL 1 and ECL 2 solution were added to the membrane and images 
captured on a Gel Doc XR + system (Bio-Rad).  
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Table 2.5 Solutions and amounts to make 10 ml of Resolving Gel or 6 ml Stacking 
Gel.  
 8% 10% 12% Stacking Gel 
5% 
dH2O 4.73 ml 4.07 ml 3.35 ml 3.44 ml 
4 x Resolving 
Gel 




2.67 ml 3.33 ml 4 ml 1ml 
TEMED 100 µl 100 µl 100 µl 60 µl 
10 % APS 6 µl 10 µl 15 µl 6 µl 
* 4 x Stacking Gel was used instead of 4 x Resolving Gel 
 
2.7.4 Total RNA Extraction 
Total RNA was extracted from cells grown to 80 % confluency in a 6-well 
plate. All media was removed and cells were incubated with 1 ml of TRI Reagent 
(Sigma) for 5 minutes. Cells were transferred to a 1.5 ml Eppendorf, containing 
200 µl chloroform (Sigma). This was vortexed for 10 seconds then left at room 
temperature for 5 minutes. Afterwards, cells were centrifuged for 15 minutes at 
13,000 rpm. The upper aqueous layer was transferred to a new 1.5 ml Eppendorf 
containing a 1:1 (v/v) ratio of isopropanol (Sigma), then briefly vortexed before a 
10 minute spin at 13,000 rpm. Supernatant was completely removed and 650 µl 
of 70% ethanol added. This was centrifuged again for 10 minutes at 13,000 rpm. 
The supernatant was removed and pellet air-dried for 5 minutes to remove 
residual ethanol, before resuspension in 87 µl of dH2O. RNA samples were 
treated for 1 hour at 37 °C with 2 µl Turbo DNase (ThermoFisher), 10 µl Turbo 
DNase buffer and 1 µl RNase Inhibitor Murine (NEB) to remove contaminating 
DNA whilst preventing RNA degradation. Subsequently, DNase treatment was 
inactivated by RNA phenol-chloroform extraction and ethanol precipitation as 
described in Section 2.5.4, after which samples were stored at - 20 °C. A 3 µl 
aliquot of each RNA sample was run on a 1% agarose gel to ensure RNA 
obtained was not degraded. 
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2.7.5 Reverse Transcription (RT-PCR) 
RT-PCR was conducted on purified and genomic DNA depleted RNA, to 
produce cDNA for further use in Real-time Quantitative PCR (qPCR). 1 µg of RNA 
was used for each RT-PCR reaction, with a RT-PCR control for each sample and 
RNA concentrations being determined by a NanoDrop 2000 spectrophotometer 
(ThermoFisher). To 1 µg of RNA, 1 µl random hexamers (Bioline) were added 
and total volume made up to 10 µl. This was primed for 5 minutes at 70 °C, then 
immediately placed on ice, before addition of 10 µl reverse transcription master 
mix or reverse transcription control mix for RT-PCR controls (see Table 2.6). The 
reactions were incubated in a PCR machine for 5 minutes at 25 °C, 1 hour at 42 
°C, 20 minutes at 70 °C and held at 10 °C. Afterwards, the cDNA samples were 
diluted in 30 µl of dH2O and stored at - 20 °C. 
 
Table 2.6 Reagents and amounts required for RT-PCR 
Master mix components for 
reverse transcription 
Amount required for 1 x 10 µl 
reaction 
10 mM dNTP mix (ThermoFisher) 1 µl 
10 x DTT (NEB) 2 µl 
RNase free water 2.5 µl 
Protoscript II RT reaction buffer 
(NEB) 
4 µl 
*Protoscript II RT enzyme (NEB) 0.5 µl 
*Same component volumes used to make Reverse Transcription control mix, 




2.7.6 Real-Time Quantitative PCR (RT-qPCR) 
For RT-qPCR, all reactions were set-up in triplicate for both RT-PCR and 
RT-PCR control samples. In each reaction, 20 – 50 ng of cDNA was added to a 
master-mix containing the following to give a total reaction volume of 8 µl: 100 
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nM of reverse primer, 100 nM of forward primer, 4 µl of 2 x Brilliant III SYBR 
Green Master Mix (Agilent) and 2.8 µl dH2O. RT-qPCR was conducted in a Rotor-
Gene Q (Qiagen) using the incubation steps shown in Table 2.7, to detect 
amplicons of < 150 - 200 nt in length. Data acquisition occurred on the green 
channel, during the incubation for 10 seconds at 60 °C. A minus RT control was 
included in all RT-qPCR experiments to check for contaminating DNA.  
 
Table 2.7 RT-qPCR incubation steps 
Temperature Time Number of cycles 





40 - 50 cycles 
 
 For normalisation, spliced b-actin primers were used as a housekeeping 
control gene that had previously been shown in the laboratory to have stable 
expression in HCT116 cells. Rotor-Gene Q Series Software v2.3.1 was used for 
analysis to calculate fold enrichment relative to a control sample and melt curves 
were investigated to check primer specificity through the amplification of a single 
DNA product. Data was analysed to determine the delta delta CT relative 
quantitation values, with each sample normalised by comparison to the 
housekeeping gene, for the amount of template cDNA, then further normalised to 
a control sample i.e. non-treated cells. All RT-qPCR experiments were replicated 
in triplicate and figures containing RT-qPCR data show the mean of three 
independent RT-qPCR experiments.  
 
2.7.7 Cell colony formation assay 
To conduct a cell colony formation assay, 300 cells were seeded into 10 
cm plates with 8 ml of DMEM media supplemented with either 500 µM auxin or 
ethanol (solvent) for 10 days. Media was replenished every 3 - 4 days. After 10 
days, media was removed and cells placed on ice. Cell plates were washed twice 
in 4 °C PBS and cells were fixed by incubation of 10 ml methanol for 10 minutes. 
Plates were stained with 0.5 % crystal violet and 25 % methanol solution for 10 
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minutes. Excess crystal violet was removed by washing with dH2O, plates were 
air-dried and images taken. For analysis, Image J particle analyser function 
(Schindelin et al 2012) was used to count cell colonies. Colonies with a density 
range between 100-600 pixels and a circularity rating of 0.75 – 1 were counted. 
 
2.7.8 Chromatin immunoprecipitation protocol (ChIP) 
To bind antibody to Sheep Antimouse Dynabeads M280 (ThermoFisher), 
firstly 40 µl of beads per sample were rinsed in 500 µl RIPA ChIP buffer, 
resuspended in 1 ml of RIPA ChIP buffer then split equally into two tubes. The 
volume was made up to 1 ml using RIPA ChIP buffer with protease inhibitors and 
to one tube, 2 µg of RNA Polymerase II CTD antibody per sample was added. 
The Dynabeads were then rotated at 18 rpm in the cold room for 2 – 3 hours.  
Cells were seeded in 10 cm plates with DMEM media supplemented with 
10 % FCS. Cell plates were rinsed in 4°C 1 x PBS solution before addition of 10 
ml PBS directly to cells. Formaldehyde was added to a final concentration of 0.5 
% and plates were placed on a shaking platform (60 rpm) for a maximum of 10 
minutes. To quench the crosslinks, 1 M glycine was added to a final concentration 
of 125 mM, then cells left on the shaking platform for 5 minutes. Afterwards, cells 
were scraped into a 15 ml falcon tube and centrifuged at 500 x g for 5 minutes at 
4 °C. Pelleted cells were resuspended in 5 ml of PBS and centrifuged again at 
500 x g for 5 minutes at 4 °C. All supernatant was removed and cells resuspended 
in 300 µl of RIPA ChIP buffer per 30 µl cell pellet volume. The cell suspension 
was transferred to a sonication tube, before being placed in the Bioruptor Plus 
sonication device (Diagenode) for 10 minutes on high setting, 30 seconds on and 
30 seconds off. Sonicated cells were centrifuged for 10 minutes, at 13000 rpm 
and 4 °C. Supernatant was aliquoted so that two Eppendorfs contained 45 % of 
the sonicated cell volume each. The remaining 10 % cell volume was stored at - 
20 °C. For each Eppendorf, the volume was made up to 1 ml with RIPA ChIP 
buffer. 
Dynabeads incubated with or without antibody were placed in a magnetic 
rack and all supernatant removed. The beads were then resuspended in 10 µl of 
RIPA ChIP buffer per sample before 10 µl of bead suspension was added to each 
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tube, being careful to distinguish between plus and minus antibody samples. For 
immunoprecipitation, suspensions were rotated at 18 rpm in the cold room for 2 
hours. Using a magnetic rack all supernatant was removed from samples. The 
beads then underwent a series of washes performed in the cold room, as 
described in Table 2.8.  
 
Table 2.8 ChIP bead-wash protocol 
Solution Amount Repetition Rotation 
RIPA ChIP buffer 500 µl x 2 No 
ChIP wash buffer 500 µl x 1 No 
ChIP wash buffer 500 µl x 3 5 minutes of 18 
rpm rotation in 
between washes 
RIPA ChIP buffer 500 µl x 2 No 
 
 
1.5 ml of Elution buffer per sample was freshly prepared. Beads were 
resuspended in 250 µl of elution buffer and rotated on a wheel for 15 minutes at 
room temperature. Using a magnetic rack, the supernatant was transferred to a 
new Eppendorf. The elution process was then repeated, adding the second 250 
µl of eluate to the first. For an input sample control, 10 µl of the 10 % sample 
stored in the freezer previously was placed into a new Eppendorf. To all samples, 
25 µl of 4 M NaCl was added and incubated for 4.5 hours at 68 °C. DNA was 
purified by DNA phenol-chloroform extraction and ethanol precipitation before 








2.8  RNA-Seq 
 
2.8.1 Seeding cells 
Cells were seeded in 10 cm plates with DMEM media supplemented with 
10 % FCS. For CPSF73-AID doxycycline inducible HCT116 cells, 2 µg / ml of 
doxycycline was added the day of seeding and cells incubated for 16 hours. 
Following this, 500 µM auxin was added to the appropriate cells for 2 hours before 
RNA extraction. For Ints11-SMASh HCT116 cells, cells were seeded in 10 cm 
plates as above. Asunaprevir was added at a final concentration of 2 µM for 30 
hours before RNA extraction occurred.  
 
2.8.2 Nuclear RNA extraction for RNA-Seq 
Cells grown on 10 cm plates were at approximately 80 % confluency upon 
nuclear RNA extraction. Firstly all media was removed and cells washed in 4 °C 
1 x PBS solution. Cells were scraped off the plate in 10 ml of 1 x PBS and placed 
into a 15 ml falcon tube. This underwent centrifugation for 5 minutes at 500 x g. 
Cell pellets were resuspended in 4 ml of HLBN and incubated on ice for 5 
minutes. The solution was then carefully underlayed with 1 ml of HLBNS. This 
was centrifuged for 5 minutes at 500 x g to obtain a nuclear pellet. The nuclear 
pellet was resuspended in 5 ml HLBN to remove any traces of cytoplasmic 
material and centrifuged for 5 minutes at 500 x g, after which the supernatant was 
discarded. To extract nuclear RNA from the isolated nuclei, Tri Reagent (Sigma) 
was used as previously described in section 2.7.4 and samples stored at - 80 °C. 
 
2.8.3 Ribosomal RNA (rRNA) removal 
RNA quality was determined by using the TapeStation apparatus (Agilent). rRNA 
was extracted from 1 µg of genomic DNA depleted, nuclear RNA using the Ribo-





2.8.4 Purify RNA beads using Agencourt RNAClean XP Kit 
Before sample library preparation, RNA samples depleted of rRNA were 
purified to remove remaining salts and buffers and to concentrate samples. To 
each sample, 160 µl of RNAClean XP beads (Beckman Coulter) were added and 
mixed by pipetting. After a room temperature incubation of 15 minutes, samples 
were placed on a magnetic stand until the beads were captured and liquid was 
clear. The supernatant was removed and beads washed with 200 µl of 80 % 
ethanol. This wash step was repeated, all ethanol removed and the pellet air-
dried for 3 minutes. Dried beads were resuspended in 11.5 µl of Resuspension 
Buffer, incubated at room temperature for 2 minutes then placed on the magnetic 
rack for 5 minutes. All supernatant was removed, placed into a 0.5 ml Eppendorf 
and stored at - 80 °C. Before proceeding, the quality and quantity of depleted 
RNA samples were checked using 2 µl from each sample on a Tapestation High 
Sensitivity RNA ScreenTape (Agilent).  
 
2.8.5 TruSeq Stranded mRNA 
Purified RNA was used to create a library of template molecules using the 
TruSeq Stranded Total RNA Sample Preparation Kits (Illumina). 8.5 µl of Elute, 
Prime, Fragment High Mix was added to each sample and mixed by pipetting. 
This was incubated for 8 minutes at 94 °C, then held at 4 °C. Following 
manufacturer’s instructions, Actinomycin was added to the First Strand Synthesis 
Act D mix to prevent spurious DNA synthesis. A master mix of Superscript II and 
First Strand Synthetic Act D was made with a volume ratio of 1:9 respectively, for 
each sample. Of this master mix, 8 µl was added to each sample then incubated 
for the following to synthesise the first cDNA strand: 10 minutes at 25 °C, 15 
minutes at 42 °C, 15 minutes at 70 °C and held at 4 °C.  
To synthesise the second strand cDNA, firstly 20 µl of Second Strand 
Marking Master Mix was added to each sample and mixed by pipetting. This was 
incubated for 1 hour at 16 °C. For separation of the double-stranded cDNA from 
the second strand reaction mix, 90 µl of AMPure XP beads (Beckman Coulter) 
were added and incubated at room temperature for 15 minutes. Beads were 
captured on a magnetic rack and supernatant discarded. Samples were washed 
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with 200 µl of 80 % ethanol twice then beads air-dried for 3 minutes. Dried beads 
were resuspended in 17.5 µl Resuspension Buffer, then placed on the magnetic 
rack and 15 µl of supernatant, now containing blunt-ended cDNA, transferred to 
a new 1.5 ml Eppendorf.  
To prevent ligation of blunt fragments, a single ‘A’ nucleotide was added 
to 3’ ends. 12.5 µl of A-Tailing Mix was added to samples and incubated at 37 °C 
for 30 minutes, 70 °C for 5 minutes and held at 4 °C. Index adaptors were then 
ligated to the ends of double stranded cDNA. Firstly 2.5 µl of Ligation Mix and 2.5 
µl RNA Adaptor Index was added to each sample and mixed by pipetting. An 
incubation of 10 minutes at 30 °C occurred before 5 µl of Stop Ligation Buffer 
was used to stop the ligation reaction. 42 µl of AMPure XP beads (Beckman 
Coulter) were added, incubated at room temperature for 15 minutes then beads 
captured on a magnetic rack. The supernatant was removed and beads washed 
with 200 µl of 80 % ethanol twice. Beads were air-dried for 3 minutes and 
resuspended in 52.5 µl of Resuspension Buffer, then placed on a magnetic rack 
and 50 µl of supernatant was transferred to a new 1.5 ml Eppendorf. Another 50 
µl of AMPure XP beads (Beckman Coulter) were added to the supernatant and 
incubated at room temperature for 15 minutes. The magnetic rack was used to 
remove the supernatant and beads washed twice with 80 % ethanol. After air-
drying the beads, they were resuspended in 22.5 µl Resuspension Buffer, then 
captured on a magnetic rack and 20 µl of supernatant transferred to a new 
Eppendorf.  
To enrich for DNA fragments with adaptor molecules on either end and 
amplify DNA amounts, 5 µl of PCR Primer Cocktail and 25 µl of PCR Master Mix 
were added to each sample. This was incubated as shown in Table 2.9. 
Afterwards, 40 µl of AMPure XP beads (Beckman Coulter) were added and 
incubated at room temperature for 15 minutes. Beads were captured on a 
magnetic rack, supernatant discarded and beads washed twice with 200 µl of 80 
% ethanol. Air-dried beads were resuspended in 32.5 µl Resuspension Buffer 
then placed on a magnetic rack. 30 µl of supernatant was transferred to a new 




Table 2.9 DNA fragment enrichment PCR for RNA-Seq 
Step Temperature Time Number of cycles 
Initial 
denaturation 




98 °C  




30 seconds  
 
15 
Final extension 72 °C 5 minutes 1 
Hold 4 °C -  -  
 
 
2.8.6 Sequencing  
Before sequencing, DNA fragment size and concentration were 
determined by running each sample on a Tapestation D1000. Samples were 
given to the Exeter Sequencing Service facility to conduct a HiSeq 2500 (Illumina) 
rapid run single-end with a read length of 50 bp. 
 
Table 2.10 Total mapped reads for all RNA-Seq data using merged replicate 
libraries* 
RNA-Seq cell lines Total mapped reads  Total exon mapped 
reads 
DIS3-AID  76561054 32900452 
DIS3-AID with auxin 56625921 22512088 




CPSF73-AID 81473198 22067230 
CPSF73-AID + auxin 81136711 17050608 





2.9 Bioinformatic analysis 
Bioinformatic software used in the analysis of sequencing data obtained 
through RNA-Seq is shown in Table 2.11. Software derived from a Bioconductor 
package in the R environment is denoted by a *. Bioinformatical analysis on RNA-
Seq data derived from the DIS3-AID cell line only, was conducted by Lee 
Davidson.  
 
2.9.1  Read alignment of RNA-Seq data 
The sequencing quality of unprocessed single-end 50 bp reads obtained 
from RNA-Seq data was determined by FastQC (Andrews, 2010). TrimGalore! 
was used to remove adaptors from reads and to discard reads shorter than 20 bp 
(Krueger, 2012). Reads were aligned to the human genome using Hisat2 with a 
known splice sites file and all analysis conducted used the Ensembl GRCh38.p10 
and GRCh38.90 human gene annotations. All non-mapped reads and reads with 
a mapping quality less than 20 were removed using SAMtools (Li, 2011).  
 
2.9.2 Differential Expression Analysis 
featureCounts was used to count all reads over a gene or transcript and 
determine expression levels, only counting reads with a minimum mapping 
quality score of 30 (Liao et al, 2014). The Integrated Genome Viewer (IGV) suite 
was used to visualise normalised coverage plots (Reads per Kilobase of 
transcript per Million mapped reads, RPKM) throughout the genome (Robinson 









Table 2.11 Bioinformatic software 
Software name Version Description Reference 
BamTools v2.4 Processes BAM files Barnett et al, 
2011 
BEDTools v2.2.5 Allows comparison of large 
sets of genomic features; 
tools for genomic analysis 
Quinlan and Hall, 
2010 
BEDOPS v2.4.33 Toolkit for processing 
genomic data 
Neph et al, 2012 
CutAdapt v1.14 Removes adaptor 
sequences from sequencing 
reads 
Martin, 2011 
Deeptools v3.0.2 Python tools for analysis of 
high-throughput sequencing 
Ramírez et al, 
2016 
FastQC v0.11.5 Quality control of raw 
sequence data 
Andrews, 2010 
FeatureCounts v1.6.0 Counts reads to genomic 
features 
Liao et al, 2014 
GenomicRanges* v1.30.2 Storage and manipulation of 
genomic intervals and 
variables 
Lawrence et al, 
2013 
HISAT2 v2.1.0 Alignment programme for 
mapping sequencing reads 
Kim et al, 2015 
IGV v2.4.3 Visualisation tool for 
genomic datasets 
Robinson et al, 
2011 
R v3.4.4 Software environment for 
statistics and graphics 
http://www.R-
project.org 
Rtracklayer* v1.38.3 Interface for manipulating 
annotation tracks 
Lawrence et al, 
2009 
SAMtools v1.6 Manipulates alignments in 
the SAM format 
Li, 2011 
TrimGalore! v0.4.4 Applies quality and adapter 







Using the gene count file created via featureCounts, which counted the 
number of reads aligned to a gene or transcript, any gene or transcript with less 
than 200 reads were removed. To each gene, an increased transcriptional 
window of 1 Kb upstream of the TSS was added. Additionally either 7 Kb, 50 Kb 
or 100 Kb was added downstream of the TES depending on the metaplot graph. 
Any genes that overlapped after this extension were removed to prevent 
repetitive counting of mapped reads using BEDTools merge (Quinlan and Hall, 
2010). RPKM normalised reads from the remaining genes were used to generate 
metaplot profiles. This was conducted using the deeptools suite (Ramírez et al, 



















2.10 Primers and oligonucleotides 
 






CACCGTCCATGTTTGAAGTATCAGT Used to make the 
gRNA for creation of 





primer 1 F 
TCTTTAGGCCACGGGATTCT First set of screening 
primers to determine 
insertion of the AID tag 
to the DIS3 gene. 
Designed outside of the 
homology arms and 








primer 2 F 
TCCATTCTCCTGCCTAGTCT Second set of 
screening primers to 
determine insertion of 
the AID tag to the DIS3 
gene. Designed outside 
of the homology arms 





















































STK II F  GGGAGTCTAAGGAAAAGGAG Primers designed to detect a 
PROMPT upstream of the 
STKII gene TSS.  
STK II R CAGTGAAAGGAGAGCGTATC 
SERPINB8 
F 
CTACTGATCACACCCTCCTC Primers designed to detect a 
PROMPT upstream of the 




FOX P4 F TGCACAATTTCACACCTAGA Primers designed to detect a 
PROMPT upstream of the 
FOX P4 gene TSS. 
FOX P4 R ATGTTAGTGACACCTGCACA 
RBM39 F GGAAATAGTGGAGAAAAGCA Primers designed to detect a 
PROMPT upstream of the 
RBM39 gene TSS. 
RBM39 R CATTTTTGAAGGAACGGTAG 
 
 









Primers to detect 
prematurely terminated 
NFU1 transcripts, by 
measuring RNA levels over 











Primers measuring NFU1 
RNA levels over the exon-




















CLIP4 transcripts, by 
measuring RNA levels over 






Primers measuring CLIP4 
RNA levels over the exon-









CCACCTCCGCGAGTTTTATG Primers to detect 
prematurely terminated 
PCBP1-AS1 transcripts, by 
measuring RNA levels over 











PCBP1-AS1 RNA levels 
over the exon-intron 











Primers to detect 
prematurely terminated 
C2orf42 transcripts, by 
measuring RNA levels over 











Primers measuring C2orf42 
RNA levels over the exon-












Table 2.16 Primers for detection of snRNAs and RNA levels downstream of their 
TES 
Primer name Sequence Description 
RNU5B-1  
300 bp F 
CCGGTAATCCCACTGCATTG Detects RNA levels 300 
bp downstream of the 
RNU5B-1 TES 
RNU5B-1  
300 bp R 
CATTGTCCATGTGTGCCGAT 
RNU5B-1   
1.5 Kb F 
AGAATCGCTTGAACCTGGGA Detects RNA levels 1.5 
Kb  downstream of the 
RNU5B-1 TES 
RNU5B-1  
1.5 Kb R 
CCAGCCTGTGTGATAAAGCC  
RNU5D-1 
200 bp F 
TGTTTGTTGCGAGGTGTGAG Detects RNA levels 200 
bp downstream of the 
RNU5D-1 TES 
RNU5D-1 
200 bp R 
GGAAAATCCCTTGAAGCCGG 
RNU5D-1   
3.5 Kb F 
TAGCTGAATGTGGTCGTGGT Detects RNA levels 3.5 
Kb downstream of the 
RNU5D-1 TES 
RNU5D-1   
3.5 Kb R 
TCCTGACCTCATGATCTGCC 
RNU1-28P 
300 bp F 
GTGCTTTCTCCAGGCCAAAG 
 
Detects RNA levels 300 
bp downstream of the 




500 bp F 
TCCGGCTTAGAGGTTTAGGA Detects RNA levels 500 
bp downstream of the 
RNU1-28P TES 
RNU1-28P 
500 bp R 
AGTCTCCTGTTCTTGAGGGC 
RNU1-28P    
1 Kb F 
GAATTGCTTGAACCCGGGAG Detects RNA levels 1 Kb 
downstream of the RNU1-
28P TES 
RNU1-28P    
1 Kb R 
AATGCACATTCGGACTCAGC  
RNU1-28P    
2 Kb F 
TCCCTTCACCTGCTTCAAGT Detects RNA levels 2 Kb 
downstream of the RNU1-
28P TES 
RNU1-28P    
2 Kb R 
AATCTACACCGGGCTGCATA 
RNU1-28P 
2.5 Kb F 
TTTCACCGTGTCATCCAGGA 
 
Detects RNA levels 2.5 
Kb downstream of the 
RNU1-28P TES RNU1-28P 2.5 Kb R 
GGGTGACAGCGAGACTTAGT 
 
RNU1-28P    
3 Kb F 
GCGGTGCAGGGTTATCTTTT Detects RNA levels 3 Kb 
downstream of the RNU1-
28P TES 
RNU1-28P    




RNU1-1     
500 bp F 
TCTCTGGGAAGAAAGCAGGG Detects RNA levels 500 
bp downstream of the 
RNU1-1 TES 
RNU1-1     
500 bp R 
ACGGCAGGAGATAGTAGGGA 
RNU1-1          
1 Kb F 
GGTTTTGTCCCTGCACTACA Detects RNA levels 1 Kb 
downstream of the RNU1-
1 TES 
RNU1-1          
1 Kb R 
AGGCTGGTCTTGAACTCCTG 
RNU1-1           
2 Kb F 
TCTCTGTTGGGTCGTGTTGA Detects RNA levels 2 Kb 
downstream of the RNU1-
1 TES 
RNU1-1          
2 Kb R 
GCCACTCTTGCAGATATTGACA 
RNU1-1           
3 Kb F 
CACCACGCCCAGCTAATTTT Detects RNA levels 3 Kb 
downstream of the RNU1-
1 TES 
RNU1-1          
3 Kb R 
TCAAGCATAAGGAGCCTGGG 
RNU4-2      
500 bp F 
ACACTATGTTGGGAACTGGGT Detects RNA levels 500 
bp downstream of the 
RNU4-2 TES 
RNU4-2      
500 bp R 
GGAAACAGCGAAAACTCCGT 
RNU4-2           
1 Kb F 
CACTACACCAGCCTCTTCCA Detects RNA levels 1 Kb 
downstream of the RNU4-
2 TES 
RNU4-2          
1 Kb R 
TTTTCCCAGCACCGTCTTTG 
RNU4-2           
2 Kb F 
ACTGCAATCTCCACTTCCCA Detects RNA levels 2 Kb 
downstream of the RNU4-
2 TES 
RNU4-2          
2 Kb R 
TGAGCCCAGGAGTTTGAGAC 
RNU4-2          
3 Kb F 
TATTGGTCAGGCTGGTCTCG Detects RNA levels 3 Kb 
downstream of the RNU4-
2 TES 





CTGGTTTCTCTTCAGATCGCA Detects levels of RNU5A-





CCAATACCCCGCCGTGAC Detects levels of RNU4-1 





TCCATTGCACTCCGGATGT Detects levels of RNU1-1 










CATGAGGAGGTTACAGGCCA Detects levels of spliced 
INTS1 mRNA.  
 
Table 2.17 Primers to detect RDHs and RNA levels downstream of their TES 
Primer name Sequence Description 
HIST1H4H 
gene body F 
GTTTGGGTAAGGGAGGAGCT Primers to detect levels of 
HIST1H4H HIST1H4H 




GACGCACTCTTTACGGCTTC Primers to detect 






150 bp F 
TTACTCGTGCTTAATCTCGCA Primers to detect RNA 
levels 150 bp downstream 
of the HIST1H4H TES 
HIST1H4H 
150 bp R 
TGTCACAATCCAGCTTACTCAC 
HIST1H4H 
600 bp F 
CTACAAAAGGCAGTGTGGGG Primers to detect RNA 
levels 600 bp downstream 
of the HIST1H4H TES 
HIST1H4H 
600 bp R 
CAGCCTGGATGAAAGAGCAA 
HIST1H4H    
1 Kb F 
TCCCAAGTGACTACAGGCTC Primers to detect RNA 
levels 1 Kb downstream of 
the HIST1H4H TES 
HIST1H4H    
1 Kb R 
CACGCCTGTAATCCCAACAC 
HIST1H4H    
2 Kb F 
TAGGGTCTTGCTCTGTTGCC Primers to detect RNA 
levels 2 Kb downstream of 
the HIST1H4H TES 
HIST1H4H    
2 Kb R 
GGACCAGCCTAACCCCATAA 
HIST1H3B 
gene body F 
GGCTCGTACTAAACAGACAGC Primers to detect levels of 
HIST1H3B HIST1H3B 




AGGGCTCTTTGAGGACACAA Primers to detect 






150 bp F 
TCTTTTCAGAGCCACCCACT Primers to detect RNA 
levels 150 bp downstream 
of the HIST1H3B TES 
HIST1H3B 
150 bp R 
GCAAGACTGACCAAACCGTT 
HIST1H3B 





300 bp R 
TGCCTAGTAAGCGCCAGTTA Primers to detect RNA 
levels 300 bp downstream 
of the HIST1H3B TES 
HIST1H3B    
2 KB F 
ATGCTCTGCTTGTACCAGGT Primers to detect RNA 
levels 2 Kb downstream of 
the HIST1H4H TES 
HIST1H3B    




AGTCTCTTCTCATGCCTCGT Primers to detect RNA 
levels 3 Kb downstream of 
























3. Results Chapter 1 : The role of DIS3 in the nucleus of human 
cells 
DIS3, also known as RRP44, is a major component of the nuclear 
exosome complex which has a vital role in the processing and degradation of a 
broad range of RNA transcripts (Allmang et al, 1999; Mitchell et al, 2014). As 
previously mentioned, DIS3 has two catalytically active domains, a RNB and a 
PIN domain, which constitute the 3’ – 5’ exonuclease and endonuclease activities 
of DIS3 respectively. DIS3 is able to act independently or as part of the exosome, 
where it associates with the exosome EXO-9 core structure at the exit pore 
(Lebreton et al, 2008; Schneider et al, 2009; Schaeffer et al, 2009; Bonneau et 
al, 2009; Lorentzen et al, 2008; Gerlach et al, 2018). At the opposing entry pore 
end of EXO-9 is where the other 3’ – 5’ exonuclease of the exosome resides, 
EXOSC10. Degradation of substrates by DIS3 is facilitated by: EXOSC10 
mediated threading of transcripts into the central channel allowing them to reach 
the active site of DIS3; MTR4 helicase unwinding of RNA; and potentially DIS3 
endonuclease function resolving complex secondary structures by cleavage, 
providing alternative 3’ ends for DIS3 and EXOSC10 (Wasmuth et al, 2014; 
Zinder et al, 2016; Falk et al, 2017; Lebreton et al, 2008).  
Whether DIS3 and EXOSC10 have their own specific substrates or work 
together is currently unclear, although it has been proposed that DIS3 provides 
the main catalytic activity of the exosome (Januszyk et al, 2011; Dziembowski et 
al, 2007). Through studies using either catalytically dead DIS3 or depleted DIS3 
levels, some clear DIS3 substrates have been elucidated. Upon DIS3 depletion, 
there is an accumulation of short transcripts derived from promoter upstream 
regions, due to bidirectional transcription. These are known as PROMPTs and 
are only detectable upon exosome dysfunction (Preker et al, 2008; Preker et al, 
2011). In addition, eRNAs, snoRNAs and prematurely terminated protein-coding 
transcripts have been suggested as DIS3 substrates (Szczepinska et al, 2015).  
Functions of the exosome have largely either been revealed in human cells 
with protein depletion by RNAi or through studies in yeast, due to the ease of 
generating gene knockout mutants. However, findings in yeast are not always 
translational to humans and RNAi methods are slow with indirect effects (Tomecki 
et al, 2010; Jackson et al, 2003; Boutros and Ahringer, 2008). Therefore, a 
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method producing rapid protein depletion would be beneficial to investigate the 
immediate effects of DIS3 loss. To this end and to further understand DIS3 
function in human cells, I aimed to generate conditional DIS3 depletion cells using 
CRISPR/Cas9 and AID technologies. This allowed rapid depletion of DIS3 and 
through the use of RNA-Seq I was able to investigate direct substrates of DIS3.  
 
3.1 Production of the DIS3-AID cell line 
For rapid and reversible knockdown of DIS3 protein we used 
CRISPR/Cas9 to produce a DIS3-AID cell line in HCT116 cells. These cells are 
derived from human colon carcinoma and have a diploid karyotype, unlike other 
standard mammalian cell culture models (Haigis et al, 2002; Horii et al, 2015). 
This allows for easier selection of homozygous tagged cell populations using only 
two drug resistance markers, making them highly suitable for genome 
manipulation. In addition, HCT116 cells have a high efficiency and ease of 
plasmid transfection. Both alleles of DIS3 were genetically modified by the 
addition of an AID tag at the 3’ end. This approach allowed us to overcome some 
of the limitations of RNAi based protein depletion.  
 
3.1.1 Plant specific TIR1 expression in HCT116 cells  
For the auxin-degron system to function in human cells, our cell line 
required the expression of the plant specific TIR1 F-box protein. This would allow 
TIR1 to recognise an AID tagged protein and promote its ubiquitination through 
the SCFTIR1 complex and recruited E2 ubiquitin ligase, leading to degradation 
(Gray et al, 1999; Nishimura et al, 2009; Holland et al, 2012). For stable TIR1 
integration into transcriptionally active loci of HCT116 cells, the sleeping beauty 
transposon system was exploited.  
The sleeping beauty (SB) system utilises a “cut-and-paste” DNA 
transposon and a transposase. Transposition of a DNA transposon is the direct 
movement of DNA through transposase-mediated excision from a donor locus 
and reinsertion into the cell genome. DNA sequences are flanked by terminal 
inverted repeats (IR) which contain transposase binding sites (Ivics and Izsvak, 
2015). Although there are several transposon delivery systems, the sleeping 
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beauty transposon was selected due to its’ ability to integrate a transposon of up 
to 10 Kb in length and is less likely to integrate into genes than HIV- or AVV-
based vectors (Izsvak et al, 2000; Izsvak and Ivics, 2004). In addition, the SB 
transposon system has been shown to produce transposon expression for a 
prolonged period of time and at an adequate level (Yant et al, 2000; Belur et al, 
2003; Kowarz et al, 2015).  
TIR1 under the control of an ON CMV promoter was expressed inside a 
SB transposon vector with flanking IR sites. For selection of transfected cells, the 
vector contained a blasticidin resistance gene. A single colony grown under drug 
selection was cultivated to produce HCT116 cells expressing TIR1, which from 
now on are referred to as HCT116:TIR1 cells. 
 
3.1.2 AID tagging of DIS3 using CRISPR/Cas9 and HDR 
To produce DIS3 protein tagged with AID, both DIS3 alleles were targeted 
for CRISPR/Cas9. Firstly, two repair templates were generated containing the 
AID tag, a self-cleaving peptide (P2A), a drug resistance selection marker of 
either hygromycin or neomycin to ensure tagging of both alleles simultaneously, 
a SV40 PAS and flanking sequences homologous to the 3’ ends of the 
endogenous DIS3 gene (Figure 3.1). Secondly a gRNA plasmid was constructed 
with sequence homology to DIS3 and containing Cas9. Both selectable marker 
constructs were integrated into the cell with the gRNA directing Cas9 specifically 
to the DIS3 gene. Cas9 cleaved the DIS3 gene resulting in a double-stranded 
break, which was then repaired using HDR and the repair templates. This 
resulted in integration of the AID tag with a P2A site, drug selection marker and 
SV40 PAS at the 3’ end of DIS3. Homozygous tagged DIS3 cell selection was 
aided by the diploid karyotype of HCT116 and obtained through drug selection. 
Transcription of the newly tagged DIS3 generates a single mRNA transcript using 
the endogenous promoter and SV40 PAS. The resulting AID-tagged protein is 
released after self-cleavage at the P2A site which removes the drug selection 






Figure 3.1 Generation of DIS3-AID using HDR and CRISPR/Cas9 
A gRNA with homology to DIS3 directs Cas9 to create a double-stranded break 
in the 3’ end of the DIS3 gene. The break is repaired by HDR using repair 
templates containing the AID tag, a P2A site, drug selection marker and SV40 
PAS. Both alleles are altered and mRNA is produced using the endogenous 
promoter and a SV40 PAS downstream of the selection marker. Following 
translation into a protein, the P2A peptide self cleaves to produce two distinct 
proteins: the AID-tagged DIS3 and drug resistant protein.  
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3.1.3 Genomic PCR validation of DIS3-AID 
After antibiotic selection of DIS3-AID cells, single colonies were isolated 
and allowed to grow. Homozygous integration was validated by a genomic DNA 
PCR screen. A nested-PCR approach was used with primers designed to flank 
the homology arms. All three clones investigated showed inclusion of DIS3 
homozygous modification compared to a control HCT116:TIR1 cell line. This can 
be seen by the single large band at the expected size for tag incorporation in 
DIS3 clones, compared to the single smaller PCR product only present in the 
control cell line (Figure 3.2). Overall this confirmed modification of both DIS3 
alleles and from this we decided to continue all further experiments with clone #1.  
 
3.2 Conditional depletion of DIS3 by auxin addition 
Following validation of the AID-tag being incorporated into both alleles of 
DIS3, DIS3-AID cells underwent western blot screening to determine if auxin 
treatment had an effect on DIS3 protein levels. An antibody binding to the C 
terminus of DIS3 was used in a western blot with HCT116:TIR1 or DIS3-AID cells 
treated or not with auxin (Figure 3.3A). Endogenous DIS3 was easily detected in 
HCT116:TIR1 cells and levels were unchanged by auxin addition. However, no 
DIS3 was detected in the DIS3-AID cell line. As the AID tag is present on the C 
terminus of DIS3, this absence of detection may have been due to the AID tag 
effecting the efficacy of antibody binding and leading to a false negative detection. 
To overcome this issue a different antibody to DIS3 was used that 
recognises an internal amino acid sequence, thus allowing detection of both 
endogenous DIS3 and AID-tagged DIS3 (Figure 3.3B). An unmodified parent cell 
line, HCT116:TIR1, was used as a control and the endogenous DIS3 protein was 
detected at approximately 117 kDa. In the DIS3-AID cell line a larger DIS3 
specific band was observed at approximately 150 kDa, suggesting incorporation 








Figure 3.2 Genomic PCR validation of DIS3-AID 
Nested PCR of genomic DNA obtained from 3 DIS3-AID clones after undergoing 
antibiotic selection (#1 - #3) and a control HCT116 cell line (C). Products were 
produced using primers designed outside the homology arm sequences as 
shown by the arrows. A single small endogenous DIS3 band can be seen 
exclusively in the control cell line, whereas a larger band with predicted size of 
DIS3 with tag incorporation is seen in all 3 DIS3-AID colonies. The endogenous 
band is not present in the DIS3-AID colonies suggesting both alleles were 
genetically modified. Clone #1 was taken forward for all future experiments.  
- tag
+ tag
#1 #2 #3 #4 C
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This band was slightly bigger than the predicted size for AID-tag incorporation, 
however I believe it represents DIS3-AID protein as often modified proteins 
migrate during SDS-PAGE at rates inconsistent with their molecular mass, known 
as gel-shifting (Rath et al, 2009; Shi et al, 2012; Guan et al, 2015).  
The lack of an endogenous DIS3 band in the DIS3-AID cells further 
supports the previous genomic PCR screen, suggesting a homozygous tagging 
of DIS3. Upon addition of auxin to cell media for 1 hour, the higher DIS3-AID band 
observed in the DIS3-AID cells is no longer detectable. However, auxin treatment 
of HCT116:TIR1 cells had no effect. Therefore, auxin is able to specifically 
deplete AID-tagged DIS3 whilst having little / no effect on endogenous DIS3 
protein levels. For protein depletion by auxin to occur, both TIR1 expression and 
inclusion of the AID-tag at the 3’ end of the protein of interest is required. In 
addition, auxin treatment was conducted for 1 hour and was able to deplete 
tagged DIS3 levels to near complete absence. This shows that the rate of protein 
depletion following auxin treatment is rapid. Interestingly, comparing the two cell 
lines without auxin treatment there appeared be to less DIS3-AID protein 
expressed than endogenous DIS3. A qRT-PCR was conducted to investigate 
whether DIS3 mRNA levels were also altered (Figure 3.3C). In DIS3-AID cells 
there was a significant depletion of spliced DIS3 mRNA levels, probably caused 
by inclusion of the AID tag, that explains the reduced protein expression 
observed. An auxin treatment time course was not carried out, due to the near 
complete depletion of DIS3 protein levels at 1 hour. Longer auxin treatment would 
have increased the likelihood of confounding secondary / downstream effects and 
possible redundant pathway activation. Shorter auxin treatment times may not 
have been long enough for a strong DIS3 depletion, although this was not tested.  
For further validation an antibody to detect the AID-tag was used in both 
control and DIS3-AID cells (Figure 3.3D). As expected, no detectable band was 
observed in the control cell line. However, the AID-tag could be readily observed 
in untreated DIS3-AID cells with a band of corresponding size absent upon 1 hour 
of auxin treatment. This further supports our findings that auxin conditionally 






Figure 3.3 Western blots of endogenous DIS3, AID-tagged DIS3 and a-AID 
A,B,D) Western blots showing the levels of specific proteins in control 
HCT116:TIR1 cells and DIS3-AID cells that had either been untreated or treated 
with auxin for 1 hour. Anti-a-tubulin was used as a loading control. A) Antibody 
to the C terminus of DIS3 detected levels of endogenous DIS3 protein. B) 
Antibody to internal sequence of DIS3 protein used to detect endogenous and 
AID-tagged DIS3 protein. C) qRT-PCR detected levels of spliced DIS3 mRNA in 
HCT116:TIR1 and DIS3-AID cells, treated or not with auxin. D) Anti-a-AID 
antibody used to detect the levels of the AID-tag. The AID-tag was detected in 
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3.2.1 Rapid depletion of DIS3 leads to accumulation of PROMPTs 
Modification of DIS3 by addition of the AID tag could potentially affect DIS3 
function, by causing substrate recognition issues or reducing catalytic activity.  To 
investigate these potential issues, the function of DIS3-AID protein and its 
depletion were tested using known substrates. As previously discussed, 
PROMPTs are well-characterised substrates of the exosome and more 
specifically DIS3 (Preker et al, 2008; Szczepinska et al, 2015). The levels of four 
different PROMPTs (STK11-IP, SERPINB8, FOXP4 and RBM39) were analysed 
by qRT-PCR (Figure 3.4A). These four PROMPTs were chosen specifically, as 
their accumulation upon DIS3 depletion had been previously shown (Preker et al, 
2008). b-actin was used as a normalising gene for RT-qPCR and b-actin mRNA 
was shown to be stable in DIS3-AID cells upon auxin dependent DIS3 depletion 
by Steven West.  
 DIS3-AID and HCT116:TIR1 cells were treated or not with auxin for 1 hour. 
Auxin had no effect on PROMPT levels in HCT116:TIR1 cells. Additionally, 
untreated DIS3-AID cells showed similar PROMPT levels to controls. Therefore, 
AID modification of DIS3 does not impact on its ability to degrade PROMPTs. 
However, upon depletion of tagged DIS3 by auxin addition there is a significant 
accumulation of all four PROMPTs tested. These results show that PROMPTs 
are acutely sensitive to depletion of DIS3-AID.  
 
3.2.2  Wild-type DIS3 is able to rescue auxin-dependent effects 
As auxin dependent DIS3-AID depletion lead to a strong increase in 
PROMPT levels, I next investigated whether expression of wildtype (WT) DIS3 
could rescue these effects. WT DIS3 was transfected into DIS3-AID cells using 
the SB system and PROMPT levels were detected by qRT-PCR (Figure 3.4B). 
Expression of PROMPTs is the same in untreated DIS3-AID and DIS3-AID cells 
transfected with WT DIS3. As previously shown, PROMPTs accumulate upon 
DIS3-AID depletion by auxin. This accumulation is rescued when WT DIS3 is 
expressed, with levels returning to the same as in untreated DIS3-AID cells. It is 
important to note here that there is no evidence that the WT DIS3 protein has 





Figure 3.4 qRT-PCR of PROMPT levels in DIS3-AID cells 
qRT-PCR detection of four PROMPTs (STK11-IP, SERPINB8, FOXP4 and 
RBM3). All levels were normalised to b actin, * denotes p < 0.05 and standard 
deviation is plotted by error bars. Data is the mean of three independent 
experiments with samples run in triplicate each time. A) PROMPT levels in 
HCT116:TIR1 and DIS3-AID cells treated or not with auxin (Aux) for 1 hour. 
PROMPT levels remain the same except in DIS3-AID cells treated with auxin, 
where PROMPTs significantly accumulate. Quantitation is expressed as relative 
RNA level to untreated parental HCT116:TIR1 cells. B) PROMPT levels in DIS3-
AID and DIS3-AID cells transfected with WT DIS3 and treated or not with Aux for 
1 hour. WT DIS3 is able to rescue PROMPT accumulation. Quantitation is 















However, overall this data suggests that it is the specific depletion of DIS3 
causing accumulation of PROMPTs and expression of WT DIS3 is able to rescue 
the effects of DIS3 loss. 
 
3.3  DIS3 is essential for cell viability 
Previous studies have shown that DIS3 is essential for cell growth in yeast 
and for cell survival in a chicken DT40 cell line (Mitchell et al, 1997; Tomecki et 
al, 2014). To establish if the same was true for DIS3 in human cells, the AID 
system allowed investigation of DIS3 protein depletion on cell viability. A cell 
colony formation assay was conducted on HCT116:TIR1 cells as a control and 
DIS3-AID cells, both in the presence and absence of auxin. After 10 days of 
growth in the presence of auxin there were no adverse effects on cell viability of 
control cells (Figure 3.5). DIS3-AID cells grown in the absence of auxin formed a 
similar number of cell colonies to controls, showing DIS3-AID does not impact 
cell viability. However, a slower growth phenotype was observed with smaller 
sized colonies. Treatment of DIS3-AID cells with auxin prevented colony 
formation, suggesting that DIS3 is essential for cell survival. Importantly, this 
lethality is specifically due to the loss of DIS3 as prolonged auxin treatment of 









Figure 3.5 Cell colony formation assay of DIS3-AID and HCT116:TIR1 
Approximately 300 cells of either HCT116:TIR1 or DIS3-AID were seeded and 
grown in the presence or absence of auxin. After 10 days, cells were fixed and 
stained before counting using ImageJ software. No colonies grew upon DIS3 
depletion by auxin. Number of colonies are expressed as a percentage of those 




3.4  RNA-Seq investigation of DIS3 substrates 
To elucidate direct substrates of DIS3 and the effects of DIS3 loss in 
human cells, a transcriptome-wide RNA-Seq analysis using single-end 50 bp 
reads was conducted. To generate RNA-Seq libraries, nascent nuclear RNA was 
extracted from DIS3-AID cells treated or not with 1 hour of auxin for DIS3 protein 
depletion. Reads were filtered and aligned to the genome, with the expression 
levels at each gene counted. This work was done in collaboration with Dr. Lee 
Davidson, who conducted the RNA-Seq and bioinformatic analyses of results. In 
addition, this and further work has been published in Davidson et al (2019).  
 
3.4.1 Metagene profile of DIS3 loss shows stabilisation of PROMPTs 
DIS3-dependent changes were first investigated by the production of a 
metagene read coverage profile. To do this, only annotated genes with an 
expression level higher than 50 reads per gene were used. The inclusion window 
was extended 3 Kb upstream of the TSS and 7 Kb downstream of the TES to 
ensure PROMPTs and other gene effects could be clearly visualised. Due to this 
extension, any overlapping genes were removed to decrease false-positive 
discovery of DIS3 loss effects. Therefore 4701 genes were included in the 
metagene plot, which represents the average transcription profile over these 
genes. The metagene figure only shows 3 Kb downstream of the TES for clarity 
(Figure 3.6 and 3.7).  
 From the metagene plot it can be seen that upon auxin induced DIS3 loss, 
there is an accumulation of reads before the TSS which is indicative of PROMPT 
accumulation (as shown by the red arrow in Figure 3.6). PROMPTs are 
transcribed in the opposing direction to their associated coding gene and are a 
result of bidirectional promoter transcription. Previous studies have found 
PROMPT transcription occurs up to 3 Kb upstream of the TSS (Flynn et al, 2011; 
Preker et al, 2008; Szczepinska et al, 2015). From the metagene plot, PROMPT 
expression peaked at 0.5 – 1 Kb upstream of the TSS and gradually decreased 
to near background levels at 3 Kb upstream. These findings correspond with the 
short length of PROMPTs and their termination proximal to the TSS, as well as 
further verifying loss of DIS3 function upon auxin addition. In addition, this 












Figure 3.6 DIS3-AID metagene plot  
Metagene plot profile of non-overlapping expressed protein coding genes in 
DIS3-AID cells with or without auxin treatment. The inclusion window is 3 Kb 
upstream of the TSS and 7 Kb downstream of the TES, with the gene body scaled 
to 5 Kb (n = 4701). The red arrow highlights the peak corresponding to 
accumulation of PROMPTs. The black arrow highlights a peak potentially 
corresponding to prematurely terminated transcripts. Profile is representative of 
1 biological replicate; an additional replicate is shown in Figure 3.7. Produced 














Figure 3.7 Second replicate of DIS3-AID metagene plot 
Second biological replicate for metagene plot profile of non-overlapping 
expressed genes in DIS3-AID cells with or without auxin treatment. The inclusion 
window is 3 Kb upstream of the TSS and 7 Kb downstream of the TES, with the 
gene body scaled to 5 Kb (n = 4701). Produced from RNA-Seq analysis 








Interestingly, DIS3 loss did not cause an observable effect on read density 
at the gene body or downstream of the TES. Previously it has been shown that 
PROMPT degradation enhances transcription of associated coding genes (Ntini 
et al, 2013), however an indicative increase in gene body reads was not observed 
in our data. It is possible that longer auxin treatment times, to further deplete DIS3 
and / or prolong accumulation of PROMPTs through their enhanced stability, may 
result in an observable phenotype for downregulation of gene transcription.  
 
3.4.2 DIS3 degrades prematurely terminated transcripts 
In addition to the PROMPT accumulation peak upstream of the TSS, the 
metagene plot also showed a slight increase in read density immediately 
downstream of the TSS (as shown by the black arrow in Figure 3.6). It was 
hypothesised that this peak could be caused by an accumulation of RNA derived 
from premature transcription termination. To investigate this, three genes 
analysed in the metagene plot were chosen at random: C2orf42, NFU1 and 
PCBP1-AS1. Firstly, RPKM normalised coverage tracks were used to visualise 
these genes individually (Figure 3.8). For both C2orf42 and NFU1 a PROMPT 
transcript was observable before the TSS, on the sense strand (shown in red), 
that is detectable only upon DIS3 depletion. For PCBP1-AS1 the reads 
observable on the sense strand could be either from PROMPT transcription or 
transcription of another gene, PCBP1, as shown. The origin of these reads is 
difficult to determine, although the presence of these reads at a similar level when 
DIS3 is present suggests they correspond to PCBP1 transcription. Importantly, 
all three genes showed an increased number of reads near the TSS and over 
early intronic regions, as highlighted by the dashed box. This increase did not 
continue over the full length of the gene suggesting an accumulation of 
prematurely terminated transcripts occurs upon DIS3 depletion.  
Secondly, qRT-PCR was used to validate these findings in the same three 
genes as above and in an additional gene, CLIP4. A relative RNA concentration 
was determined over the first intron of these genes, where promoter proximal 
transcripts might terminate, and over the exon – intron junction as a control 




Figure 3.8 RPKM coverage tracks showing prematurely terminated transcripts in 
DIS3-AID cells 
RPKM normalised coverage tracks of three protein-coding genes, C2orf42, 
PCBP1-AS1 and NFU1, in DIS3-AID cells treated or not with auxin. The dashed 
box shows an increase of reads near the TSS, corresponding to accumulation of 
prematurely terminated transcripts. For C2orf42 and NFU1 the sense reads 
shown in red correspond to PROMPTs. Sense and antisense strands are 
overlapped and the figure represents two replicates. The numbers in brackets 
show the RPKM normalised read count range.  














Figure 3.9 qRT-PCR investigating levels of prematurely terminated transcripts 
In HCT116:TIR1 and DIS3-AID cells treated or not with auxin for 1 hour, the levels 
of four transcripts were compared by qRT-PCR. In CLIP4, PCBP1-AS1, NFU1 
and C2orf42 genes, qRT-PCR using primers spanning the first intron (in 1) were 
compared to primers spanning an exon – intron (ex – in) junction. Quantitation is 
expressed as relative RNA concentration to HCT116:TIR1 cells. n = 3, * denotes 
p < 0.05, standard deviation is plotted as error bars.  Data is the mean of three 
independent experiments with samples run in triplicate each time. 
HCT116:TIR1 HCT116:TIR1 + Aux DIS3-AID DIS3-AID + Aux
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For each gene, RNA levels were not significantly different between control 
HCT116:TIR1 cells, with or without auxin treatment, and untreated DIS3-AID 
cells. However, upon auxin-induced DIS3 loss there was a significant 
accumulation of RNA over intron 1. This increase was not observed over the exon 
– intron junction. Therefore, DIS3 loss caused accumulation of promoter proximal 
transcripts, explaining the peak near the 5’ site on the earlier metagene plot and 
emphasising the role of DIS3 during multiple stages of transcription. Furthermore, 
this may suggest the exosome is recruited to promoter – proximal sites, possibly 
before transcription initiation and via previously discussed mechanics such as 
interactions between MTR4, NEXT complex and ARS2, to rapidly degrade 
pervasive or abortive transcripts. The rapid accumulation of these transcripts 
within 1 hour of auxin treatment suggests a large number of genes frequently 
undergo premature termination and DIS3 normally aids in degradation of these 
transcripts.  
As no differences in RNA levels were seen over the gene body after DIS3 
loss, this corroborates that these transcripts have arisen through premature 
termination. An alternative suggestion is that upregulated early intronic regions 
may be stabilised in some genes by readthrough from nearby PROMPT 
transcription. If intron 1 levels accumulate due to overlapping upstream 
PROMPTs, it could be assumed that PROMPTs from downstream neighbouring 
genes could overlap the TES of genes.  However, no changes are observed over 
the TES as shown in Figure 3.6, suggesting our hypothesis of the described 
transcripts arising from premature transcription is more likely. This data also 
corresponds with Szczepinska et al (2015), who showed Dis3 was highly involved 
in degrading prematurely terminated protein-coding transcripts.  
 
3.4.3 DIS3 depletion causes increased levels of unannotated genes 
Szczepinska et al (2015) also found that catalytically dead DIS3 caused 
accumulation of RNAs originating from unannotated genomic regions and known 
enhancer RNAs (eRNAs). Enhancer elements are highly conserved sequences 
that bind to transcription factors and enhance gene transcription (Lee et al, 2015; 
Banerji et al, 1981). In 2010 it was discovered that Pol II transcription can occur 
at these enhancer elements, to produce eRNAs that play a role in gene 
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transcription regulation (Kim et al, 2010b; De Santa et al, 2010). eRNAs are short 
transcripts (< 2 Kb) that undergo rapid turnover by the exosome and arise from 
bidirectional promoters (Andersson et al, 2014).   
Through RNA-Seq we were able to detect de novo transcripts that 
accumulated upon DIS3 loss and did not overlap with any known transcripts. 
Potential PROMPT transcripts were removed from this list by their proximity to 
annotated genes and short length, leaving 960 transcripts originating > 3 Kb from 
an annotated gene and aligning to distal intergenic regions. From visualisation of 
a multitude of these transcripts by Genome Viewer we established that each 
transcript consisted of two separate RNAs from the same bidirectional promoter-
like region but on opposite strands (Figure 3.10A). Between the opposing 
transcripts there is a clear separation consistent with the presence of a 
nucleosome separating a promoter boundary (Andersson et al, 2014). Therefore, 
these de novo transcripts arise from regions where bidirectional transcription 
occurs, similar to enhancer sequences.  
To ensure these transcripts were not artefacts of RNA-Seq, qRT-PCR 
validation was performed for three of the de novo transcripts chosen at random 
(Figure 3.10B). Primers were designed upstream and downstream of the region 
between the sense and antisense transcripts. Relative RNA concentration were 
similar in HCT116:TIR1 cells with or without auxin and untreated DIS3-AID cells. 
Upon DIS3 loss there was a significant accumulation of RNA in both the upstream 
and downstream regions in all cases, corresponding to the de novo transcripts in 
both directions. Therefore, with the DIS3-AID system we were able to detect 
novel transcripts of DIS3 originating from genomic regions that are normally 
rapidly degraded.  
The novel transcripts we identified could potentially be uncharacterised 
eRNAs or derive from spurious transcription from open chromatin loci. Further 
work is needed to elucidate their true characterisation. Interestingly, the use of 
the DIS3-AID system was able to detect more eRNAs and novel transcripts than 
previous RNAi experiments (Szczepinska et al, 2015). These differences could 
be due to the use of different cell lines, however the AID system may be able to 




Figure 3.10 DIS3 depletion effects levels of de novo transcripts 
A) RPKM normalised coverage tracks of three de novo transcripts from RNA-seq 
analysis of DIS3-AID cells with or without auxin. Transcripts were detected over 
intergenic intervals. B) qRT-PCRs of the same de novo transcripts with primers 
designed upstream and downstream of the region separating the opposing 
transcripts. Conducted in HCT116:TIR1 and DIS3-AID cells treated or not with 
auxin for 1 hour. Quantitation is relative RNA concentration to untreated 
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3.5  Summary 
In this chapter I have shown that a protein of interest can be rapidly and 
significantly degraded using the AID system (Figure 3.3). Fusion of an AID tag to 
the 3’ end of DIS3 using CRISPR/Cas9 is relatively simple and easily 
reproducible. The AID system causes conditional protein degradation with the 
necessary expression of a plant specific TIR1 F-box protein, by utilising human 
proteasome mediated degradation pathways. This inducible degradation is 
controlled by the addition of auxin and can be reversed by removal of auxin from 
growth media. 
The findings described in this chapter are largely consistent with data from 
previous studies using RNAi techniques to indirectly deplete exosome subunits 
by targeting mRNA (Szczepinska et al, 2015). However, the AID system causes 
protein depletion in a rapid manner, allowing easier investigation of the effects of 
immediate protein loss in a shorter time frame than RNAi. In addition, the AID 
system uncovered more PROMPT and other DIS3 substrate changes than 
typically reported, suggesting a more complete protein depletion by the AID 
system may be beneficial for studying RNA turnover. From our results gene 
fusion with the AID tag, expression of TIR1 or untagged cell growth in the 
presence of auxin has few deleterious effects on HCT116 cell function although 
DIS3-AID cells showed a slight defect in growth rate and reduced levels of spliced 
DIS3 mRNA (Figure 3.5 and Figure 3.3C). A potential reason that untreated DIS3-
AID cells showed a slow growth phenotype might be due to the levels of tagged 
DIS3 present. Results from the western blot suggested a reduction in DIS3-AID 
levels compared to endogenous DIS3 in HCT116:TIR1 cells (Figure 3.3B). A 
qRT-PCR was conducted to investigate this further and found DIS3-AID mRNA 
was present at approximately 50 % of the level of endogenous DIS3 mRNA 
(Figure 3.3C). Therefore, the AID tag may cause a decrease in DIS3-AID 
transcription or increase in its degradation and this reduction might explain why 
growth of DIS3-AID colonies is slower than that of HCT116:TIR1 cells.  
 To further prevent AID tag effects and improve protein stability a smaller 
mini-AID tag can be used in place of the larger AID tag (Natsume et al, 2016). A 
more recently described method involves expression of the auxin response 
transcription factor (ARF), that in the absence of auxin binds to the AID in plants 
(Sathyan et al, 2019). Expressing ARF in human cells utilising the AID system 
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resulted in a decrease of AID tag effects.  Additionally, I have shown that DIS3 is 
vital for cell survival with auxin-conditional depletion of DIS3 causing 100% cell 
death (Figure 3.5). This finding is analogous with previous reports by Mitchell et 
al (1997).  
PROMPTs originating from bi-directional promoters of protein-coding 
genes were detectable after only 60 minutes of DIS3 depletion by auxin addition. 
As previously described, these PROMPTs were transcribed in the opposing 
direction to the protein-coding gene (Preker et al, 2008; Flynn et al, 2011). From 
Figure 3.6, PROMPT transcription was observed upstream of the protein-coding 
gene TSS with a decrease in reads occurring within 3 Kb upstream. This suggests 
PROMPT transcription is not finite and transcription termination happens at 
approximately 3 Kb of length. PROMPT termination may still occur by 
conventional cleavage at the PAS, as poly(A) sites are more abundant upstream 
than downstream of the mRNA TSS, and PAS hexamers are located 10 – 30 nts 
upstream of PROMPT 3’ ends (Ntini et a, 2013). Termination could also occur by 
PROMPT readthrough into a neighbouring gene and the use of that genes’ PAS 
(Chen et al, 2016). Either way, this termination mechanism would provide a free 
3’ end allowing rapid degradation by DIS3 mediated pathways. DIS3 is vital for 
maintaining proper promoter directionality and preventing accumulation of 
redundant transcripts produced by bi-directional transcription.  
In addition to PROMPTs, RNA-Seq data revealed a small increase in 
reads immediately downstream of the protein-coding gene TSS (Figure 3.6). 
Through further investigation I was able to determine this peak corresponded to 
an increase in reads over the early intronic regions of genes, suggesting an 
overall accumulation of prematurely terminated / abortive transcripts (Figure 3.8 
and 3.9). Importantly, these findings support a role for DIS3 in multiple stages of 
transcription. Under normal conditions, it appears many genes frequently 
undergo premature termination and these abortive transcripts are rapidly 
degradation by DIS3, as shown by their accumulation within 60 minutes of DIS3 
depletion. This degradation potentially occurs co-transcriptionally and through 
close association with the transcribing Pol II complex. Exosome recruitment to 
promoter-proximal sites may occur through MTR4, NEXT and ARS2 interactions 
as previously mentioned.  
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Finally, accumulation of de novo transcripts originating from unannotated 
genome regions were observed upon DIS3 depletion (Figure 3.10). Analysis 
revealed that these transcripts potentially originate from bidirectional promoter-
like regions, similar to eRNAs. These de novo transcripts may be as yet 
unidentified enhancers, however further work is required for their 
characterisation. Overall, in this chapter I have been able to identify the 
importance of DIS3 in the degradation of a multitude of transcripts and its vital 
role in maintaining appropriate gene expression. In the following chapter I will 
assess the role of DIS3 and other endonucleases, including the Integrator, in the 




















4. Results Chapter 2: Endonuclease function in snRNA 
transcription and processing 
Pol II transcribes a number of non-coding transcripts including snRNAs. 
snRNAs are commonly 60 – 200 nts in length, are not polyadenylated and lack 
introns. They have a primary function in splicing of mRNA through formation of 
the spliceosome and U7 snRNA has a major role in the 3’ end formation of RDH 
mRNA (Chen and Wagner, 2010). Processing of pre-snRNAs into mature 
snRNAs involves endonuclease activity, in particular from the Integrator complex. 
The Integrator consists of 12 – 14 subunits, with catalytic activity provided by the 
endonuclease subunit INTS11. INTS11 is a homolog of CPSF73 and forms a 
heterodimer with another Integrator subunit INTS9, which is thought to be 
necessary for snRNA 3’ end processing (Dominski et al, 2005). INTS9 is similar 
to CPSF100, possessing an incomplete catalytic centre. Recent findings suggest 
INTS4 is also necessary for snRNA processing and may in fact form a 
heterotrimeric structure with INTS11 and INTS9 (Albrecht et al, 2018). Either way, 
the Integrator is able to recognise the 3’ box consensus sequence located 9 – 19 
nts downstream of the snRNA coding region and it is thought that INTS11 is then 
responsible for cleavage of snRNA near this site (Baillat et al, 2005).  
As previously described, 3’ end processing of Pol II protein-coding genes 
is tightly coupled to their transcription termination. Similarly, snRNA 3’ end 
processing has been linked to efficient termination, however the actual 
mechanisms of snRNA termination are not fully understood (Ramamurthy et al, 
1996; O’Reilly et al, 2014). Polyadenylation factors have also been suggested to 
play a role in snRNA termination (O’Reilly et al, 2014). In addition to snRNAs, the 
Integrator has been implicated in other aspects of transcriptional regulation 
including transcription initiation at protein-coding genes, termination of RDHs and 
Pol II pause-release (Gardini et al, 2014; Skaar et al, 2015; Stadelmayer et al, 
2014). 
To investigate snRNA transcription and termination, as well as the further 
characterisation of Integrator function we utilised RNA-Seq methods in a number 
of cell models allowing conditional depletion of specific endonuclease proteins 




4.1 Production of the Ints11-SMASh cell line 
To investigate the role of INTS11 we aimed to generate an inducible 
INTS11 knockdown cell line, similar to the production of the DIS3-AID cells. 
However, the last 10 amino acids of INTS11 are necessary for its interaction with 
INTS9. Abrogation of this heterodimer formation has effects equivalent to 
mutations disrupting the active site of INTS11, including interference of Integrator 
function (Wu et al, 2017). Therefore, the addition of an AID-tag to the C terminus 
of INTS11 might disrupt INTS11 function, even without addition of auxin. To 
overcome this issue, we decided to utilise the SMASh-tag system, which contains 
a NS3 protease, HCV NS3 recognition site and a destabilising degron. Using 
CRISPR/Cas9 techniques as previously described (Figure 3.1), the SMASh-tag 
was genetically integrated at the C terminus of both INTS11 alleles to produce 
INTS11-SMASh cells (Figure 4.1). The protease function of the SMASh-tag 
cleaves the NS3 recognition site under normal conditions, causing INTS11-
SMASh to become untagged and allowing normal INTS11 function. Thus, solving 
the potential issues around INTS11 protein interactions if having used the AID-
tag. Upon addition of a protease inhibiting drug, asunaprevir (asn), the SMASh-
tag is no longer cleaved causing tagged INTS11 to be degraded due to SMASh-
tag internal degron activity (Figure 1.5). Generation of the INTS11-SMASh cells 
was conducted by Steven West.  
 
4.1.1 Genomic PCR validation of Ints11-SMASh 
INTS11-SMASh colonies were grown under hygromycin and neomycin 
drugs to select for homozygous integration of the SMASh-tag. After selection, the 
cells were validated by genomic PCR with primers flanking the homology arms 
(Figure 4.2). HCT116:TIR1 cells were used as a control and show a band at the 
expected endogenous INTS11 size. Whereas the INTS11-SMASh cells show a 
much larger band of a size expected for SMASh-tag inclusion. As no other bands 
were observed for the INTS11-SMASh cells, it was concluded that both INTS11 





Figure 4.1 Generation of INTS11-SMASh using CRISPR/Cas9  
INTS11 homologous gRNA directs Cas9 to create a double-stranded break in the 
3’ INTS11 gene. The break is repaired using repair templates consisting of a 
SMASh-tag, P2A site, selection marker and SV40 PAS. After translation, the P2A 
peptide self cleaves to produce the SMASh-tagged INTS11 protein. Under 
normal conditions, the protease activity of the SMASh-tag cleaves at the NS3 
recognition site to produce an untagged INTS11 protein capable of normal 
function. Upon addition of asunaprevir (asn), the protease activity is inhibited and 
the tagged INTS11 protein is targeted for degradation due to the internal degron 









Figure 4.2 Genomic PCR validation of INTS11-SMASh 
Nested genomic PCR in control HCT116 cells (C) and INTS11-SMASh cells 
grown under drug selection (#1) using primers flanking the INTS11 homology 
arms, as shown in the diagram by the arrows. A strong band is present in the 
control cells corresponding to endogenous INTS11. In the INTS11-SMASh cells 
a much higher band is present at the predicted size for INTS11 with SMASh-tag 
incorporation. No endogenous INTS11 band is observed in the INTS11-SMASh 




4.1.2  Conditional depletion of INTS11 by asunaprevir addition 
Following validation of homozygous integration in INTS11-SMASh cells, I 
wanted to determine if addition of asunaprevir to cell media caused inducible 
INTS11 depletion. A western blot using an antibody to INTS11 was conducted for 
HCT116:TIR1 cells as a control and INTS11-SMASh cells, both with and without 
48 hours of asunaprevir treatment (Figure 4.3). An INTS11 specific band was 
detected at approximately 65 kDa and an antibody to alpha tubulin was used as 
a loading control. In HCT116:TIR1 cells the levels of INTS11 did not alter upon 
asunaprevir addition, showing asunaprevir alone does not affect INTS11 protein 
levels. INTS11-SMASh cells without asunaprevir showed similar INTS11 protein 
levels to control cells. After 48 hours of drug treatment there was a near complete 
depletion of INTS11 protein. Therefore, inducible INTS11 protein depletion is 
capable upon addition of asunaprevir to INTS11-SMASh cells. Asunaprevir 
induced INTS11 depletion is not as rapid as AID protein depletion, i.e. 1 hour of 
auxin treatment significantly depletes DIS3 in the DIS3-AID cell line. The reason 
for this is asunaprevir treatment prevents protease cleavage at the NS3 
recognition site of newly synthesised tagged INTS11 protein. This results in rapid 
degradation of tagged INTS11 protein, however untagged INTS11 that had been 
previously cleaved from the SMASh tag is still present. Therefore, the half-life of 
untagged INTS11 protein is important for complete degradation and explains the 
longer treatment times necessary for this methodology. As 48 hours of 
asunaprevir treatment produced a significant depletion of INTS11 protein levels, 
all further experiments were conducted for this length of time. Longer asunaprevir 
treatment time courses to produce further INTS11 depletion were not investigated 
due to the increased possibility of any observed depletion effects being due to 
secondary effects and not the immediate loss of INTS11. Although not shown 
here, shorter treatment times were analysed by western blot and did not produce 














Figure 4.3 Western blot of INTS11 
Western blot showing the levels of INTS11 protein in HCT116:TIR1 and INTS11-
SMASh cells, treated or not with asunaprevir for 48 hours. INTS11 levels are 
comparable between HCT116:TIR1 cells in both conditions and INTS11-SMASh 
cells without asunaprevir. Asunaprevir significantly and specifically reduced 
INTS11 protein levels in INTS11-SMASh cells after 48 hours. Alpha tubulin was 










4.1.3 Depletion of INTS11 causes accumulation of extended snRNAs 
Before further investigation into the endonuclease function of INTS11 by 
RNA-Seq, it was determined whether INTS11 depletion by asunaprevir caused 
an effect on snRNA processing. Previous studies found a coupling between 
transcription termination and Integrator cleavage of snRNAs, with disruption of 
one negatively affecting the other (Ramamurthy et al, 1996; O’Reilly et al, 2014). 
Therefore, RNA levels downstream of three snRNAs chosen at random, RNU5B-
1, RNU5D-1 and RNU1-28P, were investigated using qRT-PCR (Figure 4.4). 
HCT116:TIR1 cells were used as a control to INTS11-SMASh cells, treated or 
not with asunaprevir.  
There were no significant differences in RNA levels between 
HCT116:TIR1 cells with and without asunaprevir or untreated INTS11-SMASh 
cells (Figure 4.4). Upon depletion of INTS11, there is a significant accumulation 
of RNA immediately downstream of the TES of all three snRNAs (200 – 300 bp). 
As INTS11 would normally cleave snRNAs at their 3’ end, this accumulation of 
misprocessed snRNA is likely due to INTS11 depletion. RNA levels are 
comparable to the control by 1.5 Kb - 3.5 Kb downstream of the snRNA TES, 
suggesting that readthrough of these snRNAs is not finite and that they still 
undergo transcriptional termination when processing is impaired. Overall, INTS11 
depletion in INTS11-SMASh cells is sufficient for Integrator dysfunction as shown 
by the aberrant processing of snRNAs. Unfortunately, RNA levels downstream of 
these snRNAs could not be determined at other intervals, such as 500 bp, 1Kb 
etc, due to primer design issues with primer specificity. Therefore the locations 
downstream of the snRNAs analysed were determined by using only primers that 






Figure 4.4 RNA concentration downstream of snRNAs 
qRT-PCR detection of RNA levels downstream of the TES of three snRNAs: 
RNU5B-1, RNU5D-1 and RNU1-28P. Conducted in HCT116:TIR1 and INTS11-
SMASh cells with and without 48 hour asunaprevir treatment. Quantitation of 
RNA is expressed as fold change relative to untreated HCT116:TIR1 cells. All 
levels were normalised to b actin. n = 3, * denotes p < 0.05, error bars show 
standard deviation.  Data is the mean of three independent experiments with 











4.2 INTS11 depletion does not prevent snRNA termination 
To further investigate the effects of INTS11 on snRNA transcription, RNA-
Seq with single-end 50 bp reads was conducted on nuclear RNA obtained from 
INTS11-SMASh cells with or without asunaprevir treatment. Reads were aligned 
to the genome and filtered, with Table 4.1 showing details of the sequencing 
depth and coverage. To conduct a snRNA metagene plot, I firstly removed any 
genes with low expression (< 50 reads per gene). Not all snRNAs were enriched 
for in the RNA-Seq dataset which utilised 50 nt reads, reducing the resolution for 
small transcripts such as snRNAs (median length = 150 nt). Another reason why 
not all snRNAs are represented in the dataset is because there are variants of 
almost all snRNAs that have very similar sequences to one another 
(Kyriakopoulou et al, 2006; Sontheimer and Steitz, 1992; O’Reilly et al, 2013). 
This can prevent unambiguous mapping of reads, which are instead removed. 
Therefore, after filtering genes for expression levels, 95 non-overlapping snRNAs 
were used to generate the metagene plot with an inclusion window of 100 bp 
upstream of the snRNA TSS and 5 Kb downstream of the TES (Figure 4.5). For 
clarity, only 2 Kb downstream of the snRNA TES is shown.  
 






Sequencing depth over all exons = (Total number of mapped reads * average 
read length (bp)) / total length of exons 
Sequencing coverage over all exons = (Total number of mapped reads to exons 















Figure 4.5 shows an obvious increase in RNA reads immediately 
downstream of the snRNA TES upon INTS11 depletion, corresponding to 
readthrough of snRNA due to disruption of their cleavage by the Integrator. The 
number of reads then decrease, returning back to baseline values by 2 Kb and 
often much sooner. This suggests that extended snRNAs are terminated 
relatively close to the TES, even when not endonucleolytically cleaved by 
INTS11. To further validate these findings, individual RPKM normalised coverage 
tracks of the three snRNAs analysed in Figure 4.4, RNU5D-1, RNU5B-1 and 
RNU1-28P, were used to better visualise snRNA 3’ extension and further validate 
RT-qPCR findings (Figure 4.6). For all three snRNAs there is a slight extension 
of reads past the TES. However, this readthrough stops by 2 Kb downstream 
suggesting snRNA termination occurs within this downstream window and 
















Figure 4.5 INTS11-SMASh snRNA metagene plot  
Metagene coverage plot for 95 non-overlapping snRNAs from RNA-Seq data of 
INTS11-SMASh cells treated or not with asunaprevir. Inclusion window contains 
100 nt upstream of the snRNA TSS and 2000 bp downstream of the TES, with a 






















Figure 4.6 INTS11-SMASh RPKM coverage tracks for snRNAs 
RPKM coverage tracks for snRNAs RNU5B-1, RNU5D-1 and RNU1-28P. Upon 
depletion of INTS11 there is a 3’ extension of all three snRNAs that stops by 
approximately 2 Kb downstream of the snRNA TES. The numbers in brackets 
show the average RPKM normalised read count range. 
 
INTS11-SMASh INTS11-SMASh + asn
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4.3 Depletion of the largest Integrator subunit does not prevent snRNA 
termination 
The current findings of snRNA termination after INTS11 depletion were 
slightly unexpected, due to previous reports of the close coupling between snRNA 
3’ end processing and termination. Following this I decided to investigate whether 
disrupting Integrator complex function as a whole, instead of only the 
endonuclease subunit, would inhibit snRNA termination. INTS1 is the largest 
subunit of the Integrator with 2190 amino acids (Baillat et al, 2005; Baillat et al, 
2015). A knockout mice model of INTS1 has been shown to have growth arrest 
in early blastocyst stage embryos and apoptotic cell death (Hata and Nakayama, 
2007). Additionally, INTS1 has been suggested to function as a scaffold protein 
for Integrator assembly and therefore disruption of INTS1 in human cells results 
in a loss of Integrator complex function (Hata and Nakayama, 2007; Baillat et al, 
2005).  
INTS1 was depleted in HCT116:TIR1 cells using INTS1 siRNA. To check 
levels of INTS1 depletion by RNAi a qRT-PCR was conducted showing an 
average reduction of 84% (Figure 4.7B). As before, RNA levels downstream of 
three snRNAs (RNU1-1, RNU4-2 and RNU1-28P) were investigated in 
HCT116:TIR1 cells that had been treated with either control siRNA or INTS1 
siRNA (Figure 4.7A). Different snRNAs were used to those in Figure 4.4, to allow 
investigation of RNA levels downstream of the TES at set intervals, that was 
previously not possible due to non-specific primers. Depletion of INTS1 produced 
a similar effect to conditional depletion of INTS11 in INTS11-SMASh cells. There 
was a significant accumulation of unprocessed snRNA following INTS1 depletion, 
thus showing RNAi depleted INTS1 levels were sufficient to cause Integrator 
dysfunction. As seen with INTS11 depletion, snRNA readthrough was relatively 
short with levels returning to background by 1 – 3 Kb downstream of the snRNA 
TES. This result shows that disrupting Integrator formation causes production of 
unprocessed extended snRNAs that are still capable of termination within a 
window close to the TES. It is possible the small amount of INTS1 remaining after 
INTS1 siRNA depletion may be sufficient for extended snRNA termination. 
However, the presence of detectable snRNA readthrough demonstrates that 





Figure 4.7 RNA levels downstream of snRNAs after INTS1 depletion 
All levels were normalised to b actin. * denotes p < 0.05, error bars show standard 
deviation. Data is the mean of three independent experiments with samples run 
in triplicate. A) qRT-PCR detection of RNA levels downstream of three snRNAs: 
RNU1-1, RNU4-2 and RNU1-28P. Conducted in HCT116:TIR1 cells treated with 
control siRNA or INTS1 siRNA. Quantitation of RNA is expressed as fold change 
relative to non-depleted HCT116:TIR1 cells. B) qRT-PCR detection of INTS1 
levels in HCT116:TIR1 cells treated with control siRNA and INTS1 siRNA.  
B
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4.4 Depletion of INTS11 causes a further reduction in snRNA precursor 
transcript levels after inhibition of transcription 
I next wanted to investigate the impact of INTS11 on snRNA transcript 
turnover. To do this, INTS11-SMASh cells were grown in the presence of 
actinomycin D for 0 minutes or 15 minutes and treated or not with asunaprevir 
(Figure 4.8). Actinomycin D acts as a transcription inhibitor by intercalating into 
GC rich DNA sequences and preventing RNA polymerase elongation (Trask and 
Muller, 1988). This process is fast and acts on all three RNA polymerases, as 
well as causing hyperphosphorylation of the Pol II CTD (Cassé et al, 1999). In 
untreated INTS11-SMASh cells, inhibition of transcription caused a reduction in 
the three uncleaved snRNA precursor transcripts of RNU5A-1, RNU4-1, RNU1-
1, as measured by qRT-PCR. These snRNAs were investigated due to relevant 
primers to detect precursor transcripts already being available in the laboratory. 
The relative RNA concentration decreased to between 46 – 59% of RNA levels 
at 0 minutes of Actinomycin D treatment. This is expected as normal turnover of 
RNA occurs whilst the production of new transcripts is inhibited, overall resulting 
in a reduction of transcript levels. In comparison, when INTS11 was depleted a 
further decline in all three snRNA precursor transcripts was observed. This 
resulted in a mean RNA concentration that was reduced to between 25 – 36 % 
of levels at 0 minutes of Actinomycin D treatment. This apparent decrease in 
snRNA precursor transcript levels when INTS11 is depleted could be caused in 
a couple of ways. Firstly, INTS11 may not be depleted sufficiently to completely 
inhibit snRNA processing. Secondly, inhibiting INTS11 cleavage results in 
unprocessed snRNAs which may have increased efficacy for degradation by the 
exosome, for example. Finally, INTS11 depletion may cause a reduction in 








Figure 4.8 Precursor snRNA transcript levels after Actinomycin D treatment in 
INTS11-SMASh cells 
qRT-PCR detection of RNA concentrations for three uncleaved precursor 
snRNAs (RNU5A-1, RNU4-1 and RNU1-1) in INTS11-SMASh cells treated or not 
with asunaprevir (asn), with 0 minutes or 15 minutes of Actinomycin D (Act D) 
treatment. Primers spanning the snRNA TES and immediately downstream of the 
TES were used. Quantitation is expressed as a percentage relative to 0 minutes 
of Actinomycin D treatment in both asunaprevir treated and untreated conditions. 
All levels were normalised to b actin. * denotes p < 0.05, error bars show standard 
deviation. Data is the mean of three independent experiments with samples run 
in triplicate each time. 
* * *
INTS11-SMASh - asn; 0 mins Act D treatment 
INTS11-SMASh - asn; 15 mins Act D treatment
INTS11-SMASh + asn; 0 mins Act D treatment
INTS11-SMASh + asn; 15 mins Act D treatment
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4.5 Effect of DIS3 depletion on snRNA transcription 
To assess whether the exosome is responsible for degradation of snRNA 
precursors, I decided to investigate the effects of DIS3 depletion on snRNAs.  
This would potentially explain snRNA reduction when transcription was inhibited, 
even when INTS11 is not present (Figure 4.8), Labno et al (2016) previously 
reported an accumulation of longer snRNA transcripts when both the 
endonuclease and exonuclease activity of DIS3 had been abolished by mutations 
in the PIN and RNB domains respectively. They hypothesised these transcripts 
were readthrough snRNAs that had not been cleaved by the Integrator and 
therefore extended downstream of the TES. In addition, DIS3 was found to 
degrade mature snRNA and the extended snRNA transcripts, with a slight 
increase in levels of mature snRNA transcripts observed with catalytically dead 
DIS3. In contrast, Szczepinska et al (2015) found little to no accumulation of 
snRNAs in either DIS3 PIN, RNB or both domain mutants suggesting DIS3 may 
not be part of the main pathway for snRNA degradation. Using qRT-PCR and 
DIS3-AID RNA-Seq data I aimed to examine these contrasting findings in more 
detail.  
 
4.5.1 DIS3 depletion also produces extended snRNAs 
Firstly, RNA-Seq data of DIS3-AID cells was analysed to visualise the 
effects on three individual snRNAs: RNU5B-1, RNU5D-1 and RNU1-28P (Figure 
4.9A). These snRNAs were investigated as they had been used previously to 
validate the INTS11-SMASh cell line, show INTS11 depletion effects snRNA 
processing and confirm the observed extension of snRNAs (Figure 4.4 and 4.6) 
In all three examples there was an observable extension of the snRNA past the 
TES upon DIS3 depletion. There also appeared to be a slight increase in the 
amount of reads over the gene body. An explanation for this is that depletion of 
DIS3 may prevent degradation of snRNAs and result in their accumulation. 
Importantly, all three snRNAs showed extension that terminated before 1500 bp 





Figure 4.9 RNA levels downstream of snRNAs in DIS3-AID cells 
A) RPKM coverage tracks for snRNAs RNU5B-1, RNU5D-1 and RNU1-28P in 
DIS3-AID cells treated or not with auxin. The numbers in brackets show the 
average RPKM normalised read count range.  B) qRT-PCR detection of RNA 
levels downstream of three snRNAs: RNU5B-1, RNU5D-1 and RNU1-28P. 
Conducted in HCT116:TIR1 and DIS3-AID cells with and without auxin treatment. 
Quantitation of RNA is expressed as fold change relative to untreated 
HCT116:TIR1 cells. All levels were normalised to b actin. * denotes p < 0.05, error 
bars show standard deviation. Data is the mean of three independent 
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For validation, we measured RNA levels downstream of these snRNAs by qRT-
PCR (Figure 4.9B). Similar to the RPKM coverage tracks, extended snRNAs were 
detected upon DIS3 loss and these snRNAs terminated within 1.5 – 3.5 Kb 
downstream of the snRNA TES. 
I next wanted to determine whether DIS3 depletion had a global effect on 
snRNAs or whether the effects observed were specific to the three snRNAs 
investigated. A snRNA metagene plot was conducted using the same list of 95 
snRNAs as for the INTS11-SMASh metagene plot (Figure 4.5). For this metagene 
an inclusion window of 100 bp upstream of the snRNA TSS and 1000 bp 
downstream of the TES was used (Figure 4.10 and 4.11). There were no 
apparent differences upstream of the TSS upon DIS3 depletion, however there 
was an increased number of reads immediately downstream of the TES showing 
extension of snRNAs. This extension was not as long as seen previously upon 
INTS11 depletion (approximately 1 – 2 Kb), instead an increase in reads was 
observed up to approximately 500 bp downstream of the TES before returning to 
background levels. Additionally, there was a slight increase in reads over the 
snRNA gene body as similarly seen in RPKM coverage tracks of individual 
snRNAs (Figure 4.9). Overall these findings suggest DIS3 has a role in snRNA 
transcription. It is possible that DIS3 specifically degrades misprocessed or 
prematurely terminated snRNA transcripts, however the exact mechanism is yet 
unclear.  
 
4.5.2 Depletion of DIS3 causes an accumulation of snRNA precursor 
transcripts when transcription is inhibited 
To determine if DIS3 dysfunction had an effect on transcription of snRNA 
precursors, Actinomycin D was used to inhibit transcription in the same way as 
described previously with INTS11-SMASh cells using the same snRNA precursor 
primers (Figure 4.8). DIS3-AID cells, treated or not with auxin, underwent 0 
minutes or 15 minutes of Actinomycin D treatment (Figure 4.12). As expected, 
inhibition of transcription in untreated DIS3-AID cells caused a reduction in 











Figure 4.10 DIS3-AID snRNA metagene plot 
Metagene coverage plot for 95 snRNAs from RNA-Seq data of DIS3-AID cells 
treated or not with auxin. Inclusion window contains 100 bp upstream of the 
snRNA TSS and 1000 bp downstream of the TES, with a gene body scaled to 
200 bp (n = 95). Figure represents one biological replicate, a second replicate is 




















Figure 4.11 Second replicate of DIS3-AID snRNA metagene plot 
Second biological replicate of a metagene coverage plot for 95 snRNAs from 
RNA-Seq data in DIS3-AID cells treated or not with auxin. Inclusion window 
contains 100 bp upstream of the snRNA TSS and 1000 bp downstream of the 








Figure 4.12 snRNA precursor levels after Actinomycin D treatment in DIS3-AID 
cells 
qRT-PCR detection of RNA concentrations for three uncleaved precursor 
snRNAs (RNU5A-1, RNU4-1 and RNU1-1) in DIS3-AID cells treated or not with 
auxin and with 0 minutes or 15 minutes of Actinomycin D treatment. Primers 
spanning the snRNA TES and immediately downstream of the TES were used. 
Quantitation is expressed as a percentage relative to 0 minutes of Actinomycin D 
treatment in both auxin treated and untreated conditions. All levels were 
normalised to b actin. * denotes p < 0.05, error bars show standard deviation. 
Data is the mean of three independent experiments with samples run in triplicate 
each time. 
 





















DIS3 - asn 0 mins
DIS3 - asn 15 mins
DIS3 + asn 0 mins
DIS3 + asn 15 mins
DIS3-AID - aux; 0 mins Act D treatment 
DIS3-AID - aux; 15 mins Act D treatment
DIS3-AID + aux; 0 mins Act D treatment




On the other hand, depletion of DIS3-AID caused a reduction in snRNA precursor 
transcript levels which was much less pronounced than when DIS3 was present. 
This difference was significant for both RNU1-1 and RNU4-1. This could be 
explained by the normal function of DIS3 degrading snRNA precursor transcripts, 
causing a reduction in transcript levels when transcription is inhibited. However, 
upon loss of DIS3 the snRNA precursor transcripts are no longer degraded and 
instead accumulate. These findings support a major role of DIS3 in the 
metabolism of snRNA precursors. 
 
4.6 Depletion of INTS1 and DIS3 together has an accumulative effect on 
snRNA processing 
As both loss of Integrator and DIS3 function causes accumulation of 
extended snRNAs, I investigated the effects of eliminating both. Using DIS3-AID 
cells with auxin and a siRNA to INTS1 allowed depletion of DIS3 and INTS1 
simultaneously. RNA levels downstream of RNU4-2, RNU1-28P and RNU1-1 
snRNAs, shown previously to extend upon INTS1 depletion (Figure 4.7), were 
measured using DIS3-AID cells with a non-targeting siRNA as a control (Figure 
4.13). As now expected, loss of DIS3 caused accumulation of extended snRNAs.  
Similarly to previously demonstrated, loss of INTS1 by siRNA produced a 
readthrough effect on all three snRNAs in DIS3-AID cells. Readthrough RNA 
concentrations decreased to control levels by 1 – 2 Kb downstream of the TES. 
When DIS3-AID cells were treated with both auxin and INTS1 siRNA there was 
an enhanced accumulation of extended snRNAs compared to INTS1 depletion 
alone. Depletion of INTS1 causes loss of Integrator function, meaning snRNAs 
are no longer cleaved and explains the observed readthrough effect. As DIS3 
loss has a cumulative effect on INTS1 depletion, it may be that DIS3 can degrade 
these extended snRNAs and that loss of DIS3 results in their further 
accumulation. This supports findings by Labno et al (2016) who suggested DIS3 
degrades both mature snRNA and extended snRNA transcripts. Interestingly 
although DIS3 and INTS1 depletion alone resulted in extended snRNAs, an 
accumulative effect was not observed for extended snRNA transcript length with 
termination occurring at around 1 – 2 Kb. This shows that independent 




Figure 4.13 RNA levels downstream of snRNAs after INTS1 siRNA depletion in 
DIS3-AID cells 
qRT-PCR detection of RNA levels downstream of three snRNAs: RNU1-1, RNU4-
2 and RNU1-28P. Conducted in DIS3-AID cells treated or not with auxin and 
either control siRNA or INTS1 siRNA. Quantitation of RNA is expressed as fold 
change relative to non-depleted DIS3-AID cells with control siRNA. All levels were 
normalised to b actin. * denotes p < 0.05, error bars show standard deviation. 
Data is the mean of three independent experiments with samples run in triplicate 
each time. 
DIS3-AID + con siRNA
DIS3-AID + Aux + con siRNA
DIS3-AID + INTS1 siRNA




4.7  Termination of extended snRNAs is likely to occur without cleavage 
The results discussed so far suggest that snRNAs are still terminated in 
the absence of Integrator function. However, it is unknown whether this 
termination is caused by a downstream cleavage event by another endonuclease 
or through independent RNA Pol II dissociation from the genome. If the extended 
snRNAs were cleaved downstream of their TES, it is plausible that RNA Pol II 
would continue to extend downstream before dissociating and therefore create a 
small RNA fragment that may not have been detected in our data so far due to 
rapid degradation. XRN2 is the major 5’ – 3’ exoribonuclease in the nucleus and 
may be responsible for degradation of such a transcript, in a way that is similar 
to that suggested in the torpedo model of mRNA termination.  
XRN2-AID cells had been previously generated in our lab, as described in 
Eaton et al (2018) and were used to investigate RNA levels around the 3’ end of 
extended snRNAs that had shown extension upon Ints1 and DIS3 depletion, 
RNU1-1, RNU4-2 and RNU1-28P (Figure 4.14). XRN2 was depleted or not by 2 
hours addition of auxin and cells were either treated with control siRNA or INTS1 
siRNA. No significant differences were observed upon XRN2 depletion alone. As 
described in other cell lines, INTS1 siRNA treatment caused an accumulation of 
extended snRNAs that terminated before 2 Kb – 3 Kb downstream of the snRNA 
TES. These extended snRNAs were similarly detected upon depletion of both 
INTS1 and XRN2, however there were no significant differences in their levels 
between INTS1 depletion alone and both XRN2 and INTS1 depletion together. In 
addition there was no accumulation of RNA at 3 Kb downstream of the extended 
snRNAs and in the case of RNU4-2 at 2Kb downstream, therefore suggesting 
XRN2 does not degrade a transcript formed by Pol II extension after extended 
snRNA cleavage. From this I conclude that independently of a cleavage event, 
Pol II dissociation between 2 – 3 Kb downstream of snRNAs occurs when 









Figure 4.14 RNA levels downstream of snRNAs after INTS1 siRNA depletion in 
XRN2-AID cells 
qRT-PCR detection of RNA levels downstream of three snRNAs: RNU1-1, RNU4-
2 and RNU1-28P. Conducted in XRN2-AID cells treated or not with auxin and 
either control siRNA or INTS1 siRNA. Quantitation of RNA is expressed as fold 
change relative to non-depleted XRN2-AID cells with control siRNA. All levels 
were normalised to b actin. * denotes p < 0.05, error bars show standard 
deviation. Data is the mean of three independent experiments with samples run 
in triplicate each time. 
XRN2-AID + con siRNA
XRN2-AID + Aux + con siRNA
XRN2-AID + INTS1 siRNA





In this chapter I have used RNA-seq analysis and qRT-PCR validation to 
emphasise the importance of endonuclease functions in snRNA transcription. 
Firstly, it was shown that depletion of the Integrator causes global extension of 
snRNAs downstream of their TES, with the metagene plot suggesting snRNA 
readthrough is still terminated by 2 Kb (Figure 4.5). INTS1 and INTS11 depletion 
results in dysfunction of the Integrator by disrupting proper Integrator formation 
or through loss of Integrator endonuclease activity, respectively. Both of these 
effects resulted in loss of Integrator cleavage at the 3’ end of snRNAs upon 
recognition of the 3’ box and therefore resulted in extended snRNA transcripts. 
Furthermore, neither INTS11 nor INTS1 depletion prevented termination of 
readthrough snRNAs. Instead it was observed that extended snRNAs caused by 
Integrator dysfunction are terminated within a window of 1 – 3 Kb downstream of 
the TES (Figure 4.6 and Figure 4.7). Inhibition of transcription showed that 
INTS11 depletion caused a reduction in the levels of snRNA precursors (Figure 
4.8). Potentially these findings could be the result of increased degradation 
efficiency of extended snRNAs or an overall reduction in transcription of snRNAs 
upon INTS11 depletion.  
Secondly, I showed that DIS3 depletion was sufficient to cause extension 
of snRNAs and DIS3 plays a role in degradation of snRNA precursors / extended 
snRNA transcripts. Interestingly, DIS3 dependent snRNA extension did not 
continue further than 1 – 3 Kb downstream of the snRNA TES, similar to snRNA 
readthrough observed upon Integrator dysfunction (Figure 4.9 and Figure 4.10). 
Whether DIS3 depletion also effects snRNA processing is unclear. In addition, 
the findings observed upon transcription inhibition suggested that DIS3 depletion 
does not affect the levels of snRNA transcription (Figure 4.12). Accumulation of 
snRNA precursor transcripts occurred upon DIS3 depletion as in normal 
conditions DIS3 would degrade snRNAs. I hypothesise that DIS3 also degrades 
extended snRNAs rather than having a function in their processing. This is 
supported by the accumulative effect seen when both DIS3 and Integrator 
function are impaired, compared to either DIS3 depletion or INTS1 depletion 
alone (Figure 4.13). INTS1 depletion resulted in accumulation of extended 
snRNAs through loss of their 3’ end cleavage, which was intensified by DIS3 
depletion causing defective degradation of extended snRNAs and resulting in 
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their accumulation. DIS3 degradation of extended snRNAs has been reported 
previously by Labno et al (2016).  
Thirdly, another prominent finding throughout this chapter was that 
extended snRNAs are terminated relatively close to the snRNA TES. As 
mentioned previously this termination could be induced by Integrator independent 
transcript cleavage. It was suggested that Pol II would continue transcription 
slightly downstream of a cleavage event, as seen with protein-coding genes, and 
therefore a short transcript would be produced. This transcript would likely be 
rapidly degraded by a 5’ – 3’ exonuclease like XRN2. However, upon XRN2 
depletion there was no observed significant differences in RNA levels 
downstream of the extended snRNAs (Figure 4.14). Therefore for a downstream 
cleavage event to occur, an endonuclease other than the Integrator and a 
different 5’ – 3’ exonuclease would potentially be required. As XRN2 is the major 
exonuclease in the nucleus, it appears termination of extended snRNAs is more 
likely a result of Pol II dissociation without cleavage. The lack of an XRN2 effect 
in this data supports the work of Eaton et al (2018), who found no role for XRN2 
in snRNA termination.   
Overall I have highlighted the function of both the Integrator and exosome 
in snRNA metabolism, whilst also exploring the association between snRNA 3’ 
cleavage and termination. Although I have shown Integrator cleavage of snRNA 
is not necessary for transcription termination, it is possible that cleavage 
promotes more efficient termination and therefore disruption of the Integrator 
causes termination delay. In the following chapter I will investigate the role of 
CPSF73, an endonuclease that is also known for its role in cleavage at the 3’ end 









5. Results Chapter 3: The role of the endonuclease CPSF73 in 
processing of protein-coding genes and transcription of 
snRNAs 
Transcription has been most studied at protein-coding genes and CPSF73 
is known to have a major role in mRNA processing. CPSF73 recognises the 
AAUAAA hexamer sequence of the mRNA PAS and co-transcriptionally cleaves 
the mRNA 18 – 30 nts downstream of the PAS. This releases the nascent RNA 
and allows binding of polyadenylation factors (Proudfoot et al, 2011; Ryan et al, 
2004). In the torpedo model of transcription termination at protein coding genes, 
it is CPSF73 cleavage that enables transcription termination of mRNA. In this 
model it is believed that cleavage at a PAS site is required for mRNA transcription 
termination, with Pol II pausing after PAS transcription to enhance transcription 
termination efficiency (Fusby et al, 2016; Eaton et al, 2018). In the allosteric 
model of transcription termination, it is thought that transcription of the PAS 
results in a conformational change in the Pol II elongation complex leading to 
termination. This model is supported by data showing cleavage is not required 
for termination (Osheim et al, 1999; Osheim et al, 2002; Zhang et al, 2015a). 
Similar to the Integrator endonuclease activity at snRNAs, CPSF73 is responsible 
for 3’ end cleavage of mRNA. Therefore, I wanted to investigate whether CPSF73 
depletion would cause a processing defect on protein coding genes, like that seen 
with extended snRNAs upon INTS11 and INTS1 depletion. Additionally, these 
findings could potentially support or dispute the torpedo termination model. For 
these experiments, CPSF73 was genetically modified in HCT116 cells to bring it 
under inducible control.  
 
5.1 Production of the CPSF73-AID cell line 
To investigate the role of the endonuclease CPSF73, an inducible 
CPSF73 knockdown cell line had been previously produced by Steven West. The 
aim was to generate CPSF73-AID cells using HCT116:TIR1 parent cells and the 
same CRISPR/Cas9 protocol as for DIS3-AID cell production. However, this 
method yielded no cell colonies. It was hypothesised that the constitutively active 
TIR1 expression in HCT116:TIR1 cells might have an effect on the levels of 
tagged CPSF73. Therefore, HCT116 cells with inducible TIR1 expression under 
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a tet promoter were instead generated (HCT116:TIR1tet) and then utilised for 
CPSF73 genetic modification with the AID-tag to produce CPSF73-AID cells. 
Putting TIR1 under the control of a tet promoter allowed TIR1 inducible 
expression by addition of doxycycline, a synthetic tetracycline alternative, to cell 
media. After which addition of auxin should be able to deplete CPSF73 in 
CPSF73-AID cells.  
 
5.1.1 Full depletion of AID-tagged CPSF73 is dependent on TIR1 
expression 
To ensure the CPSF73-AID cell line was capable of inducible CPSF73 
depletion, a western blot was conducted. Using HCT116:TIR1 cells as a control, 
the levels of CPSF73 were analysed in CPSF73-AID cells treated or not with 
doxycycline (dox) for 16 hours, auxin for 2 hours or both (Figure 5.1). In untreated 
conditions CPSF73-AID cells showed similar levels of tagged CPSF73, as shown 
by the higher band, to endogenous levels of CPSF73 in HCT116:TIR1 cells. An 
endogenous CPSF73 band was not present in CPSF73-AID cells, suggesting 
both alleles of CPSF73 had been successfully tagged with the AID. Importantly, 
addition of auxin alone did not have an effect on tagged CPSF73 levels showing 
that TIR1 expression is required for CPSF73 depletion in this cell line. Auxin and 
doxycycline treatment together resulted in a near complete depletion of CPSF73. 
All further studies requiring CPSF73 depletion were then conducted by 16 hours 
doxycycline treatment and 2 hours auxin treatment in CPSF73-AID cells.  
Interestingly, doxycycline treatment alone in CPSF73-AID cells caused a 
reduction in tagged CPSF73 levels. Others have reported auxin-independent 
depletion of AID tagged proteins in human, chicken and yeast cells (Zasadzinska 
et al, 2018; Nishimura and Fukagawa, 2017; Morawska and Ulrich, 2013). This 
finding gives support to the hypothesis that TIR1 expression affects tagged 
CPSF73 levels and helps explain why generation of CPSF73-AID cells in a 
parental HCT116:TIR1 background was unsuccessful. In support of this, 
Mendoza-Ochoa et al (2019) found that in yeast, auxin independent depletion of 
the tagged protein could be caused by high levels of TIR1 expression. 
Proteasome-mediated AID tagged protein degradation in the absence of auxin 












Figure 5.1 Western blot of CPSF73 
Western blot showing the levels of endogenous CPSF73 in HCT116:TIR1 cells 
(lower band) and AID-tagged CPSF73 in CPSF73-AID cells (higher band), 
treated or not for 16 hours with doxycycline to induce TIR1 expression, 2 hours 
auxin treatment or both. Alpha tubulin was used as a loading control. Full 






To overcome this issue they expressed an auxin response transcription factor 
(ARF), which in plants binds to AID in the absence of auxin (Figure 1.3). 
Expression of ARF rescued constitutive degradation of AID tagged proteins and 
increased the rate of degradation upon auxin addition. 
 
5.2 CPSF73 depletion causes extensive readthrough of protein coding 
mRNA.  
As it is known that CPSF73 is responsible for cleavage of mRNA, I 
investigated the effects of CPSF73 depletion on transcription and termination of 
protein-coding genes. RNA-Seq was conducted on CPSF73-AID cells, using 
single-end 50 bp reads. To generate RNA libraries, nascent nuclear RNA was 
extracted from cells after 16 hours of doxycycline and 2 hours auxin treatment, 
or no treatment. For analysis, reads were aligned to the genome after filtering. 
RPKM normalisation coverage plots were used to visualise read changes 
throughout the genome. Table 5.1 shows the RNA-Seq sequencing depth and 
coverage for both replicates of CPSF73-AID cells treated or not with auxin.  
 






Sequencing depth over all exons = (Total number of mapped reads * average 
read length (bp)) / total length of merged exons 
Sequencing coverage over all exons = (Total number of mapped reads to exons 

















To produce metagene plots, all annotated genes were filtered by 
expression and low or unexpressed genes were discarded. An inclusion window 
around each gene consisting of 3 Kb upstream of the TSS and 7 Kb downstream 
of the TES was utilised (Figure 5.2A). Any genes that overlapped other genes 
due to this inclusion window were removed from the analysis, to ensure a minimal 
false-positive discovery of CPSF73 depletion effects. Therefore 4702 genes were 
included in the metagene plot analysis, showing the average transcription profile 
of these genes.  
From Figure 5.2A there appeared to be no effect on transcription levels 
upstream of the TSS when CPSF73 was depleted. On the other hand a major 
accumulation of reads extending downstream of the TES, that did not terminate 
before 7 Kb, were observed specifically upon CPSF73 depletion. This finding 
shows CPSF73 is required for protein-coding mRNA cleavage and that CPSF73 
depletion results in extended mRNA transcripts due to continuation of Pol II 
transcription. In addition, a decrease in the average read density over the gene 
body is observed upon CPSF73 depletion. This could suggest that CPSF73 
depletion has an effect on Pol II occupancy at protein-coding genes. In fact, Eaton 
et al (2018) found a general reduction in transcription upon CPSF73 loss and in 
support Mapendano et al (2010) reported an impairment in transcription with PAS 
mutations or polyadenylation factor depletion. One explanation for this is that 
upon CPSF73 depletion, Pol II will not dissociate from the genome and instead 
continues transcribing. This results in less recycled Pol II and therefore a 






Figure 5.2 Metagene profiles of protein coding genes in CPSF73-AID cells 
Metagene profile plots of non-overlapping protein-coding genes in CPSF73-AID 
cells with or without doxycycline and auxin treatment. A) Metagene of 4701 
protein-coding genes. Inclusion window is 3 Kb upstream of the TSS and 7 Kb 
downstream of the TES, with the gene body scaled to 5Kb. B) Metagene of 1715 
genes, showing 50 Kb downstream of the TES. C) Metagene of 689 genes, 
showing 100 Kb downstream of the TES. All represent one biological replicate; a 







Figure 5.3 Second replicate of protein-coding gene metagene profiles in 
CPSF73-AID cells 
Second biological replicate for metagene profile plots of non-overlapping protein-
coding genes in CPSF73-AID cells with or without doxycycline and auxin 
treatment. A) Metagene of 4701 protein-coding genes. Inclusion window is 3 Kb 
upstream of the TSS and 7 Kb downstream of the TES, with the gene body scaled 
to 5Kb. B) Metagene of 1715 genes, showing 50 Kb downstream of the TES. C) 






As mRNA readthrough caused by CPSF73 depletion was still present at 7 
Kb downstream of the TES, metagene plots with increased inclusion windows 
were generated with the aim to observe the length of extension. A metagene plot 
showing 50 Kb (Figure 5.2B) and 100 Kb (Figure 5.2C) downstream of the TES 
were generated, ensuring any overlapping genes were then removed. This 
resulted in the analysis of 1715 and 689 protein-coding genes for each metagene 
plot, respectively. Analysis of 1715 protein-coding genes showed that upon 
CPSF73 depletion there is an accumulation of extended transcripts that have 
readthrough of at least 50 Kb. Although the 100 Kb metagene plot had a slightly 
reduced average read density, showing less RNA transcripts extended to this 
length, there was still an obvious increase in the amount of extended transcripts 
upon CPSF73 depletion. The increased average read density did not reduce to 
levels comparable to those observed in the presence of CPSF73, showing that 
CPSF73-dependent readthrough can extend further than 100 Kb for some 
transcripts. Overall this data shows it is unlikely that Pol II terminates on these 
genes without CPSF73.  
 
5.2.1 Unprocessed mRNAs can show more than 400 Kb readthrough 
It is clear from the metagene plot analysis that CPSF73 depletion causes 
readthrough that can extend to 100 Kb and beyond, however it was still unclear 
when and if this extension would terminate. Using the list of 689 non-overlapping 
genes at 100 Kb, genes were randomly selected for further visualisation by RPKM 
coverage tracks. Three of these genes, AGTPBP1, GPD2 and NEK7 are shown 
in Figure 5.4. The pink area in this figure highlights the readthrough caused by 
CPSF73 loss. For all three genes extension was observed beyond approximately 
400 Kb downstream of the TES. It is possible that with an increased auxin 
treatment time (> 2 hours) and therefore longer depletion of CPSF73, this 
extension could continue further than 400 Kb. Overall these findings suggest that 
Pol II transcription termination of protein-coding genes is tightly coupled to mRNA 
cleavage by CPSF73. As mRNA extension can be observed for thousands of 
base pairs it could be argued that CPSF73 is necessary for termination. Therefore 





Figure 5.4 RPKM coverage tracks of extended mRNAs in CPSF73-AID cells 
RPKM normalised coverage tracks showing three protein-coding genes, 
AGTPBP1, GPD2 and NEK7, from CPSF73-AID cells treated or not with 
doxycycline and auxin. The pink box area highlights the extension readthrough 
caused by CPSF73 depletion. The numbers in brackets show the average RPKM 
normalised read count range. Figure represents one biological replicate, a 








Figure 5.5 Second replicate RPKM coverage tracks of extended mRNAs in 
CPSF73-AID cells 
Second biological replicate for RPKM normalised coverage tracks showing three 
protein-coding genes, AGTPBP1, GPD2 and NEK7, from CPSF73-AID cells 
treated or not with doxycycline and auxin. The pink box area highlights the 
extension readthrough caused by CPSF73 depletion. The numbers in brackets 






5.2.2 mRNA readthrough can extend into neighbouring genes 
CPSF73-dependent readthrough occurred at an extensive number of 
protein-coding genes, with extension often passing through other expressed 
genes. In these types of situations and from the RNA-Seq data alone, it was 
difficult to differentiate from which gene the readthrough originated from or 
whether increased reads over a gene were caused by readthrough into that gene 
or transcription upregulation. Instead I investigated readthrough into non-
expressed neighbouring genes (Figure 5.6). In Figure 5.6B, CPSF73 depletion 
caused readthrough of a protein-coding gene, SPIN1, that extended 
approximately 300 Kb downstream of the TES. This readthrough extended into 
another previously non-expressed protein-coding gene, NXNL2, as well as a long 
intergenic non-coding RNA (lincRNA), AL592486.1.  
Figure 5.6C shows a similar example, with readthrough from either HIF1A 
or the long non-coding RNA AL137129 extending into SYT16 which was not 
expressed in CPSF73-AID cells under no treatment conditions. In Figure 5.6A 
readthrough that may occur from multiple genes leads to the upregulation of 
reads over lincRNA AL162414 and protein-coding gene MUSK. Overall it is clear 
that readthrough does not easily terminate and instead can continue into 
neighbouring genes, passing through their PAS sites and continuing onwards. 
This is not just true for expressed or non-expressed protein-coding genes, but 
also for readthrough extending into lncRNAs and potentially causing their 
upregulation. CPSF73 depletion causes issues with gene expression and 
regulation, which is likely to lead to unviable cells. This would explain why we 
were unable to obtain tagged-CPSF73 in a constitutively TIR1 expressing cell 
background (HCT116:TIR1 cells). As shown previously, TIR1 expression causes 
a reduction in tagged CPSF73 levels (Figure 5.1). If these reduced levels were 
sufficient to cause readthrough as shown here, gene expression would be highly 







Figure 5.6 RPKM coverage tracks showing CPSF73 depletion dependent 
readthrough into neighbouring genes 
RPKM normalised coverage tracks from CPSF73-AID cells treated or not with 
doxycycline and auxin. A, B and C each show different genes with readthrough 
of various length extending into neighbouring genes that weren’t expressed under 
normal conditions. The numbers in brackets show the average RPKM normalised 
read count range. Figure represents one biological replicate, a second biological 
replicate is shown in Figure 5.7.  









Figure 5.7 Second replicate RPKM coverage tracks showing CPSF73 depletion 
dependent readthrough into neighbouring genes 
Second biological replicate for RPKM normalised coverage tracks from CPSF73-
AID cells treated or not with doxycycline and auxin. A, B and C each show 
different genes with readthrough of various length extending into neighbouring 
genes that weren’t expressed under normal conditions. The numbers in brackets 







5.3  CPSF73 does not appear to play a role in snRNA processing  
Although previous studies have shown the endonuclease component of 
the Integrator is responsible for cleavage of snRNAs, due to the homology 
between CPSF73 and INTS11 I wanted to investigate if CPSF73 had any effect 
on snRNA transcription. Using the same list of snRNAs to create the INTS11-
SMASh snRNA metagene plot (Figure 4.5), a metagene plot was generated for 
CPSF73-AID cells (Figure 5.8A). From the metagene there were no observable 
differences, suggesting depletion of CPSF73 has no effect, at any level, on 
snRNA transcription and processing. To further confirm this finding I investigated 
some individual snRNAs, including RNU5B-1 and RNU5D-1, as shown in Figure 
5.8B. RPKM coverage plots supported the finding that CPSF73 does not play a 
role in snRNA maturation, as no differences were observed upon CPSF73 
depletion. These results were not unexpected as no role for CPSF73 in snRNA 
processing has been found previously, except in plants (Liu et al, 2016). 
Additionally, although the fission yeast CPSF73 homolog, YSH1, was found to 
bind to snRNAs it was not necessary for snRNA transcription termination, unlike 
the XRN2 homolog, DHP1 (Larochelle et al, 2018). However, in humans CPSF73 
is known to interact with mature snRNAs, i.e. u7 snRNP, to regulate 3’ end 









Figure 5.8 CPSF73-AID snRNA metaplot and snRNA RPKM coverage tracks 
One biological replicate represented; see Figure 5.9 for an additional replicate. 
A) Metagene coverage plot for 95 snRNAs in CPSF73-AID cells, with an inclusion 
window 100 bp upstream of the TSS and 2000 bp downstream of the TES. The 
gene body was scaled to 100 bp. B) RPKM coverage tracks for snRNAs RNU5B-
1 and RNU5D-1 in CPSF73-AID cells treated or not with doxycycline and auxin. 













Figure 5.9 Second replicate CPSF73-AID snRNA metaplot and snRNA RPKM 
coverage tracks 
Second biological replicate. A) Metagene coverage plot for 95 snRNAs in 
CPSF73-AID cells, with an inclusion window 100 bp upstream of the TSS and 
2000 bp downstream of the TES. B) RPKM coverage tracks for snRNAs RNU5B-
1 and RNU5D-1 in CPSF73-AID cells. The numbers in brackets show the average 







RNA-seq data from CPSF73-AID cells was able to demonstrate the major 
role of CPSF73 in protein-coding mRNA processing. Upon CPSF73 depletion 
numerous protein-coding genes show aberrant transcription termination resulting 
in Pol II readthrough (Figure 5.2). In some cases this readthrough was able to 
extend past 400 Kb downstream of the TES, showing impairment of Pol II 
dissociation from the genome when mRNA cleavage is impaired (Figure 5.4). 
Additionally, readthrough was not perturbed by neighbouring genes, with 
extension causing an accumulation of reads in genes that were previously lowly 
or not expressed (Figure 5.6). The global and major readthrough effect at protein 
coding genes when CPSF73 cleavage is inhibited, demonstrates the close 
relationship between 3’ end cleavage of mRNAs and their termination. These 
findings are in line with previous work from the West laboratory (Eaton et al, 
2018), giving support to the torpedo model of transcription termination and 
disputing such studies that suggested cleavage was not essential for termination 
(Osheim et al, 1999; Osheim et al, 2002; Zhang et al, 2015a). Additionally, in this 
work no function for CPSF73 was found in snRNA transcription (Figure 5.8). 
Overall these findings are similar to those of Eaton et al (2018) who 
generated a conditional CPSF73 depletion cell line in HCT116 cells by tagging 
the C terminus of CPSF73 with a Echerichia coli DHFR-based degron. With this 
system, withdrawal of trimethoprim from cell media caused depletion of CPSF73. 
Western blot confirmed near complete depletion of tagged CPSF73 after 10 
hours, which is slower than the AID system utilised in this work. As the work of 
Eaton et al (2018) was conducted in my lab, we aimed to produce a cell line 
capable of a quicker depletion of CPSF73 than the DHFR system. In support of 
the findings within this work, Eaton et al (2018) found a significant reduction in 
PAS cleavage at MYC and ACTB genes by RT-qPCR. As I conducted RNA-Seq 
on the CPSF73-AID cells I was able to show this defect in PAS cleavage was 
more widespread. The main difference in this work compared to Eaton et al 
(2018) was the use of CPSF73-AID cells to investigate the more immediate 
effects of CPSF73 depletion and the ability to analyse thousands of genes by 
conducting RNA-Seq.  
Eaton et al (2018) performed ChIP on CPSF73-DHFR cells. They found 
that loss of CPSF73 caused a general reduction in transcription and extensive 
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transcription readthrough at MYC and ACTB, which also supports the findings in 
this chapter. Additionally, Eaton et al (2018) was able to show that a CPSF73 
active site mutant could not support efficient transcriptional termination of MYC 
or ACTB, which was something not investigated within this work.  
 In the next chapter the function of CPSF73 is explored further, by 
investigating its role in the transcription and processing of RDHs, alongside DIS3 






















6. Results Chapter 4: Endonuclease function in replication 
dependent histone transcription and processing 
Replication-dependent histones (RDHs) aid in packaging of newly 
synthesised DNA and are often found in clusters. They are transcribed by Pol II, 
are not polyadenylated and have a unique processing pathway (Figure 1.1). 
RDHs contain a 3’ stem-loop and 5’ purine-rich histone downstream element 
(HDE). Cleavage of RDH pre-mRNA occurs between the stem loop and HDE by 
the histone cleavage complex (HCC) which includes CPSF73, CPSF100, CstF64 
and Symplekin (Marzluff and Koreski, 2017). Recruitment of the HCC requires 
binding of U7 snRNP to the HDE as well as the stem-loop binding protein (SLBP) 
aiding in stabilisation of U7 snRNP on the RDH pre-mRNA, potentially through 
interactions with FLASH (Skrajna et al, 2017). Similar to spliceosomal snRNPs, 
U7 snRNP contains a binding site for a Sm ring. The core U7 snRNP consists of 
U7 snRNA bound to five Sm proteins found in spliceosomal snRNAs. However, 
it also contains Lsm10 and Lsm11 proteins which replace SmD1 and SmD2. It is 
Lsm11 binding to FLASH that creates a docking platform for the HCC (Yang et 
al, 2013; Burch et al, 2011).  
RDH pre-mRNA 3’ end cleavage occurs rapidly upon transcription of the 
processing signal and unlike polyadenylated genes, where Pol II occupancy 
continues 4 – 6 Kb downstream of the TES, transcription terminates shortly after 
as shown by a quick drop in Pol II occupancy after the RDH TES (Anamika et al, 
2012). CPSF73, as part of the HCC, is believed to be the main endonuclease 
responsible for RDH pre-mRNA cleavage and has been shown to be cross-linked 
to the RDH pre-mRNA cleavage site (Dominski et al, 2005). This endonuclease 
also has a major role in cleavage / polyadenylation of protein-coding mRNA 
(Mandel et al, 2006).  
As U7 snRNA plays a major role in RDH pre-mRNA processing, it appears 
likely that disruption of Integrator function could indirectly affect RDH transcription 
through decreased levels of processed U7 snRNA. Interestingly, the Integrator 
has also been suggested to have a direct role in RDH processing. Skaar et al 
(2015) found the Integrator binds to the 3’ end of RDH genes and knockdown of 
Integrator subunit 3 (INTS3) caused accumulation of unprocessed 
polyadenylated RDH transcripts. However, in Drosophila experiments no link 
166 
 
between Integrator dysfunction and histone pre-mRNA processing or cleavage 
and polyadenylation were found. In comparison, knockdown of CPSF73, 
CPSF100, Symplekin or SLBP was sufficient to affect RDH RNA processing 
(Ezzeddine et al, 2011). Therefore it is still not known what role, if any, the 
Integrator may have in RDH transcription. Unfortunately, RDH transcripts were 
not fully detectable in my INTS11 RNA-Seq dataset meaning I was unable to 
draw conclusions on the direct effect of Integrator depletion.  
So far I have shown DIS3 is responsible for degradation of a multitude of 
transcripts and therefore it is possible DIS3 may also play a role in RDH mRNA 
or RDH precursor degradation. In support, Mullen and Marzluff (2008) found that 
disrupting exosome function caused a reduction in histone mRNA degradation.  
In a follow-up study, Slevin et al (2014) elucidated a pathway for histone 
degradation. Firstly a 3’ – 5’ exonuclease, 3’hExo, binds to SLBP and degrades 
the histone mRNA into the stem-loop. This forms a degradation intermediate with 
SLBP still bound. Upon removal of SLBP which would otherwise block further 
degradation, the exosome is able to degrade the histone mRNA. In addition, 
depletion of DIS3 showed readthrough histone transcripts produced by CstF64 
knockdown were degradation targets of the exosome (Romeo et al, 2014). Thus, 
DIS3 as part of the exosome could be crucial for RDH mRNA and / or RDH 
precursor degradation. In this chapter I investigate the role of endonucleases on 
RDHs. 
 
6.1 CPSF73 depletion doesn’t affect RDH pre-mRNA processing 
As mentioned in the previous chapter, CPSF73-AID cells underwent RNA-
Seq to elucidate direct substrates of CPSF73. Using this data, I firstly wanted to 
elucidate the effect of CPSF73 knockdown on RDH mRNA, due to its major 
function as part of the HCC. RDH genes often cluster on the genome and 
therefore a cluster of 5 RDHs (HIST1H3A, HIST1H4A, HIST1H4B, HIST1H3B, 
HIST1H2AB) could be easily visualised together (Figure 6.1 and 6.2). 
Interestingly, no differences were observed in these five RDH transcripts upon 
CPSF73 depletion. CPSF73 may function at a specific subset of RDHs, therefore 
I further analysed another cluster of RDH genes. RPKM coverage tracks were 
used to visualise HIST1H4D, HIST1H1PS1, HIST1H3D, HIST1H2AD, 
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HIST1H2BF and HIST1H4E (Figure 6.3 and 6.4). Again, no apparent differences 
were observed.  
One possible explanation for observing no effect on RDH transcription, 
may be that another endonuclease is sufficient for RDH pre-mRNA cleavage 
upon CPSF73 depletion. For example, MBLAC1, which when depleted has been 
shown to cause accumulation of unprocessed RDH transcripts (Pettinati et al, 
2018). Another explanation is that remaining levels of CPSF73 after doxycycline 
and auxin treatment are sufficient for RDH pre-mRNA processing. However, due 
to the absence of a visible band on the western blot when cells were treated with 
doxycycline and auxin, I am confident that this is unlikely (Figure 5.1). In addition, 
the massive effects I observed of CPSF73 depletion on mRNA genes suggest a 
sufficient depletion of CPSF73 (Chapter 5).  
Pettinati et al (2018) observed an approximate readthrough of 200 bp on 
multiple, but not all, RDH genes when CPSF73 was depleted by RNAi. To ensure 
this small readthrough effect had not been visually overlooked when analysing 
the RDH genes in cluster, I investigated several genes individually. Three of these 
genes (HIST1H3B, HIST1H4B and HIST1H2BC), which were shown to have a 
major readthrough effect upon MBLAC1 depletion and similar effect upon 
CPSF73 depletion in Pettinati et al (2018), are shown in Figure 6.5. In contrast to 
the findings of Pettinati et al (2018), no readthrough effect was observed on these 
RDH mRNAs when CPSF73 was depleted in our CPSF73-AID cells.  
The differences between these two works may be due to the 
methodologies used. For example, Pettinati et al (2018) used siRNA in HeLa cells 
for depletion of CPSF73 compared to my use of the AID system in HCT116 cells. 
In addition, their study utilised cells synchronised in early S-phase during which 
RDH genes are rapidly transcribed and they specifically analysed chromatin 
associated RNA, in comparison to nuclear RNA extracted for my investigations. 
Therefore, readthrough RDH transcripts may not have been detected in this work 
due to their rapid turnover at the end of S phase of the cell cycle (Marzluff et al, 
2008). However, defective processing of RDH pre-mRNA has been shown to 
cause their aberrant polyadenylation by use of a downstream PAS (Kari et al, 
2013; Romeo et al, 2014). These polyadenylated transcripts are stable 












Figure 6.1 CPSF73-AID RPKM coverage track of a RDH gene cluster 
RPKM normalised coverage track showing five RDH genes (HIST1H3A, 
HIST1H4A, HIST1H4B, HIST1H3B and HIST1H2AB) in CPSF73-AID cells with 
or without doxycycline and auxin treatment. No apparent differences are 
visualised. The numbers in brackets show the average RPKM normalised read 
count range. Figure is representative of one biological replicate, a second 
biological replicate is shown in Figure 6.2.  
 
 











Figure 6.2 Second replicate CPSF73-AID RPKM coverage track of a RDH gene 
cluster 
Second biological replicate for RPKM normalised coverage track showing five 
RDHs (HIST1H3A, HIST1H4A, HIST1H4B, HIST1H3B and HIST1H2AB) in 
CPSF73-AID cells with or without doxycycline and auxin treatment. No apparent 
differences are visualised. The numbers in brackets show the average RPKM 
normalised read count range. 
 
 










Figure 6.3 CPSF73-AID RPKM coverage track of a second RDH gene cluster 
RPKM normalised coverage track showing six RDH genese (HIST1H4D, 
HIST1H1PS1, HIST1H3D, HIST1H2AD, HIST1H2BF, HIST1H4E) in CPSF73-
AID cells with or without doxycycline and auxin treatment. No apparent 
differences are visualised. The numbers in brackets show the average RPKM 
normalised read count range. Figure is representative of one biological replicate, 
a second biological replicate is shown in Figure 6.4.  
 
 










Figure 6.4 Second replicate CPSF73-AID RPKM coverage track of a second 
RDH gene cluster 
Second biological replicate for RPKM normalised coverage track showing six 
RDHs (HIST1H4D, HIST1H1PS1, HIST1H3D, HIST1H2AD, HIST1H2BF, 
HIST1H4E) in CPSF73-AID cells with or without doxycycline and auxin treatment. 
No apparent differences are visualised. The numbers in brackets show the 
average RPKM normalised read count range. 
 








Figure 6.5 RPKM coverage tracks of individual RDHs in CPSF73-AID cells 
A closer visualisation of RPKM normalised coverage tracks for HIST1H4B, 
HIST1H3B and HIST1H2BC in CPSF73-AID cells treated or not with doxycycline 
and auxin. No apparent differences are visualised. The numbers in brackets show 
the average RPKM normalised read count range. Figure represents one 
biological replicate, a second replicate is represented in Figure 6.6.  
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Figure 6.6 Second replicate RPKM coverage tracks of individual RDHs in 
CPSF73-AID cells 
Second biological replicate of RPKM normalised coverage tracks for HIST1H4B, 
HIST1H3B and HIST1H2BC in CPSF73-AID cells treated or not with doxycycline 
and auxin. No apparent differences are visualised. The numbers in brackets show 
the average RPKM normalised read count range. 
CPSF73-AID
CPSF73-AID + dox + aux
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6.2 DIS3 depletion causes accumulation of RDH PROMPTs 
As previously mentioned, the exosome has been found to degrade mature 
RDH transcripts. However, whether EXOSC10, DIS3 or both subunits provide 
this degradation activity is unclear. Therefore, I analysed the same cluster of 
histones as in Figure 6.1 using DIS3-AID RNA-Seq data (Figure 6.7 and 6.8). 
DIS3 depletion caused an increase in reads upstream of the TSS of some RDHs, 
including HIST1H4B and HIST1H2AB as highlighted by the arrows. These reads 
show PROMPT accumulation in the opposite transcription direction to the 
associated RDH gene, as confirmed by split strand visualisation (Figure 6.9). This 
demonstrates that PROMPTs can also derive from RDH genes and accumulate 
upon DIS3 depletion. Aside from PROMPT accumulation, no other changes in 
read levels were observed. Therefore, DIS3 may not be responsible for RDH 
mRNA degradation as an accumulation of mature RDH transcripts might have 
been expected if their degradation had been inhibited. Although DIS3 depletion 
appears to show no effects on RDH mRNA degradation, the exosome may still 
play a role. Instead, the other catalytic subunit EXOSC10 may be responsible for 
RDH degradation or may show redundancy to DIS3. Alternatively, 1 hour of DIS3 
depletion may not have been sufficient for RDH transcript accumulation. S-phase, 
when RDH genes are rapidly transcribed, lasts for approximately 8 hours and 
RDHs are quickly degraded afterwards (Hahn et al, 2009; Harris et al, 1991). 
Therefore, effects on RDH transcripts observed upon DIS3 depletion may be 
dependent on the cell cycle phase.  
  
6.3 Preventing U7 snRNA binding to the HDE of RDH genes causes 
defective RDH processing 
The role of the Integrator in RDH processing is currently unclear, although 
both a direct and indirect effect have been postulated (Skaar et al, 2015; 
Ezzeddine et al, 2011). As the Integrator is responsible for proper processing of 
snRNAs as shown in the previous chapter, Integrator dysfunction would affect U7 
snRNA processing and therefore could indirectly cause misprocessing of RDH 
transcripts. To specifically investigate the effects of Integrator dysfunction on 
RDHs through U7 snRNA misprocessing, I used an antisense morpholino 











Figure 6.7 DIS3-AID RPKM coverage track of a RDH gene cluster 
RPKM normalised coverage track showing five RDH genes (HIST1H3A, 
HIST1H4A, HIST1H4B, HIST1H3B and HIST1H2AB) in DIS3-AID cells with or 
without auxin treatment. The black arrows highlight reads corresponding to 
PROMPT transcription in the opposing direction to transcription of the associated 
RDH gene. The numbers in brackets show the average RPKM normalised read 
count range. Figure represents one biological replicate, a second biological 
replicate can be found in Figure 6.8.  
 











Figure 6.8 Second replicate DIS3-AID RPKM coverage track of a RDH gene 
cluster 
Second biological replicate of RPKM normalised coverage track showing five 
RDHs (HIST1H3A, HIST1H4A, HIST1H4B, HIST1H3B and HIST1H2AB) in DIS3-
AID cells with or without auxin treatment. The numbers in brackets show the 
average RPKM normalised read count range. 
 
 











Figure 6.9 DIS3-AID RPKM split strand coverage track of a RDH gene cluster 
RPKM normalised coverage track showing five RDHs (HIST1H3A, HIST1H4A, 
HIST1H4B, HIST1H3B and HIST1H2AB) in DIS3-AID cells (first replicate) with or 
without auxin treatment. Strands have been separated, with the sense strand in 
red and antisense strand in blue. The black arrows highlight reads corresponding 
to PROMPT transcription in the opposing direction to transcription of the 
associated RDH gene. The numbers in brackets show the average RPKM 








This allowed easy occlusion of U7 snRNP, thus inhibiting its function, in various 
cell lines and further analysis of the effects. 
 
6.3.1 Occlusion of U7 snRNP causes extension of RDHs 
After using a AMO to bind to and occlude U7 snRNP in HCT116:TIR1 cells, 
I first examined the effects on RDH pre-mRNA processing. To do this, qRT-PCR 
was conducted to measure uncleaved and downstream RNA levels of two RDH 
genes, HIST1H4H and HIST1H3B (Figure 6.10A and 6.10B). Blocking of U7 
snRNP binding caused a strong accumulation of uncleaved HIST1H4H and 
HIST1H3B in comparison to HCT116:TIR1 cells transfected with a control AMO. 
Therefore, preventing U7 snRNP binding to the HDE causes impaired cleavage 
of RDH pre-mRNA. Lsm11, a subunit of U7 snRNP, normally forms a docking 
platform with FLASH for the HCC. The defective RDH cleavage upon U7 snRNA 
inhibition is therefore likely caused by impaired recruitment of the HCC (Yang et 
al, 2013; Burch et al, 2011).  
To determine how far unprocessed RDH transcripts would extend past the 
TES when U7 snRNA was bound by AMO, RNA levels downstream of the TES 
were measured by qRT-PCR (Figure 6.10A and 6.10B). For HIST1H4H an 
increase in reads 150 bp downstream of the TES was observed, with a decline 
to background levels by 1 Kb. For HIST1H3B the observed readthrough was 
longer, with a significant increase in RNA levels at 2 Kb downstream. However, 
there were no significant differences by 3 Kb past the TES. These findings 
suggest that abrogating RDH pre-mRNA cleavage produces extended RDH 
transcripts which terminate relatively close to the TES and shows their extension 
is not finite.   
Interestingly, this extension of RDH mRNA is similar to the extension of 
snRNAs observed upon INTS11 or INTS1 depletion (Figure 4.5 and 4.7). Both 
RDH and snRNA misprocessed transcripts show extension that is not finite, with 
termination occurring by 3 Kb downstream of the TES. Therefore, correct 




Figure 6.10 RNA levels downstream of RDHs after U7 snRNP depletion 
qRT-PCR detection of RNA levels downstream of HIST1H4H or HIST1H3B in 
HCT116:TIR1 cells treated with either control antisense morpholino 
oligonucleotide (AMO) or a U7 snRNA AMO. Levels of uncleaved (UC) histones 
were measured using primers homologous to the upstream (forward primer) and 
downstream (reverse primer) region of the TES. Quantitation of RNA is 
expressed as fold change relative to HCT116:TIR1 cells with control AMO. 
Standard deviation is plotted by error bars, * denotes a p value < 0.05. A) 
Normalised to b actin. B) Normalised to gene body.  







6.3.2 No significant differences in Pol II occupancy were found on 
RDH genes after blocking U7 snRNP binding 
To determine whether using a U7 snRNP AMO affected RDH transcription 
rates, Pol II occupancy was analysed downstream of HIST1H4H and HIST1H3B 
genes by chromatin immunoprecipitation (ChIP) (Figure 6.11). This experiment 
was conducted in HCT116:TIR1 cells electroporated with either a control AMO or 
U7 snRNA AMO. For HIST1H3B there were no significant differences in Pol II 
occupancy, with levels decreasing to near zero by 2 Kb. However, HIST1H4H 
showed a significant increase of Pol II occupancy of uncleaved transcripts when 
U7 snRNA binding was obstructed. This significant increase did not continue 
downstream of the TES although levels remained higher in the U7 snRNA AMO 
condition compared to controls. At 1 Kb downstream of the TES, Pol II occupancy 
had decreased to low levels when either U7 snRNA AMO was present or absent. 
These findings suggest that Pol II occupancy is unchanged on RDH genes when 
U7 snRNA binding is inhibited, although there was a slight increase over 
uncleaved HIST1H4H transcripts. Further experimental analysis would therefore 
be required at other RDH genes to determine the full effects of U7 snRNA on Pol 
II occupancy at RDH genes.  
 
6.3.3 DIS3 depletion has no effect on RDH processing  
DIS3-AID RNA-Seq data suggested DIS3 depletion had no effect on RDH 
transcription (Figure 6.7). To validate this finding, qRT-PCR was used to 
determine levels of two RDH transcripts and RNA levels downstream of their TES 
(Figure 6.12). Primers designed over the gene body (gb) of both HIST1H3B and 
HIST1H4H showed no differences in transcript levels of these histones upon 
DIS3 depletion. In fact, for HIST1H3B levels appeared to decrease although the 
result was not significant. This corroborates the RNA-Seq findings and suggests 
RDH mRNA may not be a substrate of DIS3 or that another nuclease shows 
redundancy when DIS3 is depleted. Additionally, DIS3 depletion had no effect on 
the levels of uncleaved RDHs, showing DIS3 does not affect RDH processing 
mechanisms. In further support, RNA levels downstream of the TES were not 










Figure 6.11 ChIP of RDHs in HCT116:TIR1 cells with U7 snRNP depletion 
ChIP results measuring the relative levels of Pol II occupation to gene body 
levels, of uncleaved (UC) and downstream regions of HIST1H4H and HIST1H3B 
RDH genes. Conducted in HCT116:TIR1 cells treated with either a control AMO 
or a U7 snRNP AMO. Error bars plot standard deviation and * denotes a p value 
< 0.05. Data is the mean of three independent experiments with samples run in 
triplicate each time. 










Figure 6.12 RNA levels downstream of RDHs in DIS3-AID cells 
qRT-PCR detection of RNA levels over the gene body (gb), uncleaved (UC) or 
downstream regions of HIST1H3B and HIST1H4H. Conducted in HCT116:TIR1 
cells and DIS3-AID cells treated or not with auxin. Quantitation of RNA is 
expressed as fold change relative to HCT116:TIR1 cells. All levels are normalised 
to b actin. Error bars plot standard deviation. Data is the mean of three 
independent experiments with samples run in triplicate each time. 
HCT116:TIR1 HCT116:TIR1 + Aux






6.3.4 DIS3 depletion and U7 snRNP occlusion has a cumulative 
effect on extended RDHs 
Extended RDH transcripts have been previously reported in a CstF64 
knockdown cell model (Romeo et al, 2014). These transcripts were also found to 
be degraded by the exosome. Therefore, I used DIS3-AID cells to determine if 
DIS3 could be responsible for degradation of extended RDHs produced by U7 
snRNA occlusion. DIS3-AID cells were electroporated with either control or U7 
snRNA AMO, before treatment or not with auxin for 2 hours. RNA levels 
downstream of the TES for HIST1H4H and HIST1H3B were determined by qRT-
PCR (Figure 6.13A and 6.13B).  
As seen previously, depletion of DIS3 by auxin addition had no effect on 
RDH mRNA processing. Similar to the results in HCT116:TIR1 cells, U7 snRNA 
AMO in DIS3-AID cells produced an increase in uncleaved histones which 
showed extension that terminated by 1 – 2 Kb downstream of the TES. 
Interestingly, when U7 snRNA binding was inhibited and DIS3 depleted together 
a cumulative effect could be seen as an even bigger increase in uncleaved and 
extended RDH transcripts. The extension length of these transcripts was only 
slightly, if at all, increased by DIS3 depletion. Due to this and having observed no 
effect of DIS3 on RDH processing previously in this work, it is likely that the 
accumulation of extended RDH transcripts is due to loss of their degradation by 
DIS3.  
From the data it is currently unclear whether DIS3 degrades mature RDH 
RNA. However, from these findings it can be concluded that DIS3 is able to 
degrade unprocessed extended RDHs. It is possible that DIS3 degrades both 
mature and extended transcripts and that another nuclease shows redundancy 
for mature RDH degradation or that 1 hour of DIS3 depletion is not enough for 
mature RDH accumulation. Alternatively, DIS3 may only degrade the extended 
RDH transcripts and this discrepancy may be related to polyadenylation. Mature 
RDHs are not polyadenylated whereas it has been shown that unprocessed 
RDHs become polyadenylated by use of downstream PASs (Kari et al, 2013; 
Romeo et al, 2014; Sullivan et al, 2009). It is not understood how DIS3 recognises 





Figure 6.13 RNA levels downstream of RDHs with DIS3 depletion and U7 snRNP 
occlusion 
qRT-PCR detection of uncleaved (UC) and extended HIST1H4H and HIST1H3B 
transcripts in DIS3-AID cells electroporated with either control AMO or U7 snRNA 
AMO and treated or not with auxin. Quantitation of RNA is expressed as fold 
change relative to non-depleted Dis3-AID cells with control AMO. * denotes p < 
0.05, error bars plot standard deviation. Data is the mean of three independent 
experiments with samples run in triplicate each time. A) Normalised to b actin. B) 
Normalised to gene body. 
DIS3-AID + con AMO DIS3-AID + aux + con AMO







The accumulative effect produced by DIS3 depletion was also observed 
for snRNAs, which showed increased levels of unprocessed transcripts upon 
DIS3 and INTS1 depletion (Figure 4.13). In similarity to RDHs, DIS3 depletion did 
not alter the length of these extended snRNA transcripts. This demonstrates the 
major role of DIS3 in degrading misprocessed transcripts from a variety of genes. 
 
6.4 Summary  
Firstly, in this chapter I have shown that conditional depletion of CPSF73 
in HCT116 cells appears to have no transcriptional effect on RDH genes as 
inferred from RNA-Seq analysis. Two clusters of RDH transcripts were analysed, 
to help rule out the possibility of CPSF73 acting on only a subset of RDHs (Figure 
6.1 and 6.3). As it had been expected that CPSF73 depletion would cause 
misprocessing and readthrough of RDH transcripts, it is possible another 
endonuclease may show redundancy. One candidate for this is the endonuclease 
MBLAC1, which was shown to selectively target RDH pre-mRNA for processing 
and abrogate cell cycle progression upon its depletion (Pettinati et al, 2018). From 
the same study it was shown that either MBLAC1 or CPSF73 depletion caused 
readthrough at numerous RDH genes of approximately 200 bp in length. 
Therefore, I analysed three of the same genes used in the study that had shown 
“major” misprocessing. However, no effect was observed in this work (Figure 6.5). 
These differences may be due to variances in methodology, such as using 
unsynchronised cells as RDHs are produced and degraded during S phase 
(Marzluff et al, 2008). However, U7 snRNP AMO experiments described here 
were also conducted on unsynchronised cells and showed extension of RDH 
transcripts, suggesting that the lack of CPSF73 effect is unlikely to be caused by 
cell phase synchronisation differences. Additionally I cannot rule out the 
possibility of an incomplete depletion of CPSF73 in our cell line, although the 
western blot data and strong effect on mRNA transcripts would argue against 
this.  
Secondly, DIS3 depletion caused accumulation of RDH associated 
PROMPTs but had no effect on transcript levels or processing of RDH pre-mRNA 
(Figure 6.7 and 6.12). This finding suggests DIS3 may not be responsible for 
RDH mRNA degradation but doesn’t rule out the exosome entirely, as EXOSC10 
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may play a role. However a reason for no changes in RDH transcript levels may 
be due to the small depletion time of Dis3 at only 1 hour, as levels of RDHs are 
tightly regulated by the cell cycle.  
On the other hand, inhibition of U7 snRNA binding to RDH genes with an 
AMO was able to disrupt the normal transcription of RDHs. U7 snRNP is 
responsible for recruitment of the HCC. Interestingly, as the Integrator is 
responsible for correct production of U7 snRNA, Integrator dysfunction may have 
an indirect effect on RDHs. Unfortunately, RDH transcripts were not fully 
detectable in the Ints11 RNA-Seq data and therefore I was unable to look into 
these effects more directly. In this work, use of a U7 snRNA AMO resulted in 
accumulation of extended RDH transcripts (Figure 6.10). This misprocessing of 
RDH pre-mRNA did not have finite extension, with extended transcripts 
terminating by approximately 2 Kb downstream of the TES. However, Pol II 
occupancy levels appeared unchanged on two RDH transcripts (Figure 6.11). 
One RDH transcript, HIST1H4H, did show a significant increase in Pol II 
occupancy over the TES. This significant change did not continue further 
downstream although levels remained higher in the U7 snRNA AMO condition 
compared to controls. Therefore, the investigation of Pol II occupancy at further 
RDH transcripts is required to elucidate the full effects of U7 snRNA occlusion on 
transcription levels of RDHs.  
Finally, although DIS3 reduction appeared to have no effect on RDH 
transcription, it was able to have an accumulative effect with U7 snRNA AMO on 
RDH extended transcript levels, with little effect on extension length (Figure 6.13). 
Although it is not clear whether DIS3 can degrade mature RDH transcripts, as I 
showed DIS3 had no effect on RDH pre-mRNA processing, this data suggests 
DIS3 is responsible for degrading unprocessed RDH transcripts. If DIS3 
specifically degrades extended RDHs, a possible mechanism for differentiating 
between them and properly processed RDHs may be attributed to differences in 
polyadenylation.  
From the data in chapters 2 and 4, there are a few similarities between 
RDH and snRNA misprocessed transcripts. For example, both RDHs and 
snRNAs do not appear to require cleavage for termination of extended transcripts 
(Figure 6.10 and 4.5). Additionally, DIS3 depletion causes a further increase in 
levels of RDH and snRNA extended transcripts, with either occlusion of U7 
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snRNP or Integrator dysfunction respectively (Figure 6.13 and 4.13). However, 
DIS3 depletion alone was capable of causing an increase in misprocessed 
snRNAs whereas there was no apparent effect on RDH transcripts. It is possible 
that misprocessing commonly occurs at snRNAs and DIS3 is responsible for 
degrading such transcripts. Therefore upon DIS3 depletion, misprocessed 
transcripts accumulate. Whereas processing of RDH pre-mRNA could be more 
tightly regulated or controlled, reducing the number of misprocessed transcripts 
in normal conditions. 14 different subunits have been found in the Integrator 
complex and RNAi depletion of nearly any subunit was found to disrupt snRNA 
processing in Drosophila (Ezzedine et al, 2011). This suggests Integrator subunit 
interactions are highly sensitive to disruption and could explain common 
misprocessing of snRNAs. Alternatively, DIS3 may have a role in snRNA 



















Endonucleases play an important role in the maintenance of the RNA 
environment, as well as the processing and termination of different RNA species. 
In particular, work has shown that the catalytic subunit of the exosome, DIS3, is 
important for degradation of a multitude of RNA species including those that 
currently don’t have a known role and may be a bi-product of efficient 
transcription, such as PROMPTs (Mitchell et al, 2014; Preker et al 2011). Another 
endonuclease, CPSF73, is known to have an important role in 3’ end cleavage of 
protein-coding mRNA and has been linked to efficient transcriptional termination 
(Proudfoot et al, 2011; Fusby et al, 2016; Eaton et al, 2018). Additionally, the 
catalytic subunit of the Integrator, INTS11, has an important role in 3’ end 
cleavage of snRNAs known to form the spliceosome (Baillat et al, 2005). However 
a lot is still unknown about the substrates of these endonucleases, as well as 
their exact roles and contributions to maintaining the RNA environment.  
Previous work to elucidate endonuclease roles in transcriptional 
termination and RNA metabolism have been limited by the available methodology 
such as RNAi, which can be slow, have indirect effects and incomplete levels of 
gene downregulation. In this work I have utilised the AID and SMASh systems to 
generate cell lines capable of conditional, rapid and specific target protein 
depletion of either DIS3, INTS11 or CPSF73. I was then able to investigate the 
roles of the target endonuclease by analysing RNA effects after protein depletion, 
through RNA-Seq. In so doing, this work has provided a broad view of the 
immediate substrates for these three endonucleases in human cells. Additionally, 
the results from RNA-Seq of CPSF73-AID cells has provided further support for 
the importance of CPSF73 cleavage of protein-coding mRNA in transcription 
termination, giving support to the torpedo model of transcriptional termination.  
 
7.1 Rapid and conditional protein depletion 
The auxin inducible degron system was first discovered in plants, whereby 
it is used to mediate gene expression to regulate plant growth and development 
(Dharmasiri et al, 2005). The AID system utilises the plant specific F-box protein, 
TIR1, which forms a E3 ubiquitin ligase complex with SCF. As the SCF complex 
is also expressed in non-plant species, through the expression of TIR1 in human 
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cells, the AID system can be employed for ubiquitin-mediated proteome 
degradation and as a genomic manipulation tool (Nishimura et al, 2009; Holland 
et al, 2012). Due to developments in CRISPR/Cas9 technologies, it is now 
possible to integrate the AID tag into human target genes and thus allow their 
conditional protein depletion (Natsume et al, 2016).  
In this thesis I have shown that incorporation of an AID tag to a gene of 
interest, in human cells expressing TIR1 protein, results in a rapid, specific and 
inducible depletion of the target protein. Protein depletion occurs upon auxin 
addition and utilising this system I was able to significantly decrease DIS3 levels 
in DIS3-AID cells after 1 hour of auxin treatment (Figure 3.3) (Davidson et al, 
2019). Importantly, only AID-tagged protein levels are affected by auxin addition 
and this requires TIR1 expression, as shown by auxin having no effect on 
untagged protein levels nor when TIR1 is not expressed (Figure 3.3 and 5.1). 
Furthermore, auxin does not affect cell survival of untagged cells and AID-tagging 
the DIS3 protein also had no effect on cell survival, although a slower growth 
phenotype was observed (Figure 3.5).  
There are several reasons why the AID system may be more beneficial 
that RNAi. Firstly, as previously mentioned, the AID system has a faster rate of 
protein depletion than RNAi methods. Secondly, RNAi methods are known to 
have limitations due to off-target effects. Using connectivity maps, Smith et al 
(2017) found that RNAi protein depletion resulted in stronger and more pervasive 
off-targets than generally appreciated, whereas off-target effects from CRISPR 
methods were negligible. Additionally, RNAi methods have been found to 
produce false negative results or reduced phenotypes due to incomplete 
depletion of the target protein (Eaton et al, 2018). Finally, as shown by RNA-Seq 
on my DIS3-AID cells, the AID system was capable of elucidating more RNA 
targets than previous RNAi experiments (Szczepinska et al, 2015). Overall the 
AID system may be able to enhance our knowledge of specific gene targets and 
functions, through easier investigation of immediate depletion effects, that have 






7.2 DIS3 is responsible for degradation of a multitude of RNA transcripts 
DIS3 is a major catalytic component of the exosome, consisting of both 
exonuclease and endonuclease activity (Schaeffer et al, 2009; Schneider et al, 
2009). EXOSC10 is the other catalytic subunit of the exosome and it has been 
proposed that both EXOSC10 and DIS3 degrade separate RNA transcripts. For 
example, DIS3 has been shown to degrade numerous unstructured RNA 
transcripts whereas EXOSC10 may specifically degrade smaller RNAs including 
pre-rRNA and snoRNAs (Szczepinska et al, 2015; Januszyk et al, 2011). As part 
of the exosome, these two proteins may also show redundancy for each other 
and as such it has been difficult to elucidate and categorise specific substrates 
for either nuclease. In an attempt to overcome such issues, I utilised the AID 
system to enable rapid depletion of DIS3. This allowed investigation of the 
immediate effects of DIS3 loss, potentially before activation of redundancy 
pathways that could be mediated by EXOSC10.  
Through RNA-Seq analysis, I was able to identify accumulation of 
numerous RNA targets upon DIS3 depletion (Chapter 3). These included 
PROMPT RNAs that derived from bidirectional transcription at protein-coding 
gene promoters and RDH promoters (Figure 3.6 and 6.7). Levels of short RNAs 
derived from premature transcription termination also accumulated upon DIS3 
loss. Additionally, an upregulation of de novo transcripts from intergenic 
transcriptome regions where bidirectional transcription occurs and were similar 
to eRNAs, was observed. This experiment detected more DIS3 dependent 
accumulation of potential eRNAs and novel transcripts than previously reported 
(Szczepinska et al, 2015). The diverse range of DIS3 sensitive RNA substrates 
shown throughout this work supports previous suggestions that DIS3 is 
responsible for the majority of RNA degradation by the exosome (Dziembowski 
et al, 2007; Szczepinska et al, 2015).  
Interestingly, DIS3 may not be responsible for RDH mRNA degradation. 
DIS3 depletion had no effect on mature RDH levels but instead had a cumulative 
effect with U7 snRNA occlusion on extended RDH transcript levels (Figure 6.12 
and 6.13). Therefore, DIS3 may specifically degrade misprocessed RDH 
transcripts. These findings do not necessarily mean that the exosome is not 
involved in mature RDH degradation however. Instead, EXOSC10 may be the 
nuclease responsible for exosome mediated RDH mRNA degradation. Andersen 
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et al (2013) found mature RDH transcripts accumulate upon depletion of a core 
exosome subunit, RRP40. Similarly, depletion of another core exosome subunit, 
RRP41 or EXOSC10 slowed histone mRNA degradation (Mullen and Marzluff, 
2008). Furthermore, data from Slevin et al (2014) suggests mature RDHs are 
degraded in two phases. Firstly, degradation into the stem loop by the 3’ – 5’ 
exonuclease 3’hExo, resulting in the formation of a degradation intermediate. 
Secondly, the intermediate is degraded by the exosome containing EXOSC10. 
These findings suggest the exosome does have a role in degradation of mature 
RDHs and therefore EXOSC10 may be responsible instead of DIS3.  
 
7.3 The role of DIS3 in snRNA transcription and degradation 
Through RNA-Seq analysis and qRT-PCR I was able to show that DIS3 
plays a role in snRNA metabolism. Depletion of DIS3 alone resulted in an 
accumulation of extended snRNAs (Figure 4.9 and 4.10). An explanation for this 
would be a role of DIS3 in snRNA 3’ end processing; however I believe this is 
unlikely. There are no previous reports showing evidence of a role for DIS3 in 3’ 
end snRNA processing, except for in budding yeast (Allmang et al, 1999). 
Additionally, the average snRNA extension effect observed upon DIS3 depletion 
(approximately 500 bp downstream) is not as pronounced as when INTS11 is 
depleted (approximately 1 Kb downstream) (Figure 4.10 and Figure 4.5). 
Although there is an increased accumulation of extended snRNA transcripts upon 
DIS3 and INTS1 depletion together, compared to either alone, the length of 
extension is unaltered (Figure 4.13).  Instead I hypothesise DIS3 has a major role 
in degradation of snRNA precursor or misprocessed transcripts. This is supported 
by the data showing a greater accumulation of precursor snRNAs upon DIS3 
depletion when transcription is inhibited by actinomycin D, compared to the 
presence of DIS3 (Figure 4.12). Depleting DIS3 causes a reduction in snRNA 
precursor degradation, resulting in their increased levels.  
This does not fully explain why extended snRNAs are apparent upon DIS3 
depletion. I propose that the Integrator is not fully efficient at cleaving snRNA at 
their TES and that due to this, extended snRNAs are commonly generated. DIS3 
is responsible for degradation of these misprocessed transcripts, hence why they 
aren’t normally visible in the cell and their accumulation is observed upon DIS3 
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depletion. Rapid degradation of misprocessed snRNAs is important to prevent 
them entering the normal snRNA biogenesis pathways and sequestering 
mechanisms from correctly processed snRNAs. It is possible that the Integrator 
may still cleave extended snRNAs upon DIS3 depletion, just further downstream 
than at mature snRNAs. Whereas upon INTS11 depletion, the Integrator cannot 
cleave the snRNA and so readthrough is longer. This might explain why the 
observed extended transcripts are on average shorter upon DIS3 depletion than 
INTS11 depletion.  
In support of this hypothesis is the work by Labno et al (2016), who 
investigated the role of DIS3L2. DIS3L2 has a similar sequence to DIS3, however 
it lacks the PIN domain, is not known to be a subunit of a macromolecular 
complex and localises to the cytoplasm where it degrades RNA in an exosome-
independent manner (Lubas et al, 2013). Labno et al (2016) generated HEK293T 
cell lines expressing shRNAs that were capable of silencing endogenous DIS3L2 
and either had inducible expression of WT DIS3L2 or a catalytically dead mutant. 
Upon DIS3L2 dysfunction there was an accumulation of cytoplasmic extended 
snRNAs, without a change in mature snRNA levels. As DIS3L2 is not present in 
the nucleus, it is likely that it has a major role as a surveillance pathway for 
cytoplasmic misprocessed precursors. This and the presence of extended 
snRNAs in the cytoplasm without Integrator dysfunction, gives support to 
misprocessing of snRNAs being a common occurrence. If snRNA readthrough is 
frequent, the cell may have adapted mechanisms to ensure termination of 
misprocessed snRNAs and might help explain why termination still occurs close 
to the TES upon Integrator subunit depletion.  
 
7.4 How does DIS3 recognise target substrates for degradation?  
How DIS3 recognises specific RNA substrates and prevents accumulation 
of aberrant mRNAs and potentially toxic protein products, is currently unclear. 
This is an important question when considering transcripts that undergo the same 
processing steps and have a similar structure to mature RNAs, for example 
PROMPTs which have a 5’ cap and are polyadenylated (Preker et al, 2011). As 
previously described in Chapter 1, human cells contain a NEXT complex that has 
been shown to promote degradation of PROMPTs and 3’ extended RNAs and a 
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PAXT complex that promotes degradation of long poly(A) tailed transcripts 
(Lubas et al, 2011; Tseng et al, 2015; Hrossova et al, 2015; Meola et al, 2016). 
Both of these complexes contain the RNA helicase MTR4, that acts as a complex 
scaffold and can also associate with EXOSC10 (Lubas et al, 2011; Meola et al 
2016). Therefore, through MTR4 mediated exosome interaction with the PAXT or 
NEXT complex, the exosome may be targeted to specific RNA substrates. 
Specifically, DIS3 may be targeted to prematurely terminated transcripts by PAXT 
or NEXT, which associate with ARS2 (Anderson et al, 2013; Meola et al, 2016). 
ARS2 further associates with the CBC (to form CBCA) to recruit protein 
complexes involved in 3’ end processing, maturation and degradation (Gruber et 
al, 2009; Hallais et al, 2013; Andersen et al, 2013). Iasillo et al (2017) found 
pervasive transcript turnover was supported by ARS2 function and that ARS2 
also had a role in termination downstream of short snRNAs, RDHs, PROMPTs 
and eRNAs. Depletion of CBCA components ARS2 and CBP80, resulted in 
accumulation of 3’ extended RDH transcripts and PROMPTs. Polyadenylated, 
longer replication-independent histone gene levels were not significantly altered 
by this depletion (Andersen et al, 2013). Andersen et al (2013) also demonstrated 
a physical link between the NEXT complex and CBCA and therefore suggested 
a link from the cap to the exosome. These findings demonstrate that exosome 
interactions with associated accessory factors may mediate exosome target 
specificity. 
 In addition, the work presented in this thesis suggested DIS3 may 
specifically degrade extended RDH transcripts and not mature RDHs (Figure 6.7, 
6.12 and 6.13). As mature RDHs are not polyadenylated but extended RDH 
transcripts are, it is possible that hyperadenylation may induce DIS3-mediated 
decay (Narita et al, 2007; Romeo et al, 2014). Misprocessing of snRNAs has also 
been shown to result in their polyadenylation (Skaar et al, 2015; Yamamoto et al, 
2014). Interestingly, Bresson and Conrad (2013) suggested that the nuclear 
poly(A) binding protein promotes hyperadenylation and decay of unstable 
transcripts. In support of our findings, Romeo et al (2014) observed exosome 
mediated degradation of extended polyadenylated RDH transcripts. As many 
histone genes contain PASs downstream of their cleavage sites, they suggested 
that polyadenylation of misprocessed RDH transcripts might be a mechanism to 
prevent readthrough into neighbouring RDH genes. Due to the closely clustered 
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location of RDH genes, readthrough could generate deleterious fusion proteins. 
Polyadenylation may therefore be a signal for misprocessed transcript 
degradation.  
It has also been shown that PROMPT poly(A) signals are functional but 
linked to degradation (Ntini et al, 2013). There is a higher amount of PASs located 
upstream of protein-coding gene promoters than downstream, allowing efficient 
Pol II progression along the protein coding gene and helping to prevent 
bidirectional transcription (Ntini et al, 2013). Interestingly mRNA-like PASs are 
also frequently found downstream of snRNA and RDH genes (Almada et al, 
2013). It is possible that polyadenylation of small transcripts such as RDHs, 
snRNAs and PROMPTs, which all showed DIS3 sensitivity in this work, results in 
their termination, whereas polyadenylation of longer transcripts, such as mRNAs, 
increases stability. Ntini et al (2013) found that promoter-proximal PASs more 
efficiently couple to exosome mediated degradation than RNAs with longer 
transcription units. Additionally, Hallais et al (2013) suggested that cap-proximal 
PASs processed by CBCA lead to RNA degradation through recruitment of NEXT 
and the exosome. As PROMPTs, snRNAs and RDH transcripts are all relatively 
short, this might explain how their polyadenylation could link to their efficient 
degradation. As previously mentioned, ARS2 may help couple the exosome to 
target transcripts and ARS2 binding was found to be enriched at terminator 
regions of RDH and snRNA genes (Andersen et al, 2013).  
 
7.5 snRNA cleavage by the Integrator and transcription termination 
It is known that the Integrator has a pivotal role in 3’ end processing of 
snRNA and that the endonuclease subunit, INTS11, is thought to be responsible 
for snRNA cleavage (Baillat et al, 2005; Ezzedine et al, 2011; Dominski et al, 
2005; Abrecht and Wagner, 2012). Depletion of Integrator subunits including 
INTS11 and INTS1 causes accumulation of misprocessed snRNAs and in this 
work I have provided further support for these findings (Figure 4.5 and 4.7) 
(Ezzedine et al, 2011; Baillat et al, 2005; Hata and Nakayama, 2007). Although 
the mechanism of snRNA termination is not fully understood, previous work has 
suggested a strong link between snRNA processing and efficient transcription 
termination (Ramamurthy et al, 1996; O’Reilly et al, 2014). However, my results 
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are contradictory to these findings. Instead I found that extended snRNAs, 
caused by INTS11 or INTS1 depletion, are still capable of termination (Figure 4.5, 
4.6 and 4.7). This termination occurs within 1 – 3 Kb downstream of the snRNA 
TES, suggesting that integrator cleavage of snRNAs is not tightly linked to snRNA 
termination. One possible explanation for these apparent differences in my work 
compared to O’Reilly et al (2014) could be due to methodology.  
O’Reilly et al (2014) depleted INTS11 and INTS9 Integrator subunits using 
RNAi methods in HeLa cells. They then investigated Pol II occupancy levels 
downstream of the TES for U1 and U2 snRNAs, however they only investigated 
0.9 Kb and 1.2 Kb downstream respectively. An increase in Pol II % input was 
found downstream of the snRNA genes upon Integrator subunit depletion. 
Comparing these results with my data, I observed increased RNA levels 
downstream of snRNAs, often up to 1.2 Kb. This would corroborate with an 
increased Pol II occupancy at these locations, as seen by O’Reilly et al (2014). 
However, my data suggests termination of extended snRNAs by 1 – 3 Kb 
downstream of the TES and as such would expect Pol II occupancy to deplete 
within this window. Therefore it is possible that extended snRNA termination, as 
shown by reduced Pol II occupancy, may have been observed by O’Reilly et al 
(2014) if they had investigated further downstream of the snRNA TES. Overall, 
both of our findings show an extension of snRNA transcription upon defective 3’ 
end snRNA processing, although I have shown termination still occurs. 
Therefore, Integrator cleavage of snRNAs may promote efficient transcription 
termination but not be necessary.   
 
7.6 Is there a secondary endonuclease responsible for RDH cleavage? 
RDH pre-mRNA is cleaved at the 3’ end by the HCC complex, to form 
mature RDHs. The HCC is composed of multiple proteins including CPSF73, 
CPSF100 and Symplekin (Yang et al, 2013; Kolev et al, 2005). It is thought that 
CPSF73 endonuclease activity is responsible for histone processing, with 
cleavage occurring between the stem loop and HDE regions of the RDH gene 
(Yang et al, 2013; Dominski et al, 2005; Kolev et al, 2008; Sullivan et al, 2009). 
However, in this work I unexpectedly observed no effects on RDH pre-mRNA 
processing when CPSF73 was depleted in the CPSF73-AID cell line (Figure 6.1, 
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6.3 and 6.5). This is in contrast to findings by Pettinati et al (2018) who found at 
least 27 RDHs were misprocessed upon CPSF73 depletion.  
Comparing my data with Pettinati et al (2018) I could directly analyse the 
same RDHs as in their study. Pettinati et al (2018) found a major effect of CPSF73 
depletion on the processing of the following histone genes that I did not see any 
effect for in my CPSF73-AID cell line: HIST1H4B, HIST1H3B, HIST1H2BC, 
HIST1H2BF and HIST1H4E (Figure 6.1 and 6.3). As the observed misprocessing 
of these RDHs was approximately a 200 bp extension, I further analysed three 
histones (HIST1H4B, HIST1H3B and HIST1H2BC) more closely to ensure I had 
not visually overlooked any effect (Figure 6.5). However, I was still not able to 
detect any misprocessing effect at these RDHs upon CPSF73 depletion.  
The discrepancies between these two works could be due to a number of 
reasons. Firstly the methodology used, with Pettinati et al utilising RNAi methods 
to deplete CPSF73 in HeLa cells synchronised in early S-phase. Readthrough 
RDH transcripts may not have been detected in my work due to the use of 
unsynchronised cells and the rapid turnover of RDHs at the end of S phase 
(Marzluff et al, 2008). However, the major effect on RDH pre-mRNA processing 
observed with occlusion of U7 snRNA in the same cells would argue against this. 
Additionally, misprocessing of RDHs results in polyadenylated transcripts that are 
stable throughout the cell cycle and thus making their detection easier (Kari et al, 
2013; Romeo et al, 2014; Levine et al, 1987).  Another possible reason is 
CPSF73 was not fully depleted upon doxycycline and auxin addition, however the 
depletion appeared near complete by western blot and was sufficient for major 
aberrant processing of mRNA (Figure 5.1 and 5.2).  
From my results, CPSF73 may not be the main endonuclease for RDH 3’ 
end cleavage, although many studies have shown otherwise (Yang et al, 2009; 
Dominski et al, 2005; Yang et al, 2013; Sullivan et al, 2009; Kolev et al, 2008). 
Therefore it may be more likely another protein shows redundancy upon CPSF73 
depletion or that CPSF73 and another endonuclease act at individual sets of 
RDHs. A potential candidate for this is MBLAC1, an endoribonuclease that has a 
similar MBL domain to CPSF73 but with distinctive structural features, including 
the absence of a b-CASP domain found in CPSF73 (Pettinati et al, 2018). These 
differences could reflect specific substrate recognition. Depletion of MBLAC1 by 
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CRISPR/Cas9 techniques or siRNA resulted in readthrough RDH transcripts, 
showing a similar profile of effects to CPSF73 depletion (Pettinati et al, 2018).  
 
7.7 Endonuclease depletion results in extended RNA transcripts that 
terminate at different lengths, depending on the RNA species. 
Throughout this work I have shown that extended transcripts are 
generated when processing is disrupted or accumulate upon dysfunction of 
degradation pathways. Specifically I have shown there is an accumulation of 
extended snRNA transcripts upon DIS3 or INTS11 depletion; accumulation of 
extended RDH transcripts upon U7 snRNA occlusion, which is exacerbated by 
DIS3 depletion; and continuous readthrough of protein-coding genes upon 
CPSF73 depletion. This extension of snRNAs, RDHs and mRNAs is due to 
disruption in their processing, specifically the 3’ end cleavage of these transcripts. 
Although misprocessed snRNA and RDH transcripts extend, they terminate 
relatively close to their TES; whereas misprocessed mRNA transcripts show 
readthrough that can continue for > 400 Kb (Figure 4.5, 6.10 and 5.4). It may be 
that 3’ end cleavage and processing is tightly coupled to termination of mRNA 
transcripts, but not as much with snRNAs or RDH mRNA.  
For RDHs, it has been shown that misprocessing results in 
polyadenylation of extended transcripts (Narita et al, 2007; Romeo et al, 2014). 
In this work, CPSF73 depletion did not appear to affect processing of RDHs, 
however preventing U7 snRNA binding to the HDE caused RDH mRNA 
extension. As previously described another endonuclease may be responsible 
for RDH pre-mRNA cleavage: MBLAC1 (Pettinati et al, 2018). Either way, U7 
snRNA-dependent extended RDH transcripts terminated closely to the TES and 
this may be due to the presence of a downstream PAS site. As CPSF73 is still 
present it may cleave extended RDH transcripts at downstream PASs, resulting 
in both polyadenylation and termination. PASs have been found downstream of 
both snRNAs and RDH genes with misprocessed snRNAs also showing 
polyadenylation (Almada et al, 2013; Skaar et al, 2015; Yamamoto et al, 2014). 
Therefore, snRNAs may undergo a similar process where disrupting their 
canonical Integrator mediated cleavage instead causes CPSF73-mediated 
cleavage at a downstream PAS and termination. It is also possible a nuclease 
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other than CPSF73 enacts at these downstream PAS sites. Overall, this would 
explain the short extension of both RDHs and snRNAs observed throughout this 
work. Whereas long mRNA extension cannot be terminated at downstream PASs 
due to the loss of CPSF73, hence extension continues until RNA Pol II 
dissociates from the genome.  
The fact that mRNAs show profuse extension upon CPSF73 depletion 
strongly suggests that PAS cleavage and CPSF73 are detrimental for 
termination. This supports the XRN2 torpedo model of transcription termination 
and previous work from the West lab (Eaton et al, 2018). Interestingly, although 
snRNAs are cleaved by the Integrator, resulting in an entry site for a 5’ – 3’ 
exonuclease, there is currently no evidence that XRN2 has a role in snRNA 
transcription termination (O’Reilly et al, 2014; Eaton et al, 2018). Likewise, RDH 
pre-mRNA cleavage provides possible entry for XRN2, but no role for XRN2 in 
RDH termination has been observed (Eaton et al, 2018).  
Another reason why extended snRNAs may terminate close to their TES 
is due to the higher number of nucleosomes present 1 Kb downstream of the 
snRNA coding region (Egloff et al, 2009; O’Reilly et al, 2014). Nucleosomes can 
prevent efficient transcription and have been shown as early mRNA transcription 
quality checkpoints, causing premature termination through cleavage at cryptic 
PASs close to the TSS (Chui et al, 2018). This mechanism may be responsible 
for the production of prematurely terminated transcripts that accumulated upon 
DIS3 depletion (Figure 3.6 and 3.8). Alternatively, other work has shown intronic 
cryptic PASs can prematurely terminate mRNA transcription (Kaida et al, 2010; 
Berg et al, 2012). The nucleosome-free region in mRNA is only approximately 
100 nts from the TSS, whereas it spans the entire snRNA transcription unit 
(Schones et al, 2008; Segal et al, 2006; Egloff et al, 2009). As described in the 
introduction, NELF promotes Pol II pausing at promoter-proximal mRNA sites and 
NELF phosphorylation, along with CTD and DSIF phosphorylation, is required for 
the transition to productive elongation (Ping and Rana, 2001; Peterlin and Price, 
2006; Kwak and Lis, 2013). In contrast, at snRNA genes NELF is recruited to Pol 
II as it reaches the nucleosome dense area, coinciding with the end of the 
transcription unit. Depletion of NELF causes extension of snRNAs past the TES, 
although these transcripts still terminate (Egloff et al, 2009; O’Reilly et al, 2014). 
NELF mediated Pol II pausing on snRNAs and / or nucleosomes acting as a 
199 
 
barrier to transcription may promote snRNA transcription termination over 
continued elongation. This process of termination may not require Integrator-
mediated snRNA cleavage and therefore may also be sufficient for termination of 
extended snRNA transcripts.  
 
7.8 Future work and limitations 
This work provided a clearer role for three individual ribonucleases, DIS3, 
INTS11 and CPSF73, through the analysis of genome-wide substrate effects 
upon their depletion. In terms of DIS3 and CPSF73, as little as 2 hours of 
depletion was sufficient for significant observable substrate perturbation in 
processing, termination and degradation events. This demonstrates both the 
effectiveness of the AID system to study functional genomics and the essential 
role of these endonucleases. However, the findings within this study have left 
some unanswered questions and generated new ones.  
One issue of this study is that of protein redundancy, in particular when 
discussing DIS3 function in the exosome complex. As DIS3 is not the only active 
nuclease in the exosome complex, it is difficult to determine whether no effect 
upon DIS3 depletion translates into a non-exosome mediated degradation 
pathway. Specifically, an accumulation of mature RDH transcripts was not 
observed upon DIS3 depletion. However I cannot rule out the possibility that 
EXOSC10 and, therefore the exosome, plays a role. In addition, it has been 
shown that the exosome can exist in different isoforms, with either DIS3 binding, 
EXOSC10 binding or both together (Lykke-Andersen et al, 2011). Therefore, 
further work is required to elucidate the specific composition of the exosome 
when degrading different classes of RNA substrates. This would potentially aid in 
determining degradation pathways for specific RNAs.  
 In this discussion I have speculated on how extended transcripts may still 
terminate when their 3’ end processing pathways are disrupted. A potential 
mechanism I described was that of downstream PAS cleavage by CPSF73 in 
RDH and snRNA extended precursors. It would therefore be interesting to further 
investigate this through depletion of CPSF73 coupled with the depletion of 
necessary proteins for 3’ end cleavage of snRNAs and RDHs, for example 
INTS11 and U7 snRNA respectively. If a longer extension of transcripts was 
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observed, this may suggest PAS cleavage is responsible for misprocessed 
transcript termination.  
Although I was able to look at indirect effects of Integrator dysfunction 
through the occlusion of U7 snRNA, it would be interesting to determine if direct 
depletion of Integrator subunits affected RDH pre-mRNA processing. In particular 
due to previous reports of Integrator subunit binding to the 3’ end of RDHs and 
accumulation of misprocessed RDH transcripts upon INTS1 depletion (Skaar et 
al, 2015). Unfortunately, this was something not addressed in this work due to a 
lack of RDH mRNA expression in the INTS11-SMASh RNA-Seq dataset.  
As CPSF73 depletion did not appear to have an effect on RDH pre-mRNA 
processing in this work, it will be important to further determine the role of 
CPSF73 in RDH transcription. Whether a protein such as MBLAC1 shows 
redundancy to CPSF73 or unsynchronised cells caused the lack of an observed 
effect, may need to be elucidated. Furthermore, whether prolonged periods of 
CPSF73 depletion could help determine CPSF73 function. Prolonged auxin or 
asunaprevir treatment may be beneficial for all three endonucleases investigated 
here, to provide a greater insight into the impact of their depletion over multiple 
rounds of transcription. This may also uncover potential redundant pathways for 
endonuclease function, that are not apparent when investigating nascent 
transcripts upon short protein depletion times.  
Although this study has provided insight into the role and substrates of 
three endonucleases, there are limitations to the methodology and results. Firstly, 
it is important to note that due to the expense of RNA-Sequencing, I was only 
able to conduct 2 repeats of RNA-Seq for both DIS3 and CPSF73 depletion, or 
in the case of INTS11 only 1 repeat. In particular for INTS11 this makes the 
results less reliable as I am not able to show reproducibility. Additionally, a further 
repeat would have allowed investigation of statistical significance of findings for 
DIS3 and CPSF73. However, where possible I have aimed to provide another 
method to investigate the accuracy and significance of results found by RNA-
Seq, often through the use of RT-qPCR. This method has its own caveats, as in 
this study I only used one housekeeping gene to normalise RT-qPCR results. To 
improve the reliability of RT-qPCR results, multiple housekeeping genes could 
have been utilised.  
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Secondly, in this work there has been a focus on both protein-coding 
genes and smaller transcripts such as snRNAs and RDHs. I initially aimed to look 
at the global effects of the target protein depletion on RNA through RNA-Seq and 
therefore utilised 50 nt reads for the RNA sequencing library preparation. 
However, this resulted in limitations for detection of smaller RNAs, as they were 
not always expressed in the RNA-Seq data. To overcome this issue and for 
further investigation specifically into changes of small RNA expressions I would 
suggest a small nuclear RNA-Seq method was instead used. Furthermore, due 
to the original aims of the research, expression levels of RDHs were not enriched 
for in experiments. This made some of my findings on RDH transcription and 
termination difficult to differentiate between an actual effect or due to natural 
fluctuating RDH transcript levels in relation to cell cycle phase. To investigate, in 
particular, the findings of CPSF73 depletion having no effect on RDH 
transcription, I would in the future ensure synchronisation of cells in S phase for 
all experiments. Finally, all research conducted in this work only utilised one cell 
type, those of a human colorectal carcinoma cell line, HCT116 cells. Therefore it 
is possible that some or all results are artefacts of this particular cell line. Further 
work should be undertaken to validate these findings in other human cell lines, 
before results are determined to be accurate in all human cells.  
 
7.9 Conclusions 
 Overall, the findings within this work have shown that disruption of 
cleavage at the 3’ end of multiple transcripts results in aberrant extended 
transcripts of differing lengths. Some of these extended transcripts may not only 
be produced when cleavage is disrupted but may also occur under normal 
circumstances. For example, extended snRNA transcripts were observed to 
accumulate upon depletion of DIS3 (Figure 4.10). Although this could be due to 
DIS3 having a role in snRNA 3’ end cleavage and termination, as previously 
mentioned it is more likely that DIS3 normally degrades these extended snRNAs. 
An interesting finding in this study is the length of extension observed for 
transcripts upon cleavage disruption. It appears disruption of cleavage 
mechanisms for longer RNA transcripts, such as CPSF73 depletion effects on 
protein-coding mRNAs, show extension past the TES that continues for 
thousands of Kb (Figure 5.4). In comparison, shorter transcripts show extension 
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that terminates relatively close to the TES and does not continue indefinitely i.e. 
extension of snRNAs and RDHs upon Integrator and U7 snRNA dysfunction 
(Figure 4.5 and 6.10).  
There are a couple of mechanisms that may explain these differences in 
extension between different RNA species. In summary, it is possible that 
transcription of shorter transcripts, such as snRNAs, commonly produce 
extended transcripts due to inefficient cleavage and / or termination and are 
normally rapidly degraded. Therefore, cells may have innate mechanisms in 
place to prevent termination extending indefinitely at these transcripts. For 
example the use of redundant cleavage mechanisms, such as CPSF73 and 
MBLAC1 at RDHS, or possible feature found downstream of the TES including 
an increased number of nucleosomes that could impede further Pol II 
transcription. Furthermore, during transcription of shorter transcripts the 
transcribing Pol II does not enter an elongation phase and the resulting 
phosphorylation state of Pol II differs to that of elongating Pol II on protein-coding 
genes (ref). Due to this, Pol II may be capable to more readily dissociate at shorter 
transcripts if extension / inefficient transcription termination does occur. On the 
other hand, Pol II transcribing longer transcripts results in an elongation state that 
may not be as easily terminated if normal termination mechanisms fail or falter, 
therefore extension readily occurs and continues.  
Finally, this work further supports findings that the exosome, and in 
particular the DIS3 subunit, is responsible for degradation of a number of RNA 
substrates including de novo transcripts found in this study. Using conditional 
protein depletion cell lines I have been able to elucidate specific roles and 
substrates of DIS3, INTS11 and CPSF73. Although future work is necessary to 
investigate several unanswered questions, the results throughout this study show 
the effectiveness of using CRISPR/Cas9 techniques with an AID system for 
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